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ABSTRACT OF DISSERTATION

KEY ROLES OF SUB-CELLULAR MEMBRANES AND CO-CHAPERONE IN
TOMBUSVIRUS REPLICATION
Positive strand RNA viruses, inculding tombusviruses, are known to utilize
cellular membranes to assemble their replicase complexes (VRCs). Two tombusviruses ,
Tomato bushy stunt virus (TBSV) and Carnation Italian ringspot virus (CIRV), replicate
on different organellar membranes, peroxisomes or endoplasmic reticulum (ER) for
TBSV and mitochodria outer membranes in case of CIRV. I showed that both TBSV and
CIRV replicase proteins could assemble VRCs and replicate viral RNA on purified
microsomes (ER) and mitochondria. Different efficiencies of assembly was shown
determined by multiple domains on TBSV or CIRV replication proteins.
To study why VRC assembly could occur on an alternative organellar
membranes, I focused on the phospholipids, key lipid components in ER or mitochondria
membranes. Phospholipids directly interact with viral replicases, however, their specific
roles during (+)RNA virus replication are far less understood. I used TBSV as a model
(+) RNA virus, and established a cell-free TBSV replication system using artificial
membranes
prepared
from
different
phospholipids.
I
showed
that
phosphatidylethanolamine (PE) is required for full cycle replication of the viral
RNA.Moreover, PE is enriched at the sites of TBSV replication in plant and yeast cells,
and was up-regulated during TBSV replication. Furthermore, up-regulation of total
cellular PE content in yeast due to deletion of CHO2 leads to dramatically stimulated
TBSV replication. Overall, I identified PE as the key lipid component of membranes
required for TBSV replication, and my data highlighted that PE, an abundant
phospholipid in all eukaryotic cells, not only serves as a structural component of
membrane bilayers, its interaction with the viral replication proteins also stimulates
(+)RNA virus replication. Further experiments indicated both early secretory pathway
and endocytic pathway are involved in PE re-distribution to site of replication.
In addition to lipids and subcellular membranes, certain host proteins are also
involved in (+) RNA virus replication and VRC assembly. I identified Hop-like stressinducible protein 1 (Sti1p), which interacts with heat shock protein 70, is required for the

inhibition of CIRV replication. My findings indicate that Hop/Sti1 co-chaperone could
act as a virus restriction factor in case of mitochondrial CIRV, but not against
peroxisomal tombusvirus.
KEY WORDS: Positive strand RNA virus, phospholipids, phosphatidylethanolamine,
subcellular membrane, Sti1p
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Chapter 1

INTRODUCTION
1.1 Tombusviruses

The group of tombusvirus belongs to positive strand RNA virus that replicate their
genomes in a wild range of plant hosts (1). Tomato bushy stunt virus (TBSV) is the
prototypical species in the Tombusvirus genus and tombusviridae family. TBSV has a
single-stranded positive-sense RNA genome of ~4800 nucleotides long(1). Its RNA
genome is highly structured with 5' non-capped end, 3' non-polyadenylated end, as well
as many internal RNA elements which functions in viral protein translation enhancement,
viral replicase complex assembly and replication (1-4).
TBSV encodes five viral proteins (1), the replication proteins p33 and p92; a
capside protein p42, movement protein p22 and a suppressor of gene silencing p19. p33
and p92 are both required for viral replication (1). The sequence of p33 overlaps with Nterminal part of p92, and functions as auxiliary replication cofactor (5, 6), which is
involved in template RNA recruitment(3) and replicase complex assembly (4) with RNA
chaperone function (7). The p92 protein is a read-through product of p33, and has RNA
dependent RNA polymerase (RdRp) activity. Both p33 and p92 have two transmembrane domains(8, 9), which are predicted to be inserted into sub-cellular membranes
and expose the N-terminal and C-terminal, including RdRp, regions of replication
proteins to the cytosolic side of membranes. Besides association with the membrane, p33
and p92 could interact with each other through S1 and S2 p33:p33/p92 interaction
1

domains. This interaction leads to multimerization of replication proteins which is
important for TBSV replication (10, 11).
Tombusviruses have been developed as model viruses for studies of (+)RNA
virus replication in yeast (5, 12, 13). The tombusvirus system is based on transreplication of a defective interfering (DI) RNAs in the presence of replication proteins
p33/p92. DI RNAs are defective viral RNAs containing noncontiguous regions of the
viral RNA genome due to recombination events (5, 14-17). In the yeast system, p33 and
p92 are expressed from plasmids and support the replication of DI-72, the model replicon
(13).
Carnation italian ringspot virus (CIRV) is another tombusvirus in the same genus
and shows high sequence similarity with TBSV (14). Unlike TBSV, which use
peroxisome membrane for replicase assembly(18), CIRV assembles its replicase complex
on mitochondrial outer membrane (9, 19). Studies revealed that short motifs in TBSV and
CIRV replication proteins p33/p92 (TBSV) or p36/p95 (CIRV) are required for replicase
targeting to peroxisome (18) or mitochondria (19).

1.2 Subcellular locations of positive strand RNA virus replication

Positive strand RNA viruses are the largest group among the seven virus genetic classes
(20). They cause many diseases in human history. Egyptian tombstone as early as 1500
BC recorded a priest having typical poliovirus infection syndrome of poliomyelitis (21).
Recent epidemic of hepatitis C virus (22-25), dengue virus (26), West Nile virus (27, 28),
severe acute respiratory syndrome (SARS) virus (29, 30) and many economically
2

important animal and plant viruses highlight the importance of understanding the positive
strand RNA virus life cycle, and urgency of the discovery of novel medicines for curing
viral diseases.
Positive strand RNA viruses share some common features: i) single-stranded
RNA genome harboring ORFs on the sense-polarity (20, 31); ii) RNA genome replication
occurs within specific sub-cellular membrane compartments of their eukaryotic host cells
(15, 18, 20, 31-33); iii) Virion assembly often couples with genome replication (34-36).
iv) Use of (-)RNA only as a template for asymmetrical replication. (37)
Despite the common feature of membrane association of (+)RNA viruses,
subcellular locations of (+)RNA virus replication vary drastically throughout the whole
endomembrane systems, including endoplasmic reticulum (ER) or ER derived replication
organelles for bromovirus (38), potyvirus (38), flavivirus (34, 39, 40), arterivirus (41) and
coronavirus (35); ER-Golgi intermediate compartment (ERGIC) for enterovirus (33);
endosome for alphavirus (42); vacuole for Alfamovirus (43, 44) and tobamovirus (45);
peroxisome for tombusvirus (18); mitochondria for nodavirus (46), carmovirus (47) and
tombusvirus (48).
Questions were raised for these many replication sites. Why do (+)RNA viruses
need to explore so many different locations for replication? Are selection of these sites
random events during evolution, or some specific protein or lipid factors are determinants
of subcellular membrane selectivity of different (+)RNA viruses? Is there any common
pathway connecting different replication sites of (+)RNA viruses?
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Tombusviruses are used as model viruses to address these questions. As two
closely related viruses in genus of tombusvirus, TBSV and CIRV replicate in distinct
subcellular locations (peroxisome and ER for TBSV, mitochondria for CIRV) (9).
In a host cell, due to post-translational targeting of viral replication proteins,
TBSV replicase may already evolved to be peroxisome targeting and does not have a
chance to meet other sub-cellular membrane, like mitochondria. However, in cell-free
environment, viral protein and membrane may have a chance to interact, simply by
diffusion of molecules. Could TBSV replicate on mitochondrial membranes in a cell-free
environment? Or could CIRV replicate on ER or peroxisome membrane? To address
these questions, an cell-free system was established for TBSV replication using yeast
extract (49), which contains cytosolic proteins as well as total cellular membranes,
including peroxisome, ER or mitochondria membranes.
In Chapter 2, a further modification of yeast cell-free extract will be used to
explore sub-cellular membrane requirements of TBSV and CIRV replication. This study
leads to a deeper understanding of (+)RNA virus replication sites. The method developed
in chapter 2 was also used for identification and characterization of an inhibitory host
factor, stress induced protein 1 (Sti1) co-chaperone, of CIRV replication. Results with
Sti1 in tombusvirus replication will be discussed in Chapter 3.

1.3 Requirements of specific lipids for positive strand RNA virus replication

Although (+)RNA viruses adapted different subcellular locations for their replication,
membranes of these organelles have one common feature: mainly composed of
4

phospholipids, among which glycerophospholipids are most abundant (50-53), while
sphingolipids mostly occur in Golgi and the endosomal membranes count about 10% of
total phospholipid content (51). Major glycerolphospholipids in eukaryotic cells include:
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS),
phosphatidylinositol (PI) and phosphatidylglycerol (PG). PC is the most abundant
phospholipids in eukaryotic cells (54), and it has an almost cylindrical shape which
favors the organization of stable planar bilayer (51, 55). While PE is usually the second
most abundant phospholipid species (54), it possesses a conical molecular structure (51,
55), which could introduce negative curvature when incorporated into stable bilayer and
promotes membrane fusion (55-57). Other than PC and PE, which are neutral
phosholipids, negatively charged phospholipids, such as PS, PG, PI or phosphorylated
forms of PI, namely PIPs, bring negative charge to where they are enriched and could
attract protein effectors specifically or non-specifically (58), like Rho GTPase (59),
protein kinase C (60), SNARE protein vam7p (61) , which are involved in different
cellular pathways. Since different phospholipids involve in regulating different cellular
processes, they may regulate (+)RNA virus replication through their interactions with
viral replication proteins.
Elevation of overall fatty acid synthesis was shown to facilitate many (+)RNA
virus replication, including members of enterovirus, poliovirus (62) and coxsackievirus
B3 (CVB3) (63), and members flavivirus, Dengue virus (64) and West Nile virus (65).
Lipidomics analysis conducted with cells infected with Dengue virus and Hepatitis C
virus (66, 67) suggest that viruses induce new lipids biosynthesis, and virus infection
changes the global lipid profile of the host cell. These changes add a new level of
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complexity of virus-host interaction. However, the question remains if specific lipid
species or total lipids are more important to viruses?
In the past decade, virologists made different approaches to reveal interactions
between specific phospholipid species and (+)RNA viruses. Enterovirus is among the
most intensively studied viruses in this area. Phosphatidylinositol-4-phosphate (PI4P)
was shown to be enriched with CVB3 (enterovirus, picornaviridae) replication proteins.
RNA polymerase 3Dpol of poliovirus (PV, enterovirus, picornaviridae) selectively binds
to PI4P (33), suggesting a PI4P-rich micro-environment is the site for enterovirus
replication. Down-regulation of PI4P by Phosphatidylinositol-4-phosphate kinase (PI4K)
inhibitor or knock-down of PI4K by PI4K specific siRNA reduced the cellular PI4P
content as well as inhibited enterovirus replication. It was proposed that interaction of
PI4P with enterovirus replication proteins is required for enterovirus replication. Recent
findings (68, 69) showed that a mutant CVB3 with mutation in viral protein 3A could
bypass the requirement of PI4P or PI4Ks without lost fitness and virulence (68),
suggesting that PI4P is not required for the mutant CVB3 replication. It is interesting to
note that RNA polymerase 3Dpol was not mutated in the mutant CVB3 and still kept the
ability to interact specifically with PI4P, but the mutant virus did not require PI4P for
replication, suggesting other lipids, if any, may be responsible for enterovirus replication.
Nchoutmboube, J. et al. pulse-labeled PV infected HeLa cells with fluorescent fatty acid
(bodipy-FA) and found that bodipy-FA was mostly converted to newly synthesized lipids
which co-localized with PV replication proteins. Among the newly synthesized lipids, PC
was the most abundant, suggesting that bodipy-FA labeled PC enriched at the site of PV
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replication (62). Whether PC was enriched due to its abundant nature in the cell or
because PV replication specifically requires PC is current not clear.
Hepatitis C Virus, hepacivirus genus, a member of Flaviviridae family, has been
shown to require PI4P-enriched micro-environment for efficient replication (33, 70).
While West Nile virus (WNV), flavivirus genus, a member of Flaviviridae family, does
not require PI4P for its replication (65).
Besides phospholipids which form lipid bilayers needed for viral replicase
assembly, sterols could also be important. Sterols affect lipid bilayer fluidity and are
enriched within West Nile virus (71) and enterovirus (72) replication organelles and are
required for efficient Dengue virus and enterovirus replication. Are phospholipids species
less important for the virus than sterols? We don't know yet, but at least sterols cannot
stably exist without being inserted into lipid bilayers.
In Chapter 4, a novel method of cell-free TBSV replication assay using artificial
vesicles made from phospholipids will be shown to study phospholipids and TBSVspecific interaction. Then the findings of my research will be added to the discussion of
previously raised questions, and shed new lights on this unexplored virology area. In
Chapter 5 and 6, cellular pathways and mechanism of viral utilization of
phosphatidylethanolamine will be discussed.

Copyright © Kai Xu 2014
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Chapter 2

AUTHENTIC IN VITRO REPLICATION OF TWO TOMBUSVIRUSES IN
ISOLATED MITOCHONDRIAL AND ENDOPLASMIC RETICULUM
MEMBRANES
(This chapter was published on Journal of Virology, December 2012 vol. 86 no. 23
12779-12794., Copyright © American Society for Microbiology)

2.1 Introduction

Replication of plus-stranded (+)RNA viruses takes place in membrane-bound viral
replicase complexes (VRCs) in the cytoplasm of infected cells (13, 39, 73-79). Various
(+)RNA viruses usurp different intracellular membranes, including ER, mitochondria,
peroxisomes or endosomal membranes to aid the replication process. Other viruses induce
the formation of “viral replication organelles” or “membranous web” made from various
intracellular membranes (33, 39, 77, 79, 80). The recruited membranes are thought to
facilitate virus replication by (i) providing surfaces to assemble the VRCs; (ii)
sequestering and concentrating viral and host components; (iii) protecting the viral RNA
and proteins from nucleases and proteases (81); and (iv) facilitating regulated RNA
synthesis by harboring the (-)RNA template for production of abundant (+)RNA progeny.
The emerging picture with several (+)RNA viruses is that their replication proteins bind
to different lipids and recruit a number of host proteins, which are involved in lipid
synthesis, or modification, to the site of replication (33, 79, 82, 83). In addition, (+)RNA
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virus replication is also dependent on bending intracellular membranes that form
characteristic viral structures, such as spherules (vesicles with narrow openings) or
vesicles (76). Therefore, (+)RNA viruses likely recruit host proteins affecting membrane
curvature, as shown for ESCRT, reticulon and amphiphysin proteins in case of
tombusviruses, Brome mosaic virus and Semliki Forest virus (81, 84-86). Lipids also
affect membrane curvature and fluidity. Indeed, replication of several viruses has been
shown to be affected by sterols, fatty acids and phospholipids (31, 71, 87-90).
Tomato bushy stunt virus (TBSV) is a small (+)RNA virus that has emerged as a
model virus to study virus replication, recombination, and virus - host interactions due to
the development of yeast (Saccharomyces cerevisiae) as a model host (1, 5, 79, 91, 92).
Over 400 host genes/proteins that affected either TBSV replication or recombination have
been identified via genome-wide screens of yeast genes or global proteomics approaches
(12, 93-96). The highly purified tombusvirus replicase complex (VRC) is known to
contain the two viral replication proteins (i.e., p33 and p92pol) and 6-10 host proteins (9799). These host proteins have different functions during TBSV replication. For example,
heat shock protein 70 (Hsp70), eukaryotic elongation factor 1A (eEF1A) and the ESCRT
(endosomal sorting complexes required for transport) family of host proteins are involved
in the assembly of the VRC (75, 81, 86, 100-103). In addition, eEF1A and eEF1Bγ
facilitate (-)strand synthesis (103, 104); glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and Ded1 DEAD-box helicase have been shown to promote viral (+)RNA
synthesis (37, 105, 106); while Pex19 shuttle protein is involved in targeting of the
replication proteins to peroxisomes, the sites of replication (107).
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The auxiliary p33 replication protein, which has RNA chaperone function, is an
abundant protein and is essential for replication of TBSV in both yeast and plants (3, 7,
10, 32). The tombusvirus p33 is an integral membrane protein that has been shown to
recruit the TBSV (+)RNA into replication. The current picture is that the p33 replication
protein is the master regulator of TBSV replication by interacting with the viral RNA,
p92pol and numerous host proteins and host membranes. The host also targets p33 or the
viral RNA via nucleolin, cyclophilins or WW-domain proteins to limit tombusvirus
infections (108-112). On the other hand, the viral p92pol, which is a translational
readthrough product containing the p33 sequence at its N-terminus and a unique RdRp
domain at the C-terminus, is present in a lesser amount (1). Interaction between p92pol and
p33 replication proteins is required for assembling the functional VRC (2, 10, 49, 92).
Interestingly, the activation of the RdRp function of p92pol protein requires not only p33,
cis-acting sequences present in the viral (+)RNA and host factors, but also host
membranes (2-4, 92). This complex VRC assembly process and the many factors needed
for the RdRp activation opens the exciting questions whether tombusviruses could utilize
different cellular membranes or if various heterologous combinations of tombusvirus
replication proteins are functional.
Most tombusviruses, including TBSV, Cucumber necrosis virus (CNV), and
Cymbidium ringspot virus (CymRSV), show preference for peroxisomal membranes (10,
18, 113). Interestingly, these viruses can also replicate efficiently on the ER membrane in
the absence of peroxisomes, suggesting flexibility in intracellular membrane utilization
(15, 32, 107). Another tombusvirus, Carnation Italian ringspot virus (CIRV), however,
prefers to use mitochondrial membrane for replication (19, 48). Artificial retargeting of
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the CIRV replication proteins to the peroxisomes or CymRSV to the mitochondria via
chimeric constructs also supported CIRV and CymRSV replication (114), suggesting that
these viruses could utilize more than one intracellular environment for their replication.
To analyze if tombusviruses are indeed capable of utilizing various intracellular
membranes for their replication, we used in vitro approaches with recombinant viral
proteins and isolated intracellular organelles/membranes. Interestingly, we found that
TBSV, which originally uses the peroxisomal membrane, could also utilize ER and
mitochondrial membranes for replication in vitro. On the other hand, CIRV, which
originally utilizes the mitochondrial membranes, replicated on the isolated mitochondrial
membranes, while it could use the ER membrane less efficiently in vitro. Using
heterologous combinations of replication proteins and chimeric constructs, we identified
that multiple domains in the replication proteins are determinants of membrane
preference for tombusvirus replication. Altogether, the current paper promotes the idea
that TBSV is less restricted, while CIRV is more restricted in utilizing various
intracellular membranes for replication.

2.2 Materials And Methods

Yeast strains and expression plasmids. Saccharomyces cerevisiae strain
Saccharomyces cerevisiae strain BY4741 (MATa his3∆1 leu2∆0 met15∆0 ura3∆0) and
single-gene deletion strains pex3
∆ were obtained from Open Biosystems. Constructs
pMAL-p33 and pMAL-p92, to express TBSV p33 (renamed here as T33) and p92 (re-
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named as T92) as fusion proteins to the C-terminus of MBP were described previously
(102).
To generate the E. coli expression constructs pMAL-p36, pMAL-p95, pMALC36-T92, pMAL-T33-C95, pMAL-T33c, pMAL-T92c, pMAL-T33tc, and pMAL-T92tc,
we used the following approaches: The CIRV p36 sequence was amplified from CIRV
full-length cDNA (obtained from A. White, York University, Canada) with primers #642
(5’-GTATTTGACACCGAGGG-3’)

and

#3230

(CCGCTCGAGCTATTTGACACCGAGGGATT). The CIRV p95 sequence was
obtained by blunt-end ligation of PCR product of C36 amplified by primer #642 and
#643 (GGAGGCCTAGTGCGTCTAC) from CIRV cDNA and the C95 C-terminal
sequence

was

amplified

by

PCR

(GGAGCTCGAGCTATTTGACACCCAGGGAC)

using

primers

#

and

644
#970

(CCTAGGGAAAAACTGTCGGTA) and CIRV cDNA. C36-T92 chimeric sequence
was obtained by blunt-end ligation of PCR product of C36 sequence PCR-amplified with
primers #642 and #643 using CIRV full-length cDNA, and T92 C-terminal sequence was
amplified by PCR with primers #6 (GGAGGCCTAGTACGTCTAC) and #826
(GATTACATTGTCCCTCTATCT) using TBSV full-length cDNA. T33-C95 chimeric
sequence was obtained by blunt-end ligation of PCR products of T33 [generated by PCR
with

primers

#473

(GAGGAATTCGAGACCATCAAGAGAATG)

and

#3960

(GTATTTGACACCCAGGGAC)] and C-terminal sequence of C95 (generated by PCR
with primers #644 and #970). The T33c sequence was obtained by blunt-end ligation of
PCR product using primers #642 and #4102 amplified from CIRV cDNA and PCR
product using primers #4099 and #810 amplified from TBSV cDNA. The T92c sequence
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was obtained by blunt-end ligation of T33c (generated by PCR with primers #642 and
#3960) and T92 C-terminal sequence. The T33tc sequence was obtained by blunt-end
ligation

of

PCR

product

using

primers

#642

and

#4090

(ACGAGCCACACCCCGTTTAGC) and CIRV cDNA and the PCR-product generated
by

using

primer

#4087

(GATTACATTGTCCCTCTATCT)

and

#810

(CCCGCTCGAGTCAAGCTACGGCGGAGTCGAGGA) and TBSV cDNA. The T92tc
sequence was obtained by blunt-end ligation of T33tc (generated by PCR using primers
#642 and #3960) and the PCR-amplified C-terminal sequence of T92. All the above PCR
products were digested by EcoRI and XhoI restriction enzymes and inserted into pMALc2X (New England BioLabs).
To generate N-terminal GST-His6 fusion proteins, the C-terminal sequence of
TBSV

p33

was

PCR-amplified

using

(GGAGGAATTCATGGAGGGTTTGAAGGC)

primers
and

#633
#1593

(CGGCTCGAGCTATTTGACACCCAGGGACTCCTGT) and TBSV cDNA. The Cterminal

sequence

of

CIRV

p36

was

PCR-amplified

(GGAGGAATTCATGGAGGGTTTGAAGGC)

using
and

primers

#633
#3230

(CCGCTCGAGCTATTTGACACCGAGGGATT) and CIRV cDNA. The PCR products
were digested with BamHI and XhoI and cloned into BamHI/XhoI digested pGEX-His
(111).
To generate pGD-L-T33, pGD-L-T92, pGD-L-C36, pGD-L-95 constructs for
agro-infiltration in plants, the PCR product of TBSV p33 sequence [using primers: #788
(GGAGCTCGAGTCAAGCTACGGCGGAGTC)/

#810

(CCCGCTCGAGTCAAGCTACGGCGGAGTCGAGGA)] was digested with BamHI
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and

XhoI;

the

TBSV

p92

sequence

[obtained

using

(CCAGAGATCTATGGAGACCATCAAGAGAATG)

primers:
/

#4000
#826

(GATTACATTGTCCCTCTATCT)] was digested with BglII and XhoI, the PCR product
of

CIRV

p36

sequence

[obtained

(ACGAGCCACACCCCGTTTAGC)

using

primers:

/

#900
#3230

(CCGCTCGAGCTATTTGACACCGAGGGATT)] was digested with BamHI and XhoI,
while the PRC product of CIRV p95 sequence [obtained using primers: #900
(ACGAGCCACACCCCGTTTAGC) / #970 (CCTAGGGAAAAACTGTCGGTA)] was
digested with BamHI and XhoI. Then, the above PCR products were separately inserted
into pGD-L (81), which was digested with BamHI and XhoI, generating transient
expression vectors for agro-infiltration.
For the imaging experiments, we have constructed the following plasmids: pESCT33/DI72, pESC-C36/DI72, pYES-T92 and pYES-C95. For this, sequences of fulllength TBSV p33 (primers: #788/#810), CIRV p36 (primers: #900/#3230) and p95
(primers: #900/#970) were PCR-amplified and digested with BamHI and XhoI, while the
PCR-amplified sequence of TBSV p92 (primers: #4000/#826) were digested with BglII
and XhoI. Digested PCR products were then inserted into pESC-HisCNVp33-DI72, or
pYES-CNVp92 digested with BamHI/XhoI.
To track viral protein localization in yeast cells, we cloned rsGFP (red-shifted) sequence
upstream of the N-terminus of TBSV p33/p92, and CIRV p36/p95. The rsGFP sequence
was PCR-amplified with primers #1262
(CGGCGGATCCGGTAAAGGAGAAGAACTTTTCACT) and #1263
(CGGCGGATCCGAGTCCGGACTTGTATAGTTCA) using pGDG vector as a template
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[provided by Dr. M. Goodin (115)], followed by digestion with BamHI and inserted into
pESC-C36/DI72 or pYES-C95 digested with BamHI, generating pESC-rsGFP-C36/DI72
and pYES-rsGFP/C95. The cDNA sequence of TBSV p33 was PCR-amplified using
primers #4000/#810, while the cDNA sequence of TBSV p92 was PCR-amplified with
primers #4000/#826. The obtained PRC products were digested with BglII, followed by
ligation with the PCR-amplified rsGFP sequence digested with BamHI, generating the
cDNAs of rsGFP-T33 and rsGFP-T92. Then, the cDNAs of rsGFP-T33 and rsGFP-T92
were digested with BamHI and XhoI, and inserted into pESC-C36/DI72 or pYES-C95
digested with BamHI/XhoI, resulting in pESC-rsGFP-T33/DI72 and pYES-rsGFP-T92
expression plasmids.

Agroinfiltration and RNA extraction. N. benthamiana leaves were agroinfiltrated with
A. tumefaciens cultures containing combinations of pGD-L-T33, pGD-L-T92, pGD-LC36 or pGD-L-C95 as well as pGD-DI72sat and pGD-p19 as described (81). After 3.5
days post infiltration, agro-infiltrated leaves were collected, total RNA was extracted and
subjected for Northern blot analysis as described (81).

Preparation of CFE and soluble fraction (S100). The yeast CFE from BY4741yeast
strain was prepared as described (49). For production of S100 soluble fraction, yeast CFE
was further centrifuged at 100,000 g for 1 hour, and the supernatant (S100) was carefully
collected without disturbing the pellet, and then stored at –80°C.

Purification of yeast microsomal membranes. Yeast microsomes were prepared as
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previously described (116), except that yeast microsomes were washed in 30 mM
HEPES-KOH, pH 7.4, 150 mM potassium acetate, 2 mM magnesium acetate, containing
complete mini Protease Inhibitor Cocktail (Roche applied science). The protein
concentration of obtained yeast microsomal membranes was 4 mg/ml.

Purification of intact yeast mitochondria. Yeast intact mitochondria were purified
according to REF.: (117). Briefly, yeast cells were made into spheroplasts by incubating
with 5 mg/g (wet weight) Zymolyase-20T (Seikagaku, America), and then the
spheroplasts were homogenized and lysed with glass Dounce homogenizer in ice-cold
homogenization buffer (0.6 M sorbitol, 10 mM Tris-HCl, pH 7.4, 1 mM PMSF, 0.2%
(w/v) BSA). Then, the homogenized spheroplasts were centrifuged at 3,000 g for 5 min at
4°C and the supernatant was subjected to additional centrifugation at 12,000 g for 15 min
to obtain the crude mitochondria preparation. To further remove contaminating
membranes, the crude mitochondrial preparation was subjected to two sequential
centrifugations at 134,000 g on a sucrose gradient (0.7 ml 60%, 1.5 ml 32%, 0.7 ml 23%
and 0.7 ml 15% (w/v) sucrose with 1mM EDTA and 10 mM MOPS-KOH). The purified
mitochondrial preparation was recovered between the 60% / 32% sucrose gradient
interface and stored in SEM buffer [250 mM sucrose, 1 mM EDTA, 10 mM MOPSKOH, pH 7.2, containing complete mini Protease Inhibitor Cocktail (Roche applied
science)] at -80°C. The protein concentration was about 3 mg/ml.

Isolation of oleate-induced peroxisomes using sucrose gradients. The isolation of
peroxisomes was according to REF.: (118). Yeast was grown in peroxisome induction
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medium containing 0.12% (w/v) oleic acid, 0.2% Tween 40, 0.5% Bacto peptone and
0.3% yeast extract till 1.0 OD600. Cell wall was digested with Zymolyase to generate
spheroplasts in MES buffer (5 mM MES pH5.5, 1 mM EDTA, 1 mM KCl) with 1.2 M
sorbitol, and homogenized by gradually adding MES buffer until sorbitol concentration
reached to 0.65 M. Unlysed cells and cell debris were removed by centrifuging at 2,000
g, and crude peroxisome preparations were collected via centrifugation at 20,000 g. The
crude peroxisome preparations were applied to a linear sucrose gradient (10%-80%)
using Beckman VTi 50 rotor at 34,500 g for 2.5 hours. Fractions were collected and
stored at -80°C. Before in vitro replicase assembly assay, each membrane fraction (100
µl) was thawed on ice and diluted 5x with 30% sucrose/MES buffer, followed by
centrifugation at 20,000 g for 30 min. Then, the pellets of each fraction were carefully
suspended into 10 µl of 30% sucrose/MES buffer. The protein density in peroxisome
fractions #11 to #16 was about 1 mg/ml.

In vitro replication assay. The yeast CFE-based replication assay was modified from Ref:
(54) to study TBSV and CIRV replication using the isolated organelle preparations. The
yeast cell extract (2 µl) or purified membrane fractions (1 µl) together with S100 soluble
fraction (1 µl) was incubated at 25°C water bath for 1 hour in 8 µl cell-free replication
buffer A containing 30 mM HEPES-KOH, pH 7.4, 150 mM potassium acetate, 5 mM
magnesium acetate, 0.6 M sorbitol, as well as 15 mM creatine phosphate; 1 mM ATP,
CTP, GTP and 0.025 mM UTP; 0.1 µl of [32P]UTP, 0.1 mg/ml creatine kinase, 0.1 µl of
RNase inhibitor, 10 mM dithiothreitol, 0.5 µg DI-72 RNA transcript and 0.5 μg
recombinant MBP-fused viral proteins. Then the volume of reaction was adjusted by
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adding 16 l cell-free replication buffer B containing 30 mM HEPES-KOH, pH 7.4, 150
mM potassium acetate, 5 mM magnesium acetate, together with 15 mM creatine
phosphate; 1 mM ATP, CTP, GTP and 0.025 mM UTP; 0.2 µl of [32P]UTP, 0.1 mg/ml
creatine kinase, 0.2 µl of RNase inhibitor, 10 mM dithiothreitol, 0.05 mg/ml actinomycin
D. The reaction mixture was incubated at 25°C for 3 h. The reaction was terminated by
adding 110 µl stop buffer (1% sodium dodecyl sulfate [SDS] and 0.05 M EDTA, pH 8.0),
followed by phenol-chloroform extraction, isopropanol-ammonium acetate precipitation,
and a washing step with 70% ethanol. RNA samples were electrophoresed in denaturing
gel (5% PAGE containing 8 M urea) and analyzed by phosphorimager(Typhoon; GE).
To test the effect of sorbitol on in vitro tombusvirus replication, the purified membrane
preparations (1 µl) together with S100 fraction (1 µl) was incubated at 25 °C water bath
for 4 hour in 24 l of modified cell-free replication buffer A containing 0, 0.2 and 0.6 M
sorbitol.

Micrococcal nuclease treatment of the in vitro replication assay mixture. The The
replication assay was conducted as described above, except that at different time points of
the reaction, each sample was treated with 0.25 U/µl micrococcal nuclease and 1 mM
CaCl2 at different time point after staring of the incubation in the replication buffer A as
described previously (54). 2.5 mM EGTA was added to each sample after 15 min
incubation of micrococcal nuclease to stop the nuclease digestion.

Replication assay to determine viral (+)RNA/(−)RNA ratio. This assay was done as
described in a previous publication (95). Briefly, 2 µg of in vitro transcripts of minus-
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strand and plus-strand DI-72 RNAs were separately dot blotted onto a Hybond XL
membrane (Amersham) followed by UV cross-linking. In vitro replication products were
hybridized to the blots in ULTRAhyb solution (Ambion) at 68°C and quantified after
washing.

Western blotting. Western blotting of yeast membrane proteins was done according to
REF.: (100). The following antibodies were used: anti-porin, anti-ALP, anti-PGK and
anti-dpm1 (purchased from Invitrogen, CA, USA). Sec61p antibody was provided by Dr.
Tom Rapoport from Harvard Medical School. Fox3p antibody was provided by Dr.
Daniel J. Klionsky from University of Michigan.

In vitro membrane association assay. [35S]methionine-labeled TBSV p33 and CIRV
p36 were obtained in nuclease-treated rabbit reticulocyte lysates (Promega) in the
presence of 400 µCi/ml [35S]methionine. 1 l of translation mixture was incubated at
25°C for 1 hour with 2 l purified yeast microsomes or purified yeast mitochondrial
preparations and 2 l S100 fraction in 40 l reaction containing cell-free replication
buffer A (30 mM HEPES-KOH, pH 7.4, 150 mM potassium acetate, 5 mM magnesium
acetate, 0.6 M sorbitol) as well as 15 mM creatine phosphate; 1 mM rNTP; 0.1 mg/ml
creatine kinase, 0.1 µl of RNase inhibitor, 10 mM dithiothreitol, 0.5 µg DI-72 RNA
transcript. Each reaction mixture was diluted 3 times with the cell-free reaction buffer A,
followed by incubation on ice for 30 min. The samples were centrifuged at 100,000 g for
2 hours. Pellet was dissolved in SDS-PAGE sample buffer. Proteins from the supernatant
fractions were precipitated in 10% trichloroacetic acid (TCA) and dissolved in SDS-
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PAGE sample buffer. Samples were separated by SDS-PAGE.

In vitro MBP pulldown assay. MBP-tagged TBSV T33 (p33), T92 (p92), CIRV C36,
C95 and GST- His6-tagged TBSV p33C and CIRV p36C were expressed in E. coli,
transformed with one of the following plasmids: pMAL-T33, pMAL-T92, pMAL-C36,
pMAL-C95, pGEX-his-T33C, pGEX-his-C36C. E. coli cultures were lysed by sonication,
followed by affinity-purification via amylose columns and washed with cold column
buffer with high salt (10 mM Tris-Cl, pH 7.4; 1 mM EDTA, 200 mM NaCl, 10 mM 2mercaptoethanol) as described (119). The GST-His6-tagged p33C, GST-His6-p36C or
GST-His6 (negative control) were incubated with the MBP-tagged proteins for 1 hour at
4 °C and washed by column buffer with high salt. The bound proteins were eluted with
column buffer with high salt supplemented with 10 mM maltose (119). The presence of
GST-tagged proteins was analyzed by SDS-PAGE and Western blotting using an antiGST antibody.

Confocal laser microscopy. Visualization of Pho86-CFP ER marker protein and various
combination of tagged viral proteins in live yeast cells were as described previously (32,
107). To visualize yeast mitochondrial distribution of various viral proteins, we
transformed yeast with combinations of plasmids: pESC-GFP-T33/DI72, pESC-GFPC36/DI72, pYES-GFP-T92 or pYES-GFP-C95 with pESC-T33/DI72, pESC-C36/DI72,
pYES-T92 and pYES-C95 as described in the legend to Fig. 2.9. Transformed yeast were
grown at 23°C in minimal media supplemented with 2% galactose, and then we used
Rhodamine B (hexyl ester-perchlorate, a mitochondria-specific dye used in yeast, Catalog
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# R-648MP, Invitrogen, CA, USA) to visualize yeast mitochondria (120-122) with an
Olympus FV1000 microscope (Olympus America Inc., Melville, New York).

2.3 Results
CIRV replication proteins support RNA replication in yeast cell-free preparations in
vitro. We have previously shown that TBSV can efficiently replicate in cell-free extracts
(CFE) prepared from yeast (4, 49, 102). The CFE-based TBSV replication assay
contained purified recombinant TBSV p33 and p92pol replication proteins and T7
polymerase-made DI-72 (+)-stranded replicon (rep)RNA transcripts. The CFE supported
one single cycle of replication, starting with (-)RNA synthesis on the added (+)repRNA
transcripts, followed by robust synthesis of (+)repRNA progeny (4, 49, 102). The CFEbased assay recapitulated the known features of TBSV replication, including the
requirement of cis-acting viral RNA elements, dependence on viral and host factors and
the need for both membranous and soluble fractions of CFE. Other features of the assay
included asymmetrical replication, leading to 10-to-40-fold more (+) than (-)RNA;
association of the VRCs with membranes that led to protection against ribonucleases and
proteases after the assembly of VRCs; the release of (+)repRNA progeny to the soluble
fraction during the reaction, while retaining the (-)repRNA in the VRCs (4, 49, 102).
To test if CIRV replication proteins, which are originally associated with
mitochondrial membranes (19, 48), could support repRNA replication in the CFE-based
assay, we added purified recombinant p36 and p95pol (called C36 and C95 in this paper to
discriminate them form the homologous TBSV p33 and p92pol, named T33 and T92) in
combination with the TBSV-derived DI-72(+) repRNA to yeast CFE. Interestingly, we
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observed the replication of repRNA in samples containing both C36 and C95 (Fig. 2.1A,
lane 7), which reached about 10% of that supported by T33/T92 (lane 1). No replication
was observed when C95 protein was omitted from the CFE-based assay (Fig. 2.1A, lane
8), confirming that both CIRV replication proteins are required for repRNA replication.
The supernatant or membrane fractions of CFE alone or the Triton X100-treated CFE
could not support repRNA replication in the presence of C36 and C95 (Fig. 2.1A, lanes
10-12), similar to that observed with T33/T92 (lanes 4-6). Thus, these experiments
showed that the CIRV C36/C95 replication proteins could support repRNA replication in
CFE, albeit with reduced efficiency when compared with the TBSV T33/T92 replication
proteins.
To further test the CIRV replication process in the yeast CFE, we estimated the
ratio of newly made (+)-strand versus (-)-strand repRNA levels in the replication assay
(Fig. 2.1C). This showed that, similar to the TBSV replication proteins, the CIRV
replication proteins also performed asymmetrical viral RNA synthesis by producing ~10
times more new (+)-strands than (-)-strands in the yeast CFE (Fig. 2.1C).
Since the repRNA was the TBSV-derived DI-72 in the above assays, it is possible
that the reduced replication was due to the less efficient utilization of the heterologous
repRNA by the CIRV replication proteins in comparison with repRNA replication
supported by the homologous TBSV replication proteins. To test this possibility, we also
used the CIRV-derived DI-1 repRNA (14) in the CFE-based assay. These experiments
revealed that both repRNAs were used more efficiently by T33/T92 than C36/C95 in
vitro (Fig. 2.1B, and D, lanes 1-2 versus 3-4). Thus, the viral replication proteins
determine the efficiency of repRNA replication in this assay.
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Heterologous combinations of replication proteins supports RNA replication in yeast
cell-free preparations in vitro and in planta. To test if the heterologous combinations of
tombusvirus replication proteins could support repRNA replication, we used the CFEbased assay with the purified recombinant proteins. The CFE-based assay revealed that
the heterologous combinations of replication proteins did support repRNA replication
(Fig. 2.1B and D, lanes 5-8), albeit less efficiently than T33/T92 (Fig. 2.1B and D, lanes
1-2). Moreover, we observed that the viral RdRp protein was the major factor controlling
the efficiency of repRNA replication. Accordingly, the homologous combination of
T33/T92 (Fig 2.1B and D, lanes 1-2) or the heterologous combination of C36/T92 (lanes
5-6) supported more efficient replication than C36/C95 (lanes 3-4) or T33/C95 (lanes 78). Thus, it seems that T92 RdRp protein is ~6-20-fold more active in the CFE-based
assay than C95 RdRp. However, the small replication protein also affected the efficiency
of replication since the combinations of replication proteins that included T33 supported
up to ~3-fold more replication than C36 in a complex with the RdRp protein (compare
T33/T92 versus C36/T92; Fig. 2.1B and D, lanes 1-2 versus 5-6).
To test if the tombusvirus replication proteins behave similarly in plant cells, we
used an agro-infiltration-based approach to express the TBSV and CIRV replication
proteins and DI-72 repRNA in Nicotiana benthamiana. These experiments also revealed
that T33/T92 combination supported repRNA replication more efficiently (Fig. 2.2, lanes
1-4) than C36/C95 (lanes 5-8). However, the use of heterologous combination of
tombusvirus replication proteins revealed that T33 replication protein and not the T92
replication protein is responsible for the enhanced level of replication in plants (Fig. 2.2).
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This difference between in vitro and in planta data could be due to the ability of T33 or
C36 to induce membrane proliferation in plant cells that promote more efficient
replication (these features cannot manifest in the CFE). Nevertheless, the in planta
experiments demonstrated that the heterologous combinations of tombusvirus replication
proteins are functional in supporting repRNA replication.
Tombusvirus replication depends on the interaction between the S1/S2
subdomains common in the T33/C36 RNA chaperone and T92/C95 RdRp proteins,
which is needed for the assembly of the functional VRC (11). The above observations
that the heterologous combinations of tombusvirus replication proteins support
tombusvirus RNA replication in the CFE assay and in planta suggest that the
heterologous replication proteins likely interact with one another. To test the
heterologous interactions, we performed pull-down assay with immobilized MBP-tagged
viral replication proteins and the GST-tagged T33C (the C-terminal half, p33C) or GSTC36C (the C-terminal half, p36C). This assay confirmed interaction between the
heterologous replication proteins that were comparable with the interaction between the
homologous replication proteins (Fig. 2.2B).

Tombusviruses can replicate in microsomal and mitochondrial preparations in vitro.
To better understand the role of different subcellular membranes in tombusvirus
replication and to test what subcellular membranes can be used for repRNA replication
by TBSV and CIRV replication proteins in vitro, we isolated microsomal (representing
the ER membrane), peroxisomal and mitochondrial fractions from yeast, followed by in
vitro replication assay with purified recombinant tombusvirus replication proteins (Fig.
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2.3A). Interestingly, we found that the microsomal preps, which lacked detectable
peroxisomal and mitochondrial marker proteins (Fig. 2.3B, bottom panels), supported
repRNA replication ~16-fold more efficiently in the presence of T33/T92 than C36/C95
and the S100 fraction of CFE (the membrane-free supernatant that provides essential
soluble host proteins) (Fig. 2.3B, lane 1 versus 2). These data suggest that the isolated ER
membrane can support the assembly of both TBSV and CIRV VRCs, although the CIRV
replication proteins show poor activity in this environment.
To test if viral RNA synthesis includes the full cycle of replication in the
microsomal preparations, we estimated the ratio of newly made (+)-strand versus (-)strand repRNA levels in the in vitro replication assay (Fig. 2.3C). Interestingly, both
TBSV and CIRV replication proteins supported asymmetrical viral RNA synthesis by
producing ~11-14 times more new (+)-strands than (-)-strands in the microsomal
preparations (Fig. 2.3C). Thus, even CIRV replication proteins are capable of supporting
full replication, albeit less efficiently than the TBSV replication proteins, in the
microsomal preparations.
Similar experiments with purified mitochondrial preparations revealed that both
TBSV and CIRV replication proteins supported repRNA replication in vitro (Fig. 2.3D).
Thus, unlike with the microsomal preparations, the CIRV replication proteins are fully
active on the mitochondrial membrane, which is also used by CIRV in yeast and plants
(19, 48). Both TBSV and CIRV replication proteins supported asymmetrical viral RNA
synthesis by producing ~9-10 times more new (+)-strands than (-)-strands in the
mitochondrial preparations (Fig. 2.3E). Thus, these data indicate that the mitochondrial
membrane can support full TBSV and CIRV replication in vitro.
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Unfortunately, the isolated oleate-induced peroxisomal preparations did not
support repRNA replication with TBSV and CIRV replication proteins (not shown).
Therefore, we decided to test tombusvirus RNA replication using sucrose-gradient
fractionated crude mitochondrial and peroxisomal preparations (Fig. 2.4). We found that
fractions 12 to 16 of the crude peroxisomal preparation (obtained from yeast after
induction with oleic acid), which had the highest concentration of Fox3 peroxisomal
marker (Fig. 2.4A, lanes 12-16), while contained Sec61 ER marker or porin
mitochondrial marker proteins in small amounts, did not support repRNA replication by
C36/C95 and T33/T92. The only repRNA replication with C36/C95 and T33/T92 was
seen with fractions 3-to-11, which contained the highest amount of contaminating ER and
mitochondrial membranes (based on the presence of Sec61 ER and porin mitochondrial
marker proteins in these fractions) (Fig. 2.4A, lanes 3-11). Based on these data, we
conclude that the peroxisomal preparations obtained from yeast induced by oleic acid
cannot support tombusvirus replication in vitro. This could be due to the fragile nature of
the peroxisomes during the isolation procedure or other unknown factors.
In contrast, fractions 17 and 18 of the crude mitochondrial preparation (after high
speed centrifugation in sucrose-gradient) supported repRNA replication by C36/C95 and
T33/T92 at the highest efficiency (Fig. 2.4B, lanes 17-20). These fractions were enriched
for mitochondria since they had the porin mitochondrial marker protein in the highest
concentration, but contained Sec61 ER marker or peroxisomal, vauolar and cytosolic
markers at low levels These data confirmed that the enriched mitochondrial membrane
could provide suitable environment for tombusvirus VRC assembly and repRNA
replication in vitro.
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Since the ER membrane has been shown to support efficient TBSV replication in
yeast (32, 107), we decided to use both the purified microsomal and mitochondrial
preparations for the follow up experiments. Accordingly, to further test if the microsomal
and mitochondrial preparations could assemble authentic tombusvirus VRCs, we
performed time-course experiments with micrococcal nuclease, which digests the
unprotected viral RNA (Fig. 2.5A) (49, 102). Interestingly, similar to CFE (49, 102), both
microsomal and mitochondrial preparations with C36/C95 and T33/T92 replication
proteins protected ~15-24% of the newly made 32P-labeled repRNA (representing the
minus- and plus-stranded replication products) if added 60 min after the start of the assay
(Fig. 2.5B-C, lanes 5 and 15). The addition of micrococcal nuclease during the first 15
min of the assay eliminated repRNA synthesis (Fig. 2.5B-C, lanes 2 and 12), likely due to
the lack (or incomplete) of VRC assembly, which takes 30-60 min in vitro (49, 102).
Altogether, we observed that the recruited repRNA becomes nuclease-protected after 3045 min in the microsome preparation in the presence of the viral replication proteins (Fig.
2.5B, lanes 3 and 13), while it takes 45-60 min in the mitochondrial preparation to
assemble VRC and protect the recruited repRNA from micrococcal nuclease (Fig. 2.5C,
lanes 4-5 and 14-15). These data suggest that both microsomal and mitochondrial
preparations with C36/C95 and T33/T92 replication proteins could assemble authentic
VRCs that protect the VRC-bound viral RNA from nucleases. In addition, it seems that
the VRC assembly with C36/C95 and T33/T92 replication proteins is faster in the
microsomal than in the mitochondrial preparations.
Osmotic pressure is important during the isolation of pure and intact mitochondria
(117). To test if the osmotic pressure is important during tombusvirus replication in vitro
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in microsomal or mitochondrial membranes, we compared the effect of different
concentrations of sorbitol in the assay buffer. We found that in the absence of sorbitol in
the assay buffer, neither TBSV nor CIRV could replicate in microsomal or mitochondrial
preparations (Fig. 2.5D, lanes 3 and 7). These data suggest that intact microsomal or
mitochondrial membranes should be maintained to support viral VRC assembly or
replication. On the other hand, the purified tombusvirus replicase does not require
sorbitol for RNA synthesis in vitro (2, 92), excluding that the replicase depends on
sorbitol for function. We propose that the sorbitol is needed in the assay buffer to keep
the organellar membranes intact and functional during the assay.

Multiple domains within the replication proteins are responsible for different level of
tombusvirus replication in ER or mitochondrial membranes. To test what domain of the
tombusvirus replication proteins is responsible for the observed differences between the
TBSV and CIRV in utilizing microsomal and mitochondrial membranes, first we used
heterologous combinations of CIRV and TBSV replication proteins to support RNA
replication in vitro based on microsomal and mitochondrial preparations. Interestingly,
the heterologous combination of C36/T92 supported repRNA replication almost as
efficiently as the homologous combination of T33/T92 (Fig. 2.6A, lanes 5-6 versus 1-2)
in the microsomal preparation, while combinations of C36/C95 and T33/C95 replication
proteins supported repRNA replication only at ~10-15% level of T33/T92 (Fig. 2.6A,
lanes 3-4, and 7-8 versus 1-2). Thus, we conclude that the T92 RdRp protein is far more
active than the C95 RdRp protein and T92 is the major determinant of the efficient use of
the ER membrane for in vitro repRNA replication. In addition, we note that T33
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replication cofactor has a better stimulatory effect on the activity of the tombusvirus
replicase than C36 replication cofactor in case of the ER membrane.
The picture was different with the mitochondrial preparation because of the
improved stimulatory effect of the C36 replication cofactor on the activity of the
tombusvirus replicase (Fig. 2.6B). Accordingly, high replication level was supported by
C36/T92 and C36/C95 combinations (Fig. 2.6B). While the homologous combination of
T33/T92 supported high level replication (Fig. 2.6B, lanes 1-2), the heterologous
combination of T33 and C95 supported the lowest level of repRNA replication (Fig. 2.6B,
lanes 7-8), suggesting that the T33 protein is less efficient than C36 in the mitochondrial
membrane. The observed differences between T33 and C36 is unlikely due to differences
in membrane associations, since we found that both T33 and C36 replication proteins
associated with microsomal and mitochondrial membranes efficiently in vitro (Fig. 2.6CD).
Since the tombusvirus RdRp proteins have two major domains (Fig. 2.7A), we
have made chimeric constructs between the TBSV T92 and CIRV C95 proteins as shown
in Fig. 2.7B. The N-terminal domain of the TBSV T92 and CIRV C95 RdRp proteins is
identical with the T33 or C36 co-factor proteins (Fig. 2.7A), while the C-terminal domain
harbors the highly conserved RdRp functional motifs. Testing the chimeric RdRp
proteins in microsomal preparations revealed that C36-T92 (in combination with C36 cofactor), carrying the RdRp domain of the TBSV T92 and the N-terminal C36 domain,
supported repRNA replication up to 40% level of combination of T33 co-factor and T92
RdRp (Fig. 2.7C, lanes 7-8 versus 1-2). In contrast, the chimeric T33-C95 RdRp protein
(in combination with T33 co-factor) supported repRNA replication poorly in microsomal
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preparations (lanes 5-6). Thus, these experiments indicate that the C-terminal RdRp
domain in T92 is responsible for the efficient utilization of the ER membrane, while the
homologous RdRp domain of C95 is less efficient in this environment. The data also
support that T33 over-lapping domain within the RdRp protein is more active in the ER
than the C36 over-lapping domain.
Similar experiments with mitochondrial preparations revealed that the RdRp
domain of the TBSV T92 is still ~3-fold more active than the corresponding domain of
the CIRV C95 (compare the chimeric C36-T92 RdRp with C95 RdRp in combination
with C36 co-factor, lanes 7-8 versus 3-4, Fig. 2.7D). However, we also observed a ~2fold stimulatory effect of C36 over-lapping domain when present in the RdRp protein
(compare the chimeric C36-T92 RdRp with T92 RdRp, lanes 7-8 versus 1-2, Fig. 2.7D).
In addition, T33 co-factor and T33-C95 RdRp combination supported low level of
repRNA replication, demonstrating that the T33 over-lapping domain is poorly adapted to
the mitochondrial membrane, as noted above with the heterologous combination of
replication proteins (Fig. 2.6B, lanes 7-8).
Since it seems that the T33 protein and the T33 over-lapping domain when
present in the RdRp protein is not well suited to support RNA replication in the
mitochondrial membrane when compared with C36 cofactor, we made chimeras between
T33 and C36 and their corresponding domains in the RdRp proteins as shown in Fig.
2.8A, D. We have divided T33 and C36 sequences into three subdomains: the N-terminal
subdomain known to be involved in intracellular localization of T33 and C36 cofactors
(10, 18, 48); the central subdomain that includes the two trans-membrane sequences
(TMD); and the C-terminal subdomain involved in protein-RNA and protein-protein
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interactions (11, 119, 123).
Testing the chimeric constructs in the mitochondrial preps revealed that replacing
the N and TMD subdomains of T33 with those of C36 in T33 cofactor and T92 RdRp
resulted in a highly active chimera (T33c and T92c), which replicated the most efficiently
(Fig. 2.8C, lanes 5-6 versus 1-2). This chimera, however, replicated the repRNA more
efficiently even in the microsome preparations (Fig. 2.8B, lanes 5-6 versus 1-2),
suggesting that chimeric tombusviruses might have increased potential to replicate in
various intracellular membranes. These observations could be relevant for the evolution
of tombusviruses (see Discussion).

Combinations of heterologous replication proteins show both ER and mitochondrial
localization in yeast. The in vitro data show that TBSV can efficiently replicate in both
ER and mitochondrial membranes, while the CIRV replication proteins favor the
mitochondrial membrane over the ER membrane to support viral repRNA replication. To
test if the tombusvirus replication proteins can indeed utilize these membranes in cells,
we performed localization studies with GFP-, YFP- and CFP-tagged proteins in yeast
using homologous and heterologous combinations of the tombusvirus replication proteins.
As expected, the homologous combination of T33/T92 localized mostly in the ER
membrane in yeast (in pex3∆ yeast to mimic the in vitro situation with isolated
microsomal preparations by using yeast lacking peroxisomes) based on the Pho86 ER
protein, while only a small fraction of C36 and C95 localized to the ER membrane, albeit
these proteins were frequently located in the vicinity of the ER (Fig. 2.9A). On the
contrary, the homologous combination of C36 and C95 localized mostly in the
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mitochondrial membranes in yeast based on Rhodamine B-staining (a mitochondrial dye
used in yeast) (120-122), while only a small fraction of T33 and T92 localized in the
mitochondrial membranes (Fig. 2.9B). Indeed, most of T33 and T92 proteins did not colocalize with MTS-CFP mitochondrial marker protein or with Rhodamine B
mitochondrial dye (Fig. 2.9B). Altogether, these experiments established that the
homologous combination of T33/T92 is mostly localized in the ER (in pex3∆ yeast) and a
fraction in the mitochondria, while C36/C95 is located in the mitochondrial membrane as
shown previously (32, 48, 107).
To test the membrane preference of the heterologous combinations of the
tombusvirus replication proteins in pex3∆ yeast, first we performed co-localization
studies. We found that the heterologous combinations of either T33/C95 or C36/T92 are
co-localized in yeast cells (Fig. 2.9C). Second, we performed subcellular localization of
YFP-C95 in pex3∆ yeast co-expressing T33, which showed partial co-localization with
the CFP-Pho86 ER marker protein (Fig. 2.9D) and the mitochondrial dye (Fig. 2.9E).
Similarly, YFP-T33 showed partial co-localization with the CFP-Pho86 ER marker
protein (Fig. 2.9D) and the mitochondrial dye (Fig. 2.9E) in yeast co-expressing the
heterologous C95. Thus, it seems that T33 and C95, albeit they are co-localized, they are
present in both ER and mitochondria, with fractions of the T33 and C95 molecules
divided between the two organelles.
Intriguingly, we observed similar split/divided distribution of C36 and T92
between the ER and mitochondrial membranes (Fig. 2.9F-G) in heterologous coexpression studies in pex3∆ yeast. Therefore, we suggest that the tombusviruses
replication proteins can be localized to both ER and mitochondrial membranes in yeast
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co-expressing the heterologous combinations (T33/C95 or C36/T92) of replication
proteins. This distribution could be interesting during tombusvirus evolution by allowing
less restricted use of subcellular membranes by putative interviral tombusvirus
recombinants (see discussion).

2.4 Discussion
All known (+)RNA viruses of plants and animals depend on various subcellular
membranes for their replication. Yet, we do not know why different (+)RNA viruses
select different subcellular membranes/compartments for replication. Tombusviruses
could be valuable for understanding the roles of various subcellular membranes in viral
replication since they show different preferences. For example, TBSV, CNV and
CymRSV preferably utilize the peroxisomal membranes, or in the absence of
peroxisomes, the ER membranes (10, 18, 32, 107, 113). On the other hand, CIRV
replicates in the mitochondrial membranes (19, 48). At a late stage of tombusvirus
replication in plants, however, large multivesicular bodies form that frequently contain
ER membranes and mitochondria as well (124). These observations suggest complex
interactions between subcellular membranes and tombusvirus replication proteins.
In this paper, we have developed in vitro tombusvirus replication assays with
isolated organelles (Fig. 2.3) or enriched organellar preparations (Fig. 2.4) to directly
address the roles of the various subcellular membranes in tombusvirus replication. We
have shown that (i) both (+) and (-)-strand RNA synthesis occurring in these assays; (ii)
the process is asymmetrical leading to excess amount of (+) over (-)-strands; (iii)
membrane-bound replicase complex forms; (iv) there is requirement of cellular factors;
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(v) there is requirement of both p33 and p92 replication proteins for replication; (vi) the
newly made (+) RNAs are released to the solution; (vii) while the (-) RNA is kept
protected in the replicase bound to the membrane. All these pieces of evidence support
that the tombusvirus replication in the isolated organelles is a complete cycle of authentic
replication process, similar to that developed using the whole CFE (49, 102).
Interestingly, we find that TBSV replication proteins utilized the isolated ER
membrane efficiently for repRNA replication, while the CIRV replication proteins did
not (Fig. 2.3-2.4). These data are in agreement with the in vivo observations that TBSV
uses the ER membranes (in the absence of the peroxisomes), while CIRV favors the
mitochondria for replication in yeast and plant cells (10, 19, 32, 48, 107, 113).
Surprisingly, however, TBSV was also able to utilize the isolated mitochondria for
replication (Fig. 2.3-2.4), suggesting that this tombusvirus could be less restricted in its
ability to utilize subcellular membranes. Indeed, we did see some co-localization of
TBSV T33 and T92 replication proteins with mitochondrial markers (based on both
MTS-CFP and a mitochondrial dye, Fig. 2.9B) in pex3∆ yeast, suggesting that
mitochondria is likely used for TBSV replication at some extent, possibly at the late stage
of replication when peroxisomal or ER membranes had already been fully exploited.
Similarly, we observed some co-localization of CIRV C36 and C95 replication proteins
with the ER marker protein (Fig. 2.9A), supporting that ER membranes might be targeted
for CIRV replication. However, the activity of the CIRV replicases in the ER membranes
is likely less robust than in the mitochondrial membranes, based on the in vitro
experiments with the isolated microsomes (Fig. 2.3). Altogether, the in vitro and in vivo
experiments suggest that TBSV show rather high flexibility in membrane utilization for
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replication, while CIRV is somewhat more restricted, at least in vitro.
Unfortunately, we failed to obtain peroxisomal preparations supporting either
TBSV or CIRV replication from yeast cultured in oleic acid media to induce peroxisome
formation (Fig. 2.4). It is possible that peroxisomes are too fragile and damaged during
the isolation procedure. It is also possible that the oleic-acid induced peroxisomes are not
suitable to support TBSV replication. Indeed, addition of oleic acid to the culture media
did not increase TBSV replication in yeast (Panavas and Nagy, unpublished). Therefore,
it is highly likely that the CFEs obtained from yeast support TBSV replication occurring
mainly in the ER-derived membranes (Fig. 2.1). Because ER is as suitable to support
TBSV replication as the peroxisomes in yeast (32, 107), the obtained in vitro data are
likely valuable in dissecting TBSV replication in vitro. We also propose that the CFE
likely supports weak CIRV replication (when compared with TBSV) due to the limiting
amount of mitochondria present in the CFE prepared from yeast cultured under the
standard conditions. Indeed, comparison of CFE (Fig. 2.1) and microsomal and
mitochondrial preps (Figs. 2.3-2.4) revealed similarity between CFE and microsomal
preparations, suggesting that most of the in vitro repRNA replication in the CFE is likely
supported by the ER membrane. This could be due to the growth conditions for yeast,
which favors the presence of low number of mitochondria and peroxisomes, but abundant
ER membranes (125). The isolated mitochondrial preparation, however, supported CIRVbased repRNA replication efficiently, making this approach suitable for future
mechanistic studies.
Combinations of heterologous replication proteins reveal remarkable flexibility of
membrane usage by tombusviruses. One of the surprising discoveries from the in vitro
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tombusvirus replication assays with the combinations of heterologous replication proteins
is the extended ability of tombusviruses to utilize subcellular membranes more efficiently
than some homologous combinations. For example, CIRV C36 and C95 co-localized
more efficiently with the ER membranes when present in heterologous than in
homologous combinations (Fig. 2.9). Moreover, the CIRV C36 protein became part of a
more efficient replicase in the ER membranes when associated with T92 RdRp protein
than in homologous combination with C95 (Fig. 2.6A) without becoming less efficient in
the mitochondrial membrane (Fig. 2.6B). Also, the TBSV T92 RdRp showed increased
activity in the mitochondrial membrane when combined with C36 cofactor than in
combination with TBSV T33 (Fig. 2.6B). This suggests that tombusviruses might be able
to utilize various subcellular membranes more efficiently during some co-infections with
other tombusviruses when compared with single infections.
Even more interesting is the possibility of generation of chimeric tombusviruses
due to RNA recombination between tombusviruses. RNA recombination is well
documented for tombusviruses in vitro, in yeast, and in planta (16, 17, 93, 94, 126-130).
The formation of chimeric tombusviruses could expand the efficiency of using various
subcellular compartments by the tombusvirus replicase, based on the chimeric constructs
tested in Figs. 2.7-2.8. Indeed, particular chimeric constructs replicated efficiently in both
ER and mitochondrial preps (e.g., T33c/T92c, Fig. 2.8). We propose that the extra
flexibility in membrane-usage by these chimeric tombusviruses could be useful for
tombusviruses when infecting some plant species, thus expanding the wide range of
plants supporting tombusvirus replication. Accordingly, recombinant CIRV strains were
recently isolated that had similar N-terminal sequences to the TBSV p33 replication
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protein and targeted the peroxisome for replication (131, 132). Thus, recombination
involving the p33/p36 ORF can occur in nature creating new variants or strains.

Adaptation to subcellular membranes for robust tombusvirus replication depends on
multiple domains within the replication proteins. The heterologous combinations of
tombusvirus replication proteins revealed that T92 and C95 are major determinants of
repRNA replication in particular subcellular membranes. For example, the C95 RdRp
was mostly functional in the mitochondrial preps, while the T92 RdRp was active in both
microsomal and mitochondrial preps (Fig. 2.6C-D). Furthermore, the results with
chimeric proteins suggest that the RdRp domain in T92 is very active in both microsomal
and mitochondrial preps (Fig. 2.7C-D), while the origin of the N-terminal, overlapping
domain in the tombusvirus RdRp was also important for the activity of VRC during
replication. Therefore, we suggest that multiple domains within the replication proteins
affect the ability and efficiency of the tombusvirus VRCs to support repRNA replication
in particular subcellular membranes. It is also possible that C36 forms a single 'domain'
that favors mitochondrial targeting as a whole, and swapping its C-terminal and/or transmembrane regions with corresponding regions of T33 disrupts the structure necessary for
specific targeting to mitochondria.
Altogether, the developed in vitro tombusvirus replication assays based on CFE,
isolated microsomes and mitochondrial preparations will be powerful to gain mechanistic
insights into the roles of membranes in (+)RNA virus replication, virus-host interactions
and possibly viral evolution.
Copyright © American Society for Microbiology

37

Fig. 2.1
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Fig. 2.1 In vitro reconstitution of the CIRV replicase in yeast cell extract.
(A) Purified recombinant p33 (named T33) and p92pol (named T92) replication proteins
of TBSV or purified recombinant p36 (named C36) and p95pol (named C95) replication
proteins of CIRV in combination with the TBSV-derived DI-72 (+)repRNA were added
to the cell extract (lanes 1 and 7), to the membrane plus soluble fractions (lanes 3 and 9),
to the soluble fraction (lanes 4 and 10), to the 1% Triton-treated membrane plus soluble
fractions (lanes 5 and 11), and to the membrane fraction (lanes 6 and 12) of the yeast cell
extract. The CFE-based replication assay mixture lacked T92 (lane 2) or C95 (lane 8) as a
negative control. Denaturing PAGE analysis of the 32P-labeled repRNA products
obtained is shown. The full-length repRNA is indicated by an arrowhead. The result of
the CFE-based replication assay with T33 and T92 was chosen as 100% (lane 1). (B) The
heterologous combinations of TBSV and CIRV replication proteins are functional in the
CFE-based replication assay. The activity of the reconstituted tombusvirus replicases is
estimated as for panel A. Denaturing PAGE analysis of the replicase products is as shown
in panel A. (C) Detection of plus- and minus-stranded RNA products produced by the
reconstituted TBSV and CIRV replicases in the CFE-based replication assay. The blot
contains the same amounts of cold plus- and minus-strand DI-72 RNA, while the 32Plabeled repRNA probes were generated in the CFE-based replication assay. Note that we
used 5 times more CIRV replication products than TBSV to increase the signal. The ratio
of plus- and minus-strand RNA products was estimated. (D) The heterologous
combinations of TBSV and CIRV replication proteins with the CIRV-derived DI-1
repRNA are functional in the CFE-based replication assay. See further details described
for panel B. Each experiment was repeated.
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Fig. 2.2
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Fig. 2.2 The heterologous combinations of TBSV and CIRV replication proteins are
functional in N. benthamiana.
The accumulation of DI-72 repRNA was measured by Northern blotting in N.
benthamiana leaves. The expression of TBSV and CIRV replication proteins and the
repRNA was launched from the 35S promoter in an Agrobacterium plasmid (introduced
into the leaves via agroinfiltration). Samples were taken from the infiltrated leaves at 3.5
days after infiltration. Note that coagroinfiltration of single protein-expressing constructs
with the repRNA-expressing construct did not result in repRNA accumulation (lanes 17
to 24). Each experiment was repeated. (B) Affinity binding (pulldown) assay to detect
interaction between GST-His6-p33C (representing the C-terminal half of T33, involved
in protein interaction) or GST-His6-p36C (representing the C-terminal half of C36) and
the MBP-tagged TBSV and CIRV replication proteins. The MBP-tagged TBSV and
CIRV replication proteins and the MBP produced in E. coli were immobilized on
amylose-affinity columns. GST-His6-tagged p33C or GST-His6-p36C expressed in E.
coli was then passed through the amylose affinity columns with immobilized MBPtagged proteins. The affinity-bound proteins were specifically eluted with maltose from
the columns. The eluted proteins were analyzed by Western blotting with anti-6×His or
anti-GST antibody to detect the amount of GST-His6, GST-His6-p33C, or GST-His6p36C specifically bound to MBP-tagged viral proteins. A similarly produced GST-His6
protein preparation was used as a negative control.
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Fig. 2.3 In vitro reconstitution of the TBSV and CIRV replicases in yeast microsome
and mitochondrial preparations.
(A) Scheme of the replication assays. The purified recombinant T33 and T92 as well as
C36 and C95 replication proteins and the TBSV-derived (+)repRNA were used as
described for Fig. 2.1. (B) Top panel, denaturing PAGE analysis of the 32P-labeled
repRNA products obtained in the replication assays with the isolated yeast microsome
preparation. The synthesized full-length repRNA is indicated by an arrowhead. The result
from the replication assay with T33 and T92 was chosen as 100% (lane 1). Each
experiment was repeated. Bottom panels, Western blot analysis of various marker
proteins in the microsome preparation with the help of specific antibodies. The left lane
represents the standard yeast proteins present in CFE as positive controls. (C) Detection
of plus- and minus-strand RNA products produced by the reconstituted TBSV and CIRV
replicases in the microsome-based replication assay. See further details described for Fig.
2.1C. (D) The TBSV and CIRV replication proteins are functional in the mitochondrionbased replication assay. Top panel, the activity of the reconstituted tombusvirus
replicases is estimated as for panel B. Denaturing PAGE analysis of the replicase
products is as shown for panel B. Note that we used the 2× purified mitochondria
preparations for this assay. Bottom panels, Western blot analysis of various marker
proteins in the microsome preparations with the help of specific antibodies. The left lane
represents the standard yeast proteins from yeast induced with oleic acid as positive
controls. The crude mitochondrial sample was prepared without sucrose density gradient
centrifugation, while 1× and 2× indicate single and double sucrose density gradientpurified mitochondrial preparations, respectively. (E) Detection of plus- and minus-strand
RNA products produced by the reconstituted TBSV and CIRV replicases in the
mitochondrion-based replication assay. See further details described for Fig. 2.1C.
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Fig. 2.4 In vitro reconstitution of the TBSV and CIRV replicases in yeast membrane
fractions.
(A) Yeast was grown on oleate-rich medium to increase peroxisome numbers prior to
isolation. The crude peroxisome sample was subjected to 10 to 70% sucrose density
gradient centrifugation, and the fractions of the sucrose gradient were tested for the
ability to support RNA replication by the CIRV or TBSV replicases assembled in vitro.
The purified recombinant T33 and T92 as well as C36 and C95 replication proteins and
the TBSV-derived (+)repRNA were used as described for Fig. 2.1. Top two panels,
denaturing PAGE analysis of the 32P-labeled repRNA products obtained in the
replication assays with various membrane fractions. The synthesized full-length repRNA
is indicated by an arrow. The most active fraction in the replication assay was chosen as
100%. The fractions most enriched for peroxisome are boxed with dotted lines. The
samples on the left represent the top of the gradient (10%), while the samples on the right
are from the bottom of the gradient (70%). Bottom panels, Western blot analysis of
various marker proteins in the membrane fractions with the help of specific antibodies. (B)
The crude mitochondrial sample was subjected to 10 to 70% sucrose density gradient
centrifugation, and the fractions of the sucrose gradient were tested for the ability to
support RNA replication by the CIRV or TBSV replicases assembled in vitro. The most
active fraction in the replication assay was chosen as 100%. The fractions most enriched
for mitochondria are boxed with dotted lines. See further details described for panel A.
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Fig. 2.5 The in vitro-assembled TBSV or CIRV replicases form an RNase-resistant
structure in microsomal or mitochondrial preparations.
(A) Scheme of the in vitro assay. The in vitro reconstitution of the TBSV or CIRV
replicases is started by the addition of purified recombinant T33 and T92 as well as C36
and C95 replication proteins and the TBSV-derived (+)repRNA (zero time point) as
described for Fig. 2.1. Note that we applied a 15-min treatment with micrococcal
nuclease (which was inactivated by addition of EGTA at the end of the treatment) at
various time points, followed by RNA synthesis up to 4 h (total length of incubation). (B
and C) Denaturing PAGE analysis of the 32P-labeled repRNA products obtained. Note
that only the VRC-bound (membrane-associated) repRNA is resistant to nuclease
treatment and not the (+)repRNA released to the buffer from the VRCs. (B) Results with
microsomal preparations; (C) results with mitochondrial preparations. (D) Intact
organellar membranes are required for tombusvirus replication in vitro. Various amounts
of sorbitol in the assay buffer were used to test TBSV and CIRV replication.
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Fig. 2.6 In vitro reconstitution of heterologous combinations of tombusvirus replicases
in yeast microsome and mitochondrial preparations.
(A) Denaturing PAGE analysis of the 32P-labeled repRNA products obtained in
replication assays with the isolated yeast microsome preparation. The synthesized fulllength repRNA is indicated by an arrow. The result from the replication assay with T33
and T92 was chosen as 100% (lanes 1 and 2). (B) Denaturing PAGE analysis of the 32Plabeled repRNA products obtained in the replication assays with the isolated yeast
mitochondrial preparation. (C) SDS-PAGE analysis of microsome membrane association
assay using [35S]methionine-labeled recombinant T33 or C36 and a microsome
preparation in the presence of the soluble extract from yeast. The bottom panel (encircled)
represents samples incubated in the absence of the microsome preparation. (D)
Mitochondrial membrane association assay. [35S]methionine-labeled recombinant T33 or
C36 was used with the mitochondrial preparation in the presence of the soluble extract
from yeast. Asterisks represent 35S-labeled proteins. See further details described for
panel C.
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Fig. 2.7 In vitro reconstitution of chimeric tombusvirus replicases in yeast microsome
and mitochondrial preparations.
(A) The known functional domains in the TBSV p33 RNA chaperone and the p92pol
RdRp protein. The N-terminal segment in p92pol contains the same sequence as in p33
due to the strategy for overlapping expression of the TBSV genome, while the C-terminal
region of p92pol carries the RdRp domain. mPTS, peroxisomal membrane targeting
sequences; ub, monoubiquitinated region; TMD, transmembrane domains; late domain,
sequence recognized by the ESCRT factors; P, phosphorylation sites; RPR, arginineproline-rich RNA binding domain; S1 and S2, subdomains of the p33:p33/p92 interaction
domain. (B) Schematic representation of the chimeric RdRp proteins made between the
corresponding TBSV and CIRV replication proteins as shown. (C) Denaturing PAGE
analysis of the 32P-labeled repRNA products obtained in replication assays using the
chimeric RdRp proteins based on the isolated yeast microsome preparation. The
synthesized full-length repRNA is indicated by an arrow. The result from the replication
assay with T33 and T92 was chosen as 100% (lanes 1 and 2). (D) Denaturing PAGE
analysis of the 32P-labeled repRNA products obtained in the replication assays with the
chimeric RdRp proteins using the isolated yeast mitochondrial preparation. See further
details described for panel C.
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Fig. 2.8 In vitro reconstitution of additional chimeric tombusvirus replicases in yeast
microsome and mitochondrial preparations.
(A) Schematic representation of the chimeric replication proteins made between the
corresponding TBSV and CIRV replication proteins as shown. The T33 and C36
sequences were divided into three segments based on the known functions/roles (see Fig.
2.7A). (B) Denaturing PAGE analysis of the 32P-labeled repRNA products obtained in
replication assays using the chimeric tombusvirus replication proteins based on the
isolated yeast microsome preparation. The synthesized full-length repRNA is indicated
by an arrow. The result from the replication assay with T33 and T92 was chosen as 100%
(lanes 1 and 2). (C) Denaturing PAGE analysis of the 32P-labeled repRNA products
obtained in the replication assays with the chimeric tombusvirus replication proteins
using the isolated yeast mitochondrial preparation. See further details described for panel
B. (D) Coomassie blue-stained SDS-PAGE of the affinity-purified replication proteins
expressed in E. coli as MBP fusion proteins.

53

Fig. 2.9

54

Fig. 2.9 Distribution of TBSV and CIRV replication proteins when expressed in
heterologous combinations.
(A) Confocal laser microscopy images show the colocalization of Pho86p-CFP (ER
marker protein) with YFP-T92, YFP-T33, YFP-C95, or YFP-C36 expressed from the
GAL1 promoter in a pex3Δ yeast strain. The description on the left shows the
combination of replication proteins expressed in yeast. The merged images show the
colocalization of Pho86p-CFP with YFP-tagged replication proteins. Differential
interference contrast (DIC) images are shown on the right. (B) Localization of YFP-T92
or GFP-T92, YFP-T33 or GTP-T33, GFP-C95, or GFP-C36 expressed from the GAL1
promoter to the mitochondria in a pex3Δ yeast strain. We used rhodamine B (RhodB, red)
fluorescent dye to visualize the mitochondria. See further details described for panel A.
(C) Colocalization of YFP- or CFP-tagged TBSV and CIRV replication proteins in a
pex3Δ yeast strain. See further details described for panel A. (D) ER localization of YFPC95 or YFP-T33 in a pex3Δ yeast strain expressing heterologous combinations of
tombusvirus replication proteins. See further details described for panel A. (E)
Mitochondrial localization of GFP-C95 or GFP-T33 in a pex3Δ yeast strain expressing
heterologous combinations of tombusvirus replication proteins. See further details
described for panel A. (F) ER localization of YFP-T92 or YFP-C36 in a pex3Δ yeast
strain expressing heterologous combinations of tombusvirus replication proteins. See
further details described for panel A. (G) Mitochondrial localization of GFP-T92 or GFPC36 in a pex3Δ yeast strain expressing heterologous combinations of tombusvirus
replication proteins. See further details described for panel A. Yeast was grown under
similar conditions and images were taken as described for panel A. Each experiment was
repeated.
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Chapter 3

THE HOP-LIKE STRESS INDUCED PROTEIN 1 CO-CHAPERONE IS A
NOVEL RESTRICTION FACTOR FOR MITOCHONDRIAL TOMBUSVIRUS
REPLICATION
(This chapter was published on Journal of Virology ahead of print at 11 June 2014,
doi:10.1128/JVI.00561-14, Copyright © American Society for Microbiology)
3.1 Introduction

Cells produce a yet unknown number of host restriction factors that limit replication of
plus-stranded (+)RNA viruses. The cellular restriction factors could be virus-specific or
components of the cell-intrinsic innate systems of the host through targeting diverse
pathogens (133-139). Cellular factors are also recruited by (+)RNA viruses to aid viral
replication, which takes place in membrane-bound viral replicase complexes (VRCs) in
the cytoplasm of infected cells (13, 39, 40, 73-76, 78, 79). The diverse, often opposite
roles of host factors, is reflected by the identification of stimulatory as well as inhibitory
host proteins in genome-wide screens with various hosts and viruses, such as tomato
bushy stunt virus (TBSV), West Nile virus, brome mosaic virus (BMV), hepatitis C virus
(HCV), dengue virus and Drosophila virus C (12, 95, 140-146). However, the detailed
functions of the majority of the identified host proteins in (+)RNA virus replication have
not been fully revealed.
TBSV is a plant-infecting (+)RNA virus used extensively to study virus
replication, recombination, and virus - host interactions based on yeast (Saccharomyces
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cerevisiae) model (1, 5, 91, 92). We have performed several genome-wide screens of
yeast genes and different global proteomics approaches that have led to the identification
of over 500 host genes/proteins putatively involved in TBSV replication or
recombination (12, 93-99, 110, 126, 147-149). The above systematic screens have also
identified host stimulatory and restriction factors of TBSV replication. For example, the
Cyp40-like Cpr7p cyclophilin and the Ttc4 oncogene-like Cns1p co-chaperone are strong
inhibitors of TBSV replication in yeast and in vitro (109, 150). Additional cellular
cyclophilins, such as the CypA, and the related Ess1p parvulin also decrease TBSV RNA
accumulation in yeast and plants (109, 110, 151). Moreover, the cellular nucleolin, an
RNA binding protein, inhibits TBSV replication by blocking the recruitment of the viral
RNA into replication (112). Another group of cellular restriction factors is the WW-motif
containing host proteins, such as Rsp5p Nedd4-like E3 ubiquitin ligase, which regulate
the degradation of tombusviral p92pol in yeast cells and inhibit the activity of VRC in
vitro (108, 111). Cellular kinases, such as Pkc1p, could also restrict TBSV replication in
yeast (96). Altogether, studies on cellular restriction factors could help unraveling the full
arsenal of the native cell-intrinsic innate immune system in the host cell.
Similar to other (+)RNA viruses, tombusviruses, such as TBSV, uses intracellular
membranes for replication. Interestingly, TBSV utilizes the peroxisomal membrane,
while the closely related Carnation Italian ringspot virus (CIRV) takes advantage of the
outer mitochondrial membranes to build VRCs in infected plants and yeast (18, 19, 48).
The two viral replication proteins (i.e., p33 and p92pol for TBSV and p36 and p95pol in
case of CIRV) co-opt 8-10 host proteins to assemble the tombusvirus VRC (97-99, 152).
The highly homologous p33 of TBSV and p36 of CIRV replication proteins are master
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regulators of replication, playing multifunctional role in recruitment of the tombusviral
(+)RNA to the site of replication, the assembly of the VRC and viral RNA synthesis by
acting as RNA chaperones (3, 7, 9, 10, 32, 152). The RdRp protein p92pol of TBSV and
p95pol of CIRV are also components of the functional VRCs (2, 9, 10, 49, 92). The
subverted host proteins have been shown to bind to the viral RNA and the viral
replication proteins (13, 37, 98). Detailed studies showed that heat shock protein 70
(Hsp70), eukaryotic elongation factor 1A (eEF1A) and several members of the ESCRT
(endosomal sorting complexes required for transport) family of host proteins are required
for the assembly of VRCs (81, 100, 101, 103). Additional subverted host proteins include
the DDX3-like Ded1p and the human p68-like Dbp2 DEAD-box RNA helicases,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), eEF1Bγ and eEF1A, all of which
have been shown to affect viral RNA synthesis (37, 103, 104, 106, 153, 154).
Previous works with TBSV revealed the unexpected inhibitory function for
several TPR domain (tetratricopeptide repeats)-containing proteins, such as the Cyp40like Cpr7p cyclophilin and Ttc4-like Cns1p co-chaperone in yeast and in vitro (109, 150).
Mechanistic studies showed that the inhibitory effect of Cpr7p was due to its interaction
with the RNA-binding domain of the tombusviral p33 replication protein that leads to
inhibition of p33/p92pol -based recruitment of the TBSV (+)RNA for replication and
decrease of the efficiency of the VRC assembly. Importantly, the key element in Cpr7p
was not the cyclophilin domain, but its TPR domain consisting of three TPR modules in
Cpr7p (109). Similarly, via its TPR-domain, Cns1p bound to the tombusviral p33 and
p92pol replication proteins and inhibited VRC assembly and reduced TBSV replication in
yeast and in vitro based on a yeast cell-free (CFE) assay (150). However, in case of
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Cns1p, the interaction targeted the p33:p33/p92 interaction domain, suggesting that TPRcontaining cellular proteins might restrict TBSV replication via different mechanisms.
The TPR domains consists of repeats of 34 amino acid sequence adopting a righthanded helical helix-loop-helix structure with an amphipathic channel, which are
involved in many protein-protein interactions (155, 156). Although the TPR-domains are
highly variable, which likely affect substrate specificity, the canonical TPR-domain
contains a pattern of small and large hydrophobic amino acids. The TPR-domain proteins
are abundant in all kingdoms of life, including 200 proteins in mammals, 80 in C. elegans
and 29 in yeast (157). TPR-domain proteins function in protein trafficking, protein import
to organelles, transposon silencing, apoptosis and synaptic vesicle fusion (158, 159).
Various TPR-domain proteins are involved in numerous human diseases, such as cancer,
amyloidosis, cystic fibrosis, prion protein propagation, and bacterial pathogenesis (160165). Several TPR-domain proteins have been shown to affect infections by viruses, such
as Chikungunya virus, West Nile virus, Vesicular stomatitis virus, herpes simplex virus,
poxvirus, and baculovirus (166-171). TPR-domain proteins are also important in
interferon-induced antiviral responses, including the IFIT protein family (137, 171-174).
Our previous discoveries invited our attention to TPR-like sequences, including
the well-studied stress-induced protein 1 (Sti1p in yeast, Hop protein in mammals and
plants) co-chaperone. Sti1p, which is a conserved highly abundant protein lacking
chaperone activity on its own, is a co-chaperone of Hsp70 and Hsp90 chaperones (175,
176). Sti1p contains three TPR domains, which are involved in binding to Hsp90s and
Hsp70s. Sti1p plays a role in client protein transfer from the Hsp70 complex to the Hsp90
complex. Interestingly, Sti1p can simultaneously bind to Hsp70 and Hsp90 and by
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inhibiting the ATPase activity of Hsp90, Sti1p stabilizes the ternary Hsp70 : Hsp90 :
client protein intermediate complex (177, 178).
In this paper, we show that the yeast Sti1p co-chaperone has a strong inhibitory
function during the mitochondrial CIRV replication but not in the peroxisomal
tombusvirus replication. Detailed analysis of Sti1p revealed that it interacted with the
RNA-binding domain of CIRV p36 replication protein and ultimately restricted VRC
assembly in vitro and CIRV RNA accumulation in yeast and the orthologous Hop
inhibited CIRV accumulation in plants. Thus, TPR-containing cellular co-chaperone
proteins emerge as new cell-intrinsic restriction factors of a mitochondrial (+)RNA virus.

3.2 Materials And Methods

Yeast strains and expression plasmids. Yeast strains BY4741 (MAT a his3Δ1 leu2Δ0
met15Δ0 ura3Δ0) and sti1Δ (single-gene deletion strain) were obtained from Open
Biosystems (Huntsville, AL, USA). For tombusviral replication in yeast, pESCHisCNVp33-DI72, pYES-CNVp92, pESC-C36/DI72, pYES-C95 were described
previously (9). To generate pESC-C36/DI1, CIRV DI-1 (14) (constructed by D. Barajas
and

Nagy,

unpublished)

was

PCR-amplified

using

primers

#4124

(CCGGAATTCAGAAATATCTCAGGATTTGACCGTCC)/#1069(CCGGTCGAGCTC
TACCAGGTAATATACCACAACGTGTGT) and digested with EcoRI/SacI, then
inserted

into

EcoRI/SacI-digested

pESC-HisCNVp33-DI72,

generating

pESC-

HisCNVp33-DI1. Then, CNV p33 sequence was removed by BamHI/XhoI digestion, and
replaced with BamHI/XhoI-digested CIRV p36 sequence, which was PCR-amplified from
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pESC-C36/DI72

using

primers

#900

(CGACGGATCCGAGGGTTTGAAGGCTGAGTCTACCA)/#3230
(CCGCTCGAGCTATTT-GACACCGAGGGATT),

generating

pESC-C36/DI1.

To

generate Twin-Strep-tagged CIRV and CNV replication proteins, the following primer
pairs:

#5351

(CATCCACAATTCGAAAAATCTGCTGGTGGAGGTGG-

ATCCATGGATACCATCAAGAGGATG)/#952

(CCCGCTCGAGTCATGCTACGG-

CGGAGTCAAGGA),

#5350

(GTGGTTCTGGTGGTGGTTCTGGTGGTTCTGCTTGGTCTCATCCACAATTCGAAAAATCTG)/#952,

#5349

(GGAAGATCTAAAAA-

TGTCTGCTTGGTCTCATCCACAATTCGAAAAAGGTGGTGGTTCTGGTGGTGGT
TCTGGTGG)/#952, were sequentially used for PCR using template pYES-CNVp92 to
introduce Twin-Strep tag on CNV p92, generating Twin-Strep-tagged CNVp92
sequence. The DNA was then digested with BglII/XhoI and inserted into pESC-DI72,
generating pESC-StrepCNVp92/DI72. CIRV p36 sequence was PCR-amplified using
primers #900/#3230 and digested with BamHI/XhoI, and then inserted into BamHI/XhoIdigested pESC-StrepCNVp92/DI72, generating pESC-StrepC36/DI72. To generate
pYES-StrepC95, pYES2-NTA (Invitrogen) was digested with HindIII/KpnI and then
treated with T4 DNA polymerase, and subsequently self-ligated to remove 6xHis tag. The
modified pYES2-NTA vector without 6xHis tag was digested with BamHI/XhoI and used
with BglII/XhoI-digested PCR product of Twin-strep-tagged CNVp92 for ligation,
generating pYES-StrepC92. CIRV p95 sequence was PCR-amplified using primers
#900/#970 (CCCGCTCGAGTCAAGCTACGGCGGAGTCGAGGA) from pYES-C95
and digested with BamHI/XhoI, and then inserted into BamHI/XhoI-digested pYES-

61

StrepC92, generating pYES-StrepC95. To generate yeast vector expressing STI1 gene,
pTEF1 promoter and tCYC1 terminator was PCR-amplified from yeast genomic DNA
and

pESC-C36/DI72

(9),

respectively,

using

primer

pair

#2764

(CCGCGAGCTCATAGCTTCAAAATGTTTCTAC)/#3726
(CCGCGCGGCCGCGTAATTAAAACTTAGATTAGATTGC),

or

(CCGCGTCGACGAGGGCCGCATCATGTAA)

#3728
/#3730

(CCGCGGGCCCAGCTTGCAAATTAAAGCCTTC), and digested with SacI/NotI or
ApaI/SalI. Digested pTEF1 and tCYC1 were sequentially inserted into SacI/NotI or
ApaI/SalI-digested pRS315 vector, generating pRS315-pTEF1 (Zhenghe Li and PD
Nagy, unpublished data). pRS315-pTEF1 was digested with NotI/SalI and ligated with
annealed

primers

of

#5157

GGCCGAAAATGAGATCTGGCACTAGTGACTACAAGGACGACGATGACAAGG
GTGGCGGTC

/#5158

CTAGGACCGCCACCCTTGTCATCGTCGTCCTTGTAGTCACTAGTGCCAGATCT
CATTTTC to introduce Flag-tag, generating pRS315-NFlag.
Plasmids expressing wt Sti1p or derivatives (C49Y, G325D; ∆TPR2; or ∆TPR1)
were generated by using available STI1 mutants (179, 180) in PCR-amplifications using
primer

pairs

#2863

CGCGGGATCCATGTCATTGACAGCCGATG

CGCGCTCGAGTTAGCGGCCAGTCCGGATG

or

/#2864
#5156

CGCGGGATCCAACCCAAAAACTAGCGAAATGATG /#2864, and the obtained PCR
products were treated with BamHI/SalI and then were inserted into BamHI/SalI-digested
pRS315-NFlag. To visualize Sti1p in yeast, mRFP1 was PCR-amplified from pGADPEX13-RFP

(81)

using
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primers

#2630

CGCGGGATCCATGGCCTCCTCCGAGGACGTC

/#5159

GGACTAGTGGCGCC-

GGTGGAGTGG, and the PCR product was digested with BamHI/PstI, and inserted into
BglII/PstI-digested pRS315-Sti1 to generate pRS315-mRFP1-Sti1.
E. coli-based expression plasmids, pGEX-2T-Sti1 and mutated derivatives (C49Y,
G325D, ∆TPR1,

∆TPR2)

were

generated

by

(CGCGGGATCCATGTCATTGACAGCCGATG)

PCR

using

primers

and

#2863
#4860

(CGCCGAATTCTTAGCGGCCAGTCCGGATGAT), followed by digestion with
BamHI/EcoRI and then ligation into BamHI/EcoRI-digested pGEX-2T.
Arabidopsis thaliana STI1 ortholog AtHOP-1 (181) and the TPR1 deletion
version (AtHOP1∆TPR1) were PCR -amplified from Arabidopsis cDNA using primers
#5659

CGCTGATCAATGGCGGAAGAAGCAAAATCCAAAGG

CCGCTCGAGTTACCGGACCT-GAACAATTCCGGCACTAACC

and

/#5661
#5660

CGCTGATCAATGGATCCGGGGACTAGGGTTTATTTGGAG /#5661, respectively,
followed by digestion with BclI/XhoI, and the PCR products were inserted into
BamHI/SalI digested pRS315-NFlag, generating pRS315-AtHOP1 and pRS315AtHOP1∆TPR1, respectively.

Analysis of CIRV repRNA replication in yeast. For measuring CIRV repRNA
accumulation, yeast strains BY4741 and sti1∆ were transformed with plasmids pESCC36/DI72 and pYES-C95. For complementation and overexpression studies, we
transformed yeast strains BY4741 and sti1∆ with pRS315-Sti1 (FLAG-Sti1 plasmid).
Tombusvirus repRNA replication was induced by culturing in sc-ULH- with 2%
galactose medium after overnight culture and then yeast was cultivated for 2 days at
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23°C. Total RNA was isolated from yeast and used for detection of repRNA levels by
Northern blot analysis as described previously (182). Replication was calculated by
measuring the accumulation of CIRV DI1 repRNA or the TBSV DI-72(+) repRNA
relative to the accumulation of 18S ribosomal RNA. The tombusvirus replication protein
analysis was performed as described previously using an anti-His6 antibody as the
primary antibody for the detection of His6-p36 and His6-p95. Detection of Flag-Sti1p and
Sti1p was carried out using primary anti-Flag and anti-Sti1 antibody, respectively. The
secondary antibody for both primary was alkaline phosphatase-conjugated anti-mouse
immunoglobulin G (Sigma) (109).

Analysis of protein-protein interaction by split-ubiquitin assay. The bait constructs,
pGAD-BT2-N-His36 and pGAD-BT2-N-His33, expressing CIRV replication protein p36
and p33 tombusvirus replication protein have been published before (99, 110). The PCR
products of STI1 and its various truncation versions were digested with BamHI/XhoI and
ligated into the pPRN-N-RE vector digested with BamHI/SalI enzymes. Yeast strain
sti1∆/NMY51 was co-transformed with pGAD-BT2-N-His36 or pGAD-BT2-N-His33
and pPR-N-RE (NubG) or one of the prey-constructs carrying STI1 and plated onto Trp/Leu- (TL-) synthetic minimal medium plates for plasmid selection (99, 110). Yeast
colonies were re-suspended in 50 µl water and spotted onto Trp-/Leu-/His-/Ade- (TLHA) plates for 2-4 days to detect bait–prey interactions. Plasmid containing the yeast SSA1
Hsp70 gene served as the positive control and empty vector (pPR-N-RE) as negative
control in this assay (99, 110).
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Protein purification from E. coli. pMAL-p33 (TBSV p33), pMAL-p92 (TBSV p92),
pMAL-p36 (CIRV p36), and pMAL-p95 (CIRV p35) (149) were transformed separately
into E. coli strain BL21DE3CodonPlus. Protein expression was induced using isopropyl
β-D-thiogalactopyranoside (IPTG) for 8 h at 16°C, and the cells were harvested by
centrifugation at 5,000 rpm at 4°C for 5 min to remove the medium prior to -80°C
storage. Affinity columns containing amylose resin (NEB) were used to purify MBPtagged recombinant proteins. The frozen pellets were suspended and sonicated in MBP
column buffer containing 20 mM Tris-Cl pH 8.0, 150 mM NaCl, 1 mM EDTA, 10 mM
β-mercaptoethanol and 1 mM phenylmethylsulfonyl fluoride (PMSF). The sonicated
extract was centrifuged at 15,000 rpm for 5 min, and the supernatant was added to the
pre-equilibrated amylose resin for 1 h rotating incubation at 4°C. After washing the resin
3 times with column buffer and once with a low salt column buffer (25 mM NaCl), the
proteins were eluted with a low salt column buffer containing 0.18% (V/W) maltose and
stored at -80°C in 6% (V/V) glycerol. Protein fractions used for the replication assays
were 95% pure, as determined by 12% SDS-PAGE and staining with Coomassie-Blue.
Expression of GST-tagged proteins Cpr7p, Cpr7-TPRp, Cns1p, Sti1p and its
mutated versions (C49Y, G325D, ∆TPR1, and ∆TPR2) were induced using isopropyl β-Dthiogalactopyranoside (IPTG) for 6 h at 23°C, and the cells were harvested by
centrifugation at 5,000 rpm at 4°C for 5 min to remove the medium and stored at -80°C.
Purification of GST-tagged proteins was carried out using glutathione resin and eluted
with 10 mM glutathione, 10 mM ß-mercaptoethanol in the column buffer following the
same protocol as MBP-proteins.
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In vitro tombusvirus replication assay using yeast mitochondrial preparations. Yeast
intact mitochondria were purified as described previously (149). The purified
mitochondrial fraction (1 µl) and different dilutions of GST, Sti1p, Cpr7p, or Cns1p
proteins (8, 16, 32 µM each) were incubated at 25°C for 1 hr in 8 µl buffer A (containing
30 mM HEPES-KOH [pH 7.4], 150 mM potassium acetate, 5 mM magnesium acetate,
and 0.6 M sorbitol) with 15 mM creatine phosphate, 1 mM ATP, and GTP, 0.1 mg/ml
creatine kinase, 0.1 μl of RNase inhibitor, 10 mM dithiothreitol, 0.5 μg DI-72 RNA
transcript, and affinity-purified 0.5 μg MBP-36 (CIRV p36) and MBP-p95 (CIRV p95).
The volume of the reaction mixture was then adjusted by adding 16 μl buffer B
(containing 30 mM HEPES-KOH [pH 7.4], 150 mM potassium acetate, and 5 mM
magnesium acetate) with 15 mM creatine phosphate, 1 mM ATP, CTP, and GTP, 0.025
mM UTP, 0.2 μl of [32P]UTP, 0.1 mg/ml creatine kinase, 0.2 μl of RNase inhibitor, 10
mM dithiothreitol, and 0.05 mg/ml actinomycin D. The reaction mixture was incubated at
25°C for 3 h and terminated by adding 100 µl stop buffer (1% sodium dodecyl sulfate
and 0.05 M EDTA, pH 8.0) followed by 100 µl phenol-chloroform extraction,
isopropanol-ammonium acetate precipitation overnight at -20°C and washing by 70%
ethanol. The newly synthesized 32P-labeled RNA products were incubated at 85°C for 5
min and separated by electrophoresis in a 5% polyacrylamide gel containing 0.5× Trisborate-EDTA buffer with 8 M urea. Signals were detected using a Typhoon 9400
imaging scanner (GE/Amersham) and quantified by imageQuant software.

Co-purification of host proteins with Twin-Strep-tagged CIRV replication proteins
from yeast. To purify the protein of interest, 200 mg BY4741 yeast cells transformed
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with plasmids pESC-StrepC36/DI72 pYES-StrepC95 and pFLAG-Sti. Cultured yeasts
were re-suspended and homogenized in Buffer B (50 mM Tris-HCl, pH 7.5; 15 mM
MgCl2, 10 mM KCl, 10 mM β-mercaptoethanol, 1% [V/V] yeast protease inhibitor
cocktail) by glass beads [modified from (92)]. Membrane fractions from cell
homogenates were collected and solubilized with column buffer (50 mM Tris-HCl pH
7.5, 15 mM MgCl2, 500 mM KCl, 1% Triton X-100, 5% SB3–10 [caprylyl sulfobetaine]
(Sigma), 10 mM β-mercaptoethanol, 1% [V/V] yeast protease inhibitor cocktail), and
incubated with 40 µl StrepTactin Superflow hi-capacity 50% resin (IBA Life Sciences)
for 1 hour at 4°C in a column. StrepTactin resin was then washed two times with column
buffer, two times with wash buffer (50m M Tris-HCl pH 7.5, 15 mM MgCl2, 10 mM
KCl, 0.1% Triton X-100, 10 mM β-mercaptoethanol, 1% [V/V] yeast protease inhibitor
cocktail), and eluted with SDS-PAGE loading buffer, then subjected to SDS-PAGE and
Western blotting analysis with Strep-Tactin AP Conjugate (IBA Life Sciences), anti-Flag
and anti-Hsp70 antibodies (Abcam).

Confocal laser microscopy. Wild type BY4741 or sti1∆ yeast strains were transformed
with the following expression plasmids: pESC-GFP-C36/DI72, pYES-C95, or pESCGFP-C33/DI72, pYES-C92 (9), as well as pRS315-RFP-Sti1p. The yeast cultures were
incubated in galactose medium overnight, sampled and imaged with Olympus FV1000
confocal laser scanning microscope (Olympus America Inc., Melville, NY). The
microscope settings were the following: excitation and emission for GFP and RFP were
488nm laser/500-530nm filter and 543nm laser/560-660nm filter, respectively.
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Virus induced gene silencing of Sti1/HOP ortholog gene. Virus induced gene silencing
(VIGS) in Nicotiana benthamiana was performed as described in (183). The C-terminal
fragment of N. benthamiana HOP gene (yeast STI1 ortholog, based on Arabidopsis
AtHOP-1 gene) was PCR-amplified from total N. benthamiana cDNA using primers
#5786

(CGCGGATCCAGGGCATACAGCAACAGGGC)

/#5787

(CCGCTCGAGTTATTTGACTTGAATAATTCCTGCACTAACCAAC). The obtained
PCR product was digested with BamHI/XhoI and inserted into pTRV2 digested with
BamHI/XhoI, generating pTRV2-NbHop. As a control for the VIGS experiments, the Cterminal-half

of

GFP

sequence

was

PCR-amplified

by

CGCGGATCCGAAGGTGATACCCTTGTTAATAGAATCGAG

primers

#5353
/#3712

CGGCCTCGAGTTACGCATAGTCAGGAACATCGTATGGGTAGAGTCCGGACTT
GTATAGTT from pESC-GFP-C36/DI72, digested with BamHI/XhoI and inserted into
pTRV2 generating pTRV2-1/2GFP. VIGS-treated N. benthamiana plants were sap
inoculated with CIRV or CNV inocula on the 14th day post silencing. Samples from the
inoculated leaves were harvested and subjected to total RNA extraction and Northern blot
analysis for viral RNA (81, 183). Efficiency of NbHOP silencing was evaluated by semiquantitative reverse transcription PCR using NbHOP and Actin gene-specific primer
pairs: #5785 (CGCGGATCCAGAGCAGCAAGAGTATTTCGATCCAC) /#5787 and
#3993

(GGAAGTAGCATAAGATGGCAGATGGAGAGG)

(CCAGATCTTCTCCATATCATCCCAGTTGCTGAC), respectively.

3.3 Results
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/#3994

Yeast-based studies reveal that Sti1p co-chaperone selectively inhibits mitochondrial
CIRV replication, but not the peroxisomal TBSV replication. Based on our previous
findings that two abundant cytosolic TPR-containing cellular proteins, namely Cpr7p
cyclophilin and Cns1p co-chaperone, showed robust restriction activity against TBSV
(109, 150), we also tested the abundant TPR-containing protein Sti1p co-chaperone for
possible effect on the accumulation of TBSV and CIRV replicon (rep)RNAs in sti1∆
yeast versus wt yeast cells. Interestingly, sti1∆ yeast supported CIRV repRNA
accumulation at a ~3-fold higher level than in wt yeast (Fig. 3.1A, lanes 5-6 versus 1-2).
However, replication of the TBSV repRNA was comparable in sti1∆ and wt yeast (Fig.
3.1B, lanes 4-6 versus 1-3), suggesting that Sti1p has a CIRV-specific inhibitory effect.
To test if Sti1p-based inhibition targets the CIRV RNA, we also tested TBSV repRNA
accumulation in the presence of CIRV p36 and p95pol replication proteins, which are
capable of supporting the replication of the heterologous TBSV repRNA (9), in sti1∆
yeast versus wt yeast cells. The obtained data showed ~2-fold increased level of TBSV
repRNA accumulation (Fig. 3.1C, lanes 4-6 versus 1-3), demonstrating that the inhibitory
effect of Sti1p is targeted against the CIRV p36 and p95pol and not the viral RNA.
Comparison of the accumulation of CIRV p36 and p95pol in sti1∆ yeast versus wt yeast
cells revealed similar replication protein levels (Fig. 3.1C), arguing that Sti1p is unlikely
to affect translation or stability of CIRV p36 and p95pol in yeast cells.
To further test if Sti1p can inhibit CIRV replication in vivo, we over-expressed Nterminally FLAG-tagged Sti1p in yeast supporting CIRV or TBSV accumulation. We
found that over-expression of Sti1p reduced CIRV accumulation by ~3-fold in wt yeast
(Fig. 3.2A, lanes 4-6 versus 1-3) and by ~5-fold in sti1∆ yeast (Fig. 3.2A, lanes 10-12
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versus 7-9). The level of CIRV p36 and p95pol replication proteins was comparable in
sti1∆ or wt yeasts over-expressing FLAG-Sti1p (Fig. 3.2A), suggesting that Sti1p is
unlikely to affect the stability of these viral proteins in yeast. In contrast, replication of
the TBSV repRNA was not affected by the over-expression of Sti1p in wt (Fig. 3.2B,
lanes 13-16) or in sti1∆ or wt yeasts (lanes 17-24). Altogether, these data support that
Sti1p is a strong inhibitor of the CIRV p36 and p95pol replication proteins, while Sti1p
seems to be ineffective against the tombusviral p33 and p92pol replication proteins in
yeast.

The binding of Sti1p involves different regions in CIRV p36 and the TBSV p33
replication proteins. Sti1p contains three TPR domains (Fig. 3.3A) that are predicted to
interact with the tombusviral replication proteins. To test if Sti1p can interact with the
CIRV p36 versus the TBSV p33 replication proteins, we first used the split-ubiquitin
based two-hybrid assay in sti1∆ yeast (184, 185). We observed strong interaction
between Sti1p and p36 (Fig. 3.3B) and Sti1p and p33 (Fig. 3.3C). We confirmed the
interaction between Sti1p and p36 replication protein in sti1∆ yeast (Fig. 3.3D, lane 2)
using a co-purification assay with recombinant Sti1p. The reciprocal co-purification
assay with Strep-tagged p36 also resulted in co-purification of Flag-Sti1p from sti1∆
yeast (Fig. 3.3E, lane 1).
To test what region(s) of Sti1p interacts with p36, we used well-characterized
Sti1p mutants lacking particular functional domains (179, 180) as shown in Fig. 3.3A.
The split-ubiquitin assay showed that the interaction with p36 was not eliminated by
deletion (∆TPR1) or mutation (C49Y, and K73E) in the TPR1 region (Fig. 3.3B), which
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binds to Hsp70 (175, 186). Similarly, deletion (∆TPR2) or mutations (G325D or T526I) in
the TPR2 region (Fig. 3.3B), which binds to Hsp90, did not debilitate interaction with
p36 replication protein. These findings were confirmed in the reciprocal co-purification
experiments (Fig. 3.3D-E), demonstrating that Sti1p could use both the TPR1 and TPR2
sequences to bind to the p36 replication protein. Interestingly, binding of Sti1p to the
TBSV p33 replication protein showed similar features with p36 binding (Fig. 3.3C versus
Fig. 3.3B). Thus, the binding characteristics of Sti1p to CIRV p36 versus TBSV p33 do
not explain why Stip1 can selectively inhibit CIRV replication, but not TBSV replication
in yeast cells.
To map the Sti1p binding site in CIRV p36 replication protein, we have used
pull-down experiments with immobilized MBP-p36 truncation derivatives (Fig. 3.4A)
and Sti1p present in either E. coli lysate (Fig. 3.4B) or yeast extract containing Flag-Sti1p
(Fig. 3.4C). These experiments revealed that Sti1p binds to a region that includes the
RPR motif of p36, which is involved in RNA binding (Fig. 3.4B-C, lane 6, construct
p36C4 in Fig. 3.4A). The RPR-motif in replication proteins is required for specific viral
(+)RNA recruitment and replicase assembly, and it also binds to Cpr7p Cyp40-like
cyclophilin (4, 102, 109, 187). Interestingly, the same RPR-containing region in p36
replication protein could bind to both the TPR1 and TPR2 sequences in Sti1p (Fig. 3.4DE, lane 6).
To map the Sti1p binding site in the TBSV p33 replication protein, we have used
similar pull-down experiments with immobilized MBP-p33 truncation derivatives (Fig.
3.4F) in combination with yeast extract containing Flag-Sti1p or its truncation derivatives
(Fig. 3.4G). We found that Sti1p binds to the C-terminal region of TBSV p33 containing
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the p33:p33/p92 interaction sequences (Fig. 3.4F). Deletion of the RPR motif, involved in
RNA binding, did not inhibit p33 binding to Sti1p (Fig. 3.4G, lane 13). Thus, there is a
major difference in Sti1p binding to CIRV (the RPR-containing sequence) and TBSV
replication proteins (the C-terminal region in TBSV p33), suggesting that the mechanism
of inhibition of CIRV replication by Sti1p could be based on blocking the RNA-binding
function of CIRV p36 replication protein.

Sti1p is co-localized with CIRV p36 in yeast cells. To study if the mostly cytosolic Sti1p
is recruited to the mitochondrial membranes, where CIRV replication takes place (9, 48),
by the CIRV p36 in yeast cells, we co-expressed GFP-p36 with RFP-Sti1p in wt or sti1∆
yeast cells. Confocal laser microscopy revealed the robust recruitment of RFP-Sti1p by
CIRV p36 to punctate structures, likely representing the mitochondrial membranes as
shown before (9, 18, 48) in both wt and sti1∆ yeast cells (Fig. 3.5A). In contrast, the
GFP-tagged p33 did not efficiently recruit RFP-Sti1p to p33-containing punctate
structures (Fig. 3.5B), which likely represent peroxisomal membranes (10, 107). RFPSti1p showed diffused, mostly cytosolic distribution in yeast expressing p33 replication
protein. Based on these data, we suggest that unlike p33, the CIRV p36 replication
protein efficiently recruits Sti1p to the site of replication, leading to robust inhibition of
CIRV replication.

The TPR1 domain in Sti1p is required to inhibit CIRV replication in isolated
mitochondria-based assay and in yeast cells. To test what domain of Sti1p is required to
block CIRV replication, we expressed mutated versions of Sti1p in wt yeast. We
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observed ~2-fold inhibition of CIRV repRNA accumulation by ∆TPR2 and G325D
mutants, comparable to that obtained with the full-length Sti1p (Fig. 3.6A), while
expression of ∆TPR1 or C49Y mutants had no detectable and lesser inhibitory effects,
respectively (lanes 9-12 and 21-24 in Fig. 3.6A). All these mutated versions of Sti1p
were expressed at comparable levels in wt yeast without substantially affecting CIRV p36
or p95 levels (Fig. 3.6B-C). Altogether, based on these data, we suggest that the TPR1
domain of Sti1p is required to inhibit CIRV replication in yeast.
To further test the roles of the TPR sequences of Sti1p in CIRV replication, we
applied an isolated mitochondria-based replication assay, which take advantage of
purified recombinant CIRV p36, p95pol replication proteins and repRNA transcripts to
support full CIRV replication in vitro (Fig. 3.7A) (9, 49, 102). Addition of the affinitypurified full-length recombinant GST-Sti1p (Fig. 3.7B) decreased the production of
repRNA by up to 3-fold (Fig. 3.7C, lanes 5-7 versus 2-4), confirming that Sti1p has an
inhibitory effect on CIRV replication in vitro. Pre-incubation of Sti1p either with Ssa1p
Hsp70 chaperone or p36 replication protein to facilitate protein complex formation did
not alter the inhibitory effect of Sti1p (Fig. 3.7D), suggesting that Sti1p has robust effect
on CIRV replication in vitro. The presence of recombinant Sti1p lacking functional TPR2
domain (e.g., ∆TPR2 or mutant G325D) was also inhibitory, reducing CIRV replication by
up to ~5-fold in the isolated mitochondria-based assay (Fig. 3.7C, lanes 11-16 and 7D,
lanes 15-22). In contrast, inactivation of TPR1 (∆TPR1 or mutant C49Y) resulted in the
loss of the inhibitory function of Sti1p (Fig. 3.7C, lanes 8-10, 17-19 and 7D, lanes 11-14)
in the isolated mitochondria-based replication assay, thus emphasizing the critical role of
the TPR1 sequence in Sti1p.
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Comparison of the inhibitory effects of host proteins carrying TPR domains on CIRV
replication in isolated mitochondria-based replication assay. Two other cellular proteins
with TPR domains, namely Cpr7p cyclophilin and Cns1p co-chaperone, have been shown
to inhibit TBSV replication (109, 150). Test if these host proteins have comparable
activities to Sti1p in inhibition of CIRV replication, we used the isolated mitochondriabased in vitro replication assay and purified recombinant cellular proteins and CIRV
replication proteins (Fig. 3.8A-B). Interestingly, all these TPR-containing proteins
inhibited CIRV replication in vitro with Sti1p and the TPR region of Cpr7p showing up
to ~10-fold reduction in repRNA production in the isolated mitochondria-based
replication assay (Fig. 3.8A, lanes 6-8 and 12-14 versus 3-5). Cns1p was the least
effective in this assay (Fig. 3.8A, lanes 15-17), but this could be due to the lower amount
of recombinant GST-Cns1p obtained from E. coli (Fig. 3.8B). However, the purified
recombinant GST-Cns1p was the most effective inhibitor of TBSV replication by
reducing TBSV replication by up to ~20-fold in total cell-free extract (CFE)-based
replication assay (Fig. 3.8C) (150). Altogether, the TPR-containing Cpr7p seems to have
strong inhibitory effect against both TBSV and CIRV replication, while Sti1p efficiently
inhibits CIRV, but its effect is only moderate on TBSV replication in vitro.

The plant Hop ortholog of the yeast Sti1p inhibits CIRV replication in yeast and plants.
Arabidopsis thaliana has three orthologs of Sti1p co-chaperone, namely AtHop1-3, that
carry TPR1 and TPR2 domains (181, 188). To test if AtHop-1 could inhibit CIRV
replication, we expressed it in yeast. Similar to the yeast Sti1p, AtHop-1 inhibited CIRV
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accumulation by ~5-fold in yeast (Fig. 3.9, lanes 4-6). Deletion of the TPR1 sequence
made AtHop-1 less effective inhibitor of CIRV replication (Fig. 3.9, lanes 7-9),
suggesting that the TPR1 sequence is important for the inhibitory function of AtHop-1.
To test the relevance of the plant Hop protein in tombusvirus replication, we
tested the accumulation level of Hop mRNA in Nicotiana benthamiana host. The semiquantitative RT-PCR analysis revealed the induction of NbHop mRNA upon infection
with CIRV (Fig. 3.10A). In addition, knockdown of NbHop level via VIGS in N.
benthamiana led to ~3-fold increased CIRV genomic RNA accumulation (Fig. 3.10B).
As expected, due to the high level CIRV accumulation, the Hop-knockdown in N.
benthamiana plants died even more rapidly than control plants when infected with CIRV
(Fig. 3.10C). In contrast, the accumulation of the genomic RNA of the related CNV (a
peroxisomal replicating tombusvirus, closely related to TBSV) was not significantly
affected by Hop-knockdown N. benthamiana plants (Fig. 3.10D). Also, the symptom
severity of CNV-infected knockdown or control plants was comparable (Fig. 3.10E).
Based on these in planta experiments, we suggest that the plant Hop ortholog plays a
potent inhibitory role, similar to the yeast Sti1p, in the mitochondrial CIRV replication,
but not in the peroxisomal CNV replication.

3.4 Discussion

Identification of the Hop-like Sti1p co-chaperone as a novel cell-intrinsic restriction
factor against CIRV replication in mitochondria. Cellular protein chaperones are
important for virus replication and during other steps of the infectious process (74, 18975

195). For example, Hsp70 has been shown to affect the intracellular localization and
membrane insertion of TBSV replication proteins and the assembly of the tombusviral
VRCs (100-102). Although Hsp70 interacts directly with the tombusviral replication
proteins, it is possible that other cellular factors could affect the subversion of Hsp70s by
TBSV. Since co-chaperones facilitate selection and delivery of client proteins to the
major Hsp70 and Hsp90 chaperones (196-198), some co-chaperones might also be
involved in viral infections as demonstrated in this paper and earlier (74, 189-195).
Our finding that the conserved cellular Hop-like Sti1p co-chaperone is a restriction
factor for CIRV replication in the mitochondria contributes to the emerging complex
roles of cellular chaperones in virus replication (74). While deletion of Sti1p led to a 2-to4-fold increase in CIRV replication in yeast model host or knockdown of the orthologous
Hop in N. benthamiana increased CIRV accumulation by ~3-fold, over-expression of
Sti1p or AtHop-1 in yeast was inhibitory. In vitro CIRV replication experiments based on
isolated mitochondria also confirmed the robust inhibitory effect of Sti1p on CIRV.
Moreover, the expression of the Sti1 ortholog Hop is increased during CIRV replication
in plant leaves. Thus, Sti1p is a new member of the growing family of cell-intrinsic
restriction factors.
However, Sti1p did not have robust effect on replication of the closely related TBSV
in yeast or on the replication of CNV in plants, both of which utilize the peroxisomal
membranes for replication (10, 107). This contrasting finding with Sti1/Hop for different
tombusviruses exploiting different subcellular locations could be due to the difference in
accessibility of Sti1/Hop to replication proteins of tombusviruses in their respective
cellular environments. For example, it has been shown in plants that Hop/Sti1 is involved
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in transportation of freshly synthesized mitochondrial and chloroplast proteins from the
cytosol into these organelles (199). Moreover, the delivery/import of mitochondrial
preproteins from the cytosol to the mitochondria often depends on Hsp70/Hsp90
chaperones and includes Hop/Sti1 and the TPR domain in Tom70 mitochondrial receptor
(200, 201). Also, the CIRV p36 replication protein was shown to interact with various
Tom receptor proteins, which might have roles in mitochondrial membrane insertion of
p36 (19). Based on these studies, we propose that Sti1/Hop might be easily accessible and
bind efficiently to the mitochondria-targeted CIRV replication proteins in cells, while the
cellular Sti1/Hop co-chaperone has a lesser chance to bind to the peroxisome-targeted
TBSV and CNV replication proteins. Accordingly, live cell imaging showed the relocalization of Sti1p to the mitochondria in the presence of CIRV p36, while Sti1p
showed mostly cytosolic localization in yeast cells expressing the CNV p33 replication
protein (Fig. 3.5). Thus, the difference in accessibility of Sti1/Hop could be the major
mechanism restricting CIRV but not TBSV or CNV replication.

Mechanisms of Sti1p co-chaperone-driven restriction of CIRV replication.
Recruitment of the tombusvirus (+)RNA into replication requires selective binding by the
tombusvirus replication proteins via recognition of a RNA recruitment element (named
p33RE) within the polymerase gene sequence (3, 202). The same p33RE element is also
required for the VRC assembly and activation of the polymerase function of the
replication protein (4, 203). The specific recognition of p33RE is performed by arginines
within the RPR motif in p33/p92pol (123, 204). Therefore, binding of cellular factors to
the RPR motif containing region could block the ability of p33/p92pol to bind the viral
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(+)RNA, thus inhibiting the essential viral processes of (+)RNA recruitment, VRC
assembly and replicase activation (203, 205). Indeed, the TPR domain of Cpr7p binds to
the RPR region in the tombusvirus replication proteins and blocks the above viral
processes, thus acting as a restriction factor (109). We find that Sti1p also binds to the
RPR region in the CIRV p36/p95pol replication proteins (Fig. 3.4) and this could explain
the strong in vitro inhibitory effect of recombinant Sti1p on CIRV replication based on
mitochondrial preparations (Fig. 3.7). The CIRV p36 interaction with Sti1p also leads to
the recruitment of Sti1p to punctate structures (mitochondrial membranes) in yeast cells,
suggesting robust p36:Sti1p interaction in cells. Thus, direct interaction between the
Sti1p and CIRV p36 might block viral RNA recruitment (see Model 1, Fig. 3.11).
However, the picture on the mechanism of CIRV inhibition is likely more complex.
This is because both the TPR1 and TPR2 regions of Sti1p bind to the RPR domain of
CIRV p36, yet the expression of TPR1 is inhibitory, while TPR2 is less effective in
reducing CIRV accumulation in yeast or CIRV replication in vitro with mitochondrial
preparations (Figs. 3.6-3.7). Thus, the binding to the RPR domain in p36 is unlikely
enough for Sti1p to effectively inhibit p36 functions.
Interestingly, Sti1p does not bind to the RPR region of the TBSV p33 replication
protein. The binding between p33 and Sti1p involves the C-terminal region of p33
containing the p33:p33/p92 interaction sequence (Fig. 3.4F-G). It is possible that this
interaction is not robust/stable enough to interfere with p33 functions in cells. It is likely
that p33 could readily interact with additional p33 molecules, while binding to Sti1p
molecules by p33 might be less favored in cells. Indeed, Sti1p is not efficiently
relocalized to punctate structures containing the p33 molecules in yeast cells (Fig. 3.5B).
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A similar situation was observed with Cpr6p Cyp40-like cyclophilin, which also binds to
p33 within the C-terminal domain and does not inhibit p33 functions (109). Yet, this rule
is not general, since Cns1p co-chaperone binds to the p33:p33/p92 interaction sequence
in TBSV p33 replication protein and effectively inhibits TBSV replication in yeast (150)
and in vitro (Fig. 3.8C). It seems that the intracellular accessibility of these TPRcontaining host proteins might be a major factor in their ability to inhibit replication of
different tombusviruses.
Although direct interaction between the RPR region of CIRV p36 and the TPR1
sequence in Sti1p might explain the inhibitory effect on CIRV replication (Fig. 3.11,
model 1), it is also possible that Sti1p limits the functions of subverted cellular factors,
such as Hsp70, for its ontiviral activity. Cytosolic Hsp70s are co-opted by tombusviruses
and they are permanent residents in the tombusviral VRCs (98). This model is supported
by the observation that, in spite of the binding of both TPR1 and TPR2 sequences to the
RPR region of CIRV p36 (Fig. 3.3), only the expression of the Hsp70-interacting TPR1
region (175, 177) was able to robustly inhibit CIRV replication in yeast and in vitro
(Figs. 3.6-3.7). Moreover, mutation within the TPR1 sequence (i.e., mutant C49Y) that
debilitates the interaction with Hsp70, but not with p36 (Fig. 3.3) had lesser inhibitory
effects on CIRV replication when expressed in yeast (Fig. 3.6). In contrast, a mutation
(i.e., mutant G325D) that affects interaction with Hsp90 did not interfere with the
inhibitory function of Sti1p in vivo or in vitro. Based on these findings, we propose that
the recruited Sti1p co-chaperone inhibits the proviral function of the co-opted cellular
Hsp70 molecules during CIRV replication. For example, the predicted Sti1p:Hsp70
interaction during the formation of VRC or within the assembled VRC might inhibit the
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Hsp70-driven activation of the polymerase function of p95 or other steps/functions (Fig.
3.11, model 2).
The major role of Sti1p co-chaperone in eukaryotic cells is to bring Hsp70:client
protein complex together with Hsp90 chaperone to facilitate robust refolding/activation
of client proteins by the powerful Hsp90 system (177, 206, 207). This is facilitated by the
ability of Sti1p to bind simultaneously to Hsp70 (via the TPR1 sequence) and Hsp90 (via
the TPR2A region). However, based on our data, it is unlikely that this function of Sti1p
is critical to inhibit CIRV replication. This is because deletion of the entire TPR2 domain
from Sti1p did not eliminate the inhibitory function of Sti1p in vitro or in yeast (Fig. 3.63.7). Also, blocking the function of Hsp90 by applying geldanamycin inhibitor in yeast
had no effect on tombusvirus replication (data not shown), arguing against the functional
role of Hsp90 in tombusvirus replication. Therefore, the direct effect of Sti1p on CIRV
p36/p95 and the co-opted Hsp70 is the best suited to explain the current experimental
data (Fig. 3.11).
Sti1/Hop is the first cellular restriction factor specifically affecting one tombusvirus
(i.e., the mitochondria replicating CIRV), but not other tombusviruses (TBSV and CNV,
both replicating in peroxisomal membranes). The previously identified TPR domaincontaining cellular proteins, namely Cpr7p and Cns1p, could inhibit the replication of all
these tombusviruses [this work and (109, 150)]. Interestingly, all three cellular factors are
part of the Hsp70/Hsp90 chaperone system, suggesting that they, at least in part, inhibit
tombusvirus replication via regulating chaperone functions. Because the Hsp70/Hsp90
chaperone system is known to affect many viruses [reviewed in (74, 208)], it is possible
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that the identified restriction factor activities of these TPR-containing cellular proteins
might be functional against other viruses and pathogens.
Another use of Hop/Sti1 in host innate defense against pathogens is its role in
maturation and transport of rice chitin receptor OsCERK1, which is a pattern recognition
receptor (PRRs), against rice blast fungus (209). This function of Hop/Sti1 might link the
functions of PRRs, small Rho-type GTPases and resistance against pathogens. Sti1p is
also known to affect prion propagation in yeast (210) and its expression is increased in
SV40-transformed MRC-5 fibroblasts and some tumor tissues (165, 211). Thus, Hop/Sti1
is emerging as a possibly key component in propagations of several infectious agents and
innate defense responses of host cells.

Summary: The current and recent works (109) with tombusviruses indicate that some
members of the large family of TPR-containing proteins might act as cell-intrinsic
restriction factors of tombusviruses. The list includes the Hop-like Sti1p and Ttc4
oncogene-like Cns1p co-chaperones and Cyp40-like Cpr7p cyclophilin. Yet, based on the
yeast Cyp40-like Cpr6p cyclophilin (109), we already know that not all TPR-containing
proteins are viral restriction factors in spite of their abilities to interact with tombusvirus
replication proteins. Since many TPR-containing proteins are expressed in all eukaryotes,
it will be important to identify all the members of these cellular protein family that act as
restriction factors during tombusvirus and other (+)RNA virus replication.
Copyright © American Society for Microbiology
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Fig 3.1
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Fig. 3.1 Increased CIRV replication in sti1∆ yeast.
(A) Northern blot analysis of accumulation of CIRV DI-1 repRNA in sti1∆ or wt yeast
strains at 23ºC. We launched CIRV repRNA replication by expressing CIRV His6-p36
and His6-p95 from the galactose-inducible GAL1 promoter and DI-1 (+)repRNA from the
galactose-inducible GAL10 promoter in sti1∆ and the parental (wt, BY4741) yeast
strains. Note that the data were normalized based on 18S rRNA. Each experiment was
repeated three times. (B) Northern blot analysis of accumulation of TBSV DI-72 repRNA
in sti1∆ or wt yeast strains. TBSV repRNA replication was launched by expressing CNV
His6-p33 and CNV His6-p92 from the GAL1 promoter and DI-72 (+)repRNA from the
GAL10 promoter in sti1∆ and the parental (wt BY4741) yeast strains. See further details
in panel A. Bottom images: Western blot analysis of CNV His6-p33, CNV His6-p92
accumulation by anti-His antibody and Sti1p accumulation by anti-Sti1 antibody. (C) Top
images: Northern blot analysis of the CIRV p36/p95-driven TBSV DI-72 RNA
accumulation in sti1∆ or wt yeast strains. Same as panel A except DI-72 was used as a
repRNA with CIRV His6-p36 and His6-p95, which support viral RNA replication on
mitochondrial membrane surfaces. Bottom images: Western blot analysis of CIRV His6p36, CIRV His6-p95 accumulation by anti-His antibody and Sti1p accumulation by antiSti1 antibody.
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Fig 3.2
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Fig. 3.2 Over-expression of Sti1p inhibits CIRV accumulation in yeast.
(A) Top panel: Northern blot analysis of CIRV RNA accumulation in wt or sti1∆ yeasts
overproducing the FLAG-tagged Sti1p. Second panel: Northern blot analysis to
demonstrate the comparable level of ribosomal RNA loading in the yeast samples.
Bottom panels: Western blot analysis of CIRV His6-p95 and CIRV His6-p36
accumulation by anti-His antibody and Sti1p accumulation by anti-Sti1 antibody. (B)
Northern blot analysis of TBSV DI-72 repRNA accumulation in wt or sti1∆ yeasts
overproducing the FLAG-tagged Sti1p in the presence of peroxisomal CNV p33/p92
replication proteins. See further details in panel A
.
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Fig 3.3
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Fig. 3.3 Interaction between Sti1p and CIRV p36 replication protein in yeast and in
vitro.
(A) Domain structure of the yeast Sti1p. TPR1 (tetratricopeptide repeat) sequence
interacts with Hsp70, while DP1 (dipeptide repeat of aspartic acid and proline) might
stabilize the bound client protein. TPR2A and TPR2B bind to Hsp90 and together inhibit
the ATPase activity of Hsp90. TPR2B also binds to Hsp70, but only in concert with
Hsp90 binding to TPR2A. The debilitating mutations are marked with an asterisk and
deletion constructs are shown schematically at the bottom of the panel. (B) Split ubiquitin
MYTH assay was used to test intracellular interaction between CIRV p36 and the wt or
mutated yeast Sti1p. The bait p36 was co-expressed with the prey Sti1p protein in sti1∆
yeast. SSA1 (HSP70 chaperone), and the empty prey vector (NubG) were used as positive
and negative controls, respectively. (C) The same split ubiquitin MYTH assay as in panel
B, except TBSV p33 was used as a bait protein. (D) Co-purification of CIRV p36
replication protein with the yeast Sti1p from yeast cells. The membrane fraction of yeast
co-expressing the wt or mutated FLAG-Sti1p and His6-p36 was solubilized and the Sti1p
variants were purified using a FLAG-column. The eluted proteins were tested using
Western blotting with anti-FLAG antibody (top image) and anti-His6 antibody (bottom
image). (E) Reciprocal co-purification of the yeast Sti1p with CIRV p36 and p95
replication proteins from yeast cells. The same as in panel D, except yeast co-expressed
the twin-strep-tagged CIRV p36 and p95 and Flag-Sti1p. The purification was based on
streptactin columns. The eluted proteins were tested using Western blotting with antiStrep-Tactin-AP conjugate (top image), anti-Flag antibody (middle image) and antiHsp70 antibody (bottom image).

Note: Experiments in Fig. 3.3B, C&D were in collaboration with Dr. Jing-Yi Lin.
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Fig 3.4
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Fig. 3.4 Defining the sequence within the tombusvirus replication proteins needed for
binding to Sti1p in vitro.
(A) Schematic representation of the CIRV p36 and its truncated derivatives used in the
binding assay. The various domains include: TMD, transmembrane domain; RPR,
arginine-proline-rich RNA binding domain; P; phosphorylated serine and threonine; S1
and S2 subdomains involved in p36:p36/p95 interaction. (B-E) Affinity binding (pulldown) assay to detect interaction between Flag- or His6-Sti1p, ∆TPR1, ∆TPR2 and the
MBP-tagged CIRV p36 protein derivatives. The MBP-tagged viral proteins produced in
E. coli were immobilized on amylose-affinity columns. Then, the recombinant Sti1p and
derivatives expressed in E. coli (panels B, D, E) or in yeast (panel C) was passed through
the amylose-affinity columns with immobilized MBP-tagged p36 protein (its truncated
versions). The affinity-bound proteins were eluted with maltose from the columns (shown
in the bottom image). Top images in each panel: The eluted proteins were analyzed by
Western blotting with anti-Flag or anti-His antibodies to detect the amount of Flag- or
His6-Sti1p specifically bound to MBP-tagged viral proteins. Bottom image: SDS-PAGE
analysis of the viral protein and its truncated derivatives after elution from the amyloseaffinity columns. Note that the MBP has a C-terminal extra tail sequence (not present in
the fusion protein constructs) due to the sequence in the original cloning vector. (F)
Schematic representation of the TBSV p33 and its truncated derivatives used in the
binding assay. (G) Affinity binding (pull-down) assay to detect interaction between
FLAG-Sti1p and the MBP-tagged viral p33 protein (the soluble C-terminal portion). The
MBP-tagged viral protein or MBP control produced in E. coli was immobilized on
amylose-affinity columns. See further details in panel B above. The eluted proteins were
analyzed by Western blotting with anti-FLAG antibody to detect the amount of FLAGSti1p specifically bound to MBP-tagged viral protein.

Note: Experiments in Fig. 3.4G were in collaboration with Dr. Jing-Yi Lin.
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Fig 3.5
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Fig. 3.5 Relocalization of yeast Sti1p co-chaperone when co-expressed with CIRV p36
replication protein in yeast.
(A) Confocal laser microscopy images show the partial co-localization of RFP-Sti1 with
CIRV GFP-p36 in wt (top images), or in sti1∆ yeast strains. The merged images show the
co-localization within punctate structures, likely representing mitochondria, which are the
sites of CIRV replication. DIC (differential interference contrast) images are shown on
the right. (B) Absence of co-localization of RFP-Sti1 and GFP-p33 in yeast. Note the
cytosolic distribution of RFP-Sti1, while GFP-p33 is present in punctate structures
representing the peroxisomes. Each experiment was repeated.
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Fig 3.6
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Fig. 3.6 Functional TPR1 domain of Sti1p is required for inhibition of CIRV
replication in yeast.
(A) Northern blot analysis of CIRV accumulation in wt yeast overproducing the FLAGtagged Sti1p or derivatives. Bottom panel: Northern blot analysis to demonstrate the
comparable level of ribosomal RNA loading in the yeast samples. (B) Western blot
analysis of CIRV His6-p36, and CIRV His6-p95 accumulation by anti-His antibody from
yeast overproducing Sti1p or derivatives. (C) Detection of the overproduced FLAG-Sti1p
or its derivatives in yeast by Western blot analysis using anti-FLAG antibody.
Note: Experiments in Fig. 3.6 were in collaboration with Dr. Jing-Yi Lin.
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Fig 3.7
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Fig. 3.7 Functional TPR1 domain of Sti1p blocks CIRV replication in vitro.
(A) Scheme of in vitro reconstitution of the CIRV replicase in yeast mitochondrial
preparation. The purified GST-tagged Sti1p or derivatives, the purified recombinant
CIRV MBP-p36 and MBP-p95 proteins and the TBSV-derived (+)repRNA were used in
isolated mitochondrial preparations. (B) Coomassie Blue stained SDS-PAGE was used
for analysis of affinity-purified GST-tagged Sti1 or derivatives. (C) Denaturing PAGE
analysis of the 32P-labeled repRNA products obtained in the replication assays with the
isolated yeast mitochondrial preparation and the soluble fraction of yeast CFE that
provided soluble host factors. The synthesized full-length repRNA is pointed at by an
arrow. The replication assay with CIRV p36 and p95 (without added Sti1) was chosen as
100% (lane 1). The recombinant proteins were added in 8, 16 and 32 μM amounts. Each
experiment was repeated. (D) CIRV mitochondrial replication assays were performed
(see panel A) to test the effect of pre-incubation of various components. Lanes “a” show
samples when the purified Ssa1p Hsp70 (from sti1∆ yeast strain) was pre-incubated for
10 min with comparable amount of GST, GST-Sti1p or mutants (from E. coli), while in
lanes “b”, the MBP-p36/MBP-p95 of CIRV (from E. coli) was pre-incubated with Ssa1p.
In lanes “c”, the MBP-p36/MBP-p95 of CIRV was pre-incubated with GST, GST-Sti1p
or mutants, while in lanes “-“ no pre-incubation was performed. In each experiment, we
used comparable amounts of each component for pre-incubation that lasted for 10 min in
the reaction buffer. After the pre-incubation step, we added the missing components and
performed the CIRV replication assay (see panel A). Each experiment was repeated at
least twice.

Note: Experiments in Fig. 3.7 were in collaboration with Dr. Jing-Yi Lin.
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Fig 3.8
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Fig. 3.8 Comparison of the inhibitory effects of TPR-containing cellular proteins on
CIRV replication in isolated mitochondria in vitro.
(A) Denaturing PAGE analysis of the 32P-labeled repRNA products obtained in the
replication assays with the isolated yeast mitochondrial preparations. The purified GSTtagged Sti1p, the yeast Cpr7p Cyp40-like cyclophilin, the TPR domain of Cpr7p or
Cns1p co-chaperone (8, 16 and 32 μM) was added in combination with purified
recombinant CIRV MBP-p36 and MBP-p95 proteins and the TBSV-derived (+)repRNA
to the isolated mitochondrial preparations to perform the in vitro replication assay. The
synthesized full-length repRNA is marked by an arrow. See further details in Fig. 3.7. (B)
Coomassie Blue stained SDS-PAGE was used for analysis of affinity-purified GSTtagged Sti1p, Cpr7p and Cns1p. (C) The level of in vitro TBSV repRNA replication in
total yeast cell-free extracts in the presence of purified TBSV p33 and p92 replication
proteins and purified GST-tagged Sti1p, Cpr7p, the TPR domain of Cpr7p or Cns1p (16
and 32 μM).

Note: Experiments in Fig. 3.8 were in collaboration with Dr. Jing-Yi Lin.
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Fig 3.9
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Fig. 3.9 Inhibition of CIRV replication by expression of the orthologous AtHop-1 in
yeast.
(A) Northern blot analysis of CIRV RNA accumulation in wt yeast overproducing the
FLAG-tagged AtHop-1 or its TPR1-deletion derivative. Second panel: Northern blot
analysis to demonstrate the comparable level of ribosomal RNA loading in the yeast
samples. Third and fourth panels: Western blot analysis of CIRV His6-p36, and CIRV
His6-p95 accumulation by anti-His antibody. Bottom panels: Detection of the
overproduced FLAG-AtHop-1 in yeast by Western blot analysis using anti-FLAG
antibody and the Coomassie-stained SDS-PAGE as a loading control.
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Fig 3.10
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Fig. 3.10 Knockdown of Hop gene by VIGS increases CIRV accumulation in whole
plants.
(A) Semi-quantitative RT-PCR analysis of the accumulation of NbHOP mRNAs in
CIRV-infected N. benthamiana plants (3 dpi, days post-inoculation) and in the control
mock-inoculated plants. Semi-quantitative RT-PCR analysis of NbActin mRNA level
served as a control. (B) Top image: Accumulation of CIRV genomic and subgenomic
RNAs in the inoculated leaves of HOP knockdown N. benthamiana plants 2 dpi, based
on Northern blot analysis. VIGS was performed via agroinfiltration of TRV vectors
carrying NbHOP sequence or the TRV vector carrying the C-terminal half of GFP insert
(as a control). Inoculation with CIRV gRNA was done 14 days after VIGS. Second
image: Ribosomal RNA level in the samples used as loading control. Bottom images:
Semi-quantitative RT-PCR analysis of the accumulation of NbHOP mRNA in the
knockdown N. benthamiana plants and in the control plants 2 days after inoculation with
CIRV. Semi-quantitative RT-PCR analysis of the NbActin mRNA from the same
samples served as a control. (C) Accelerated CIRV-induced symptom development in the
NbHOP knockdown plant (shown on the right) at 7 dpi when compared to the control
plant infiltrated with the control TRV vector. Note the minor phenotypic effect in the
uninfected NbHOP knockdown N. benthamiana plants when compared to the control
plants, which were agroinfiltrated with the pTRV1/2GFP vector (the plants on the left
side of the images). (D) Accumulation of CNV gRNA in the inoculated leaves of HOP
knockdown N. benthamiana plants 2 days post-inoculation, based on Northern blot
analysis. See further details in Panel B. (E) Comparable CNV-induced symptom
development in the HOP knockdown and control plants. See further details in Panel C.
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Fig 3.11
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Fig. 3.11 Models on the inhibitory role of Sti1p co-chaperone in CIRV replication.
Model 1 predicts that direct interaction between Sti1p and the RPR region of CIRV p36
replication protein blocks the viral (+)RNA recruitment function of p36, and thus blocks
replication of CIRV. Model 2 emphasizes the additional role of Sti1p through the coopted Hsp70 chaperone. Binding of the TPR1 domain of Sti1p to Hsp70 within the CIRV
replicase might inhibit the function of the subverted Hsp70 in VRC assembly, by possibly
stabilizing the Hsp70-p95 complex. Note that both mechanisms might operate inside the
cell.
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Chapter 4

RNA VIRUS REPLICATION DEPENDS ON ENRICHMENT OF
PHOSPHATIDYLETHANOLAMINE AT REPLICATION SITES IN
SUBCELLULAR MEMBRANES

4.1 Introduction

Many steps in the infection cycles of positive-strand RNA viruses, including entry into the
cell, replication, virion assembly and egress, are associated with subcellular
membranes(20). Therefore, viruses have to interact with different lipids, such as
phospholipids and sterols, which affect the biophysical features of membranes, including
the fluidity and curvature (57, 64, 70, 144). The subverted cellular membranes could
protect the viral RNA from recognition by the host nucleic acid sensors or from destruction
by the cellular innate system. In addition, membranes facilitate the sequestration of viral
and co-opted host proteins to increase their local concentrations and promote
macromolecular assembly, including formation of the replicase complex or virion
assembly. To optimize viral processes, RNA viruses frequently manipulate lipid
composition of various intracellular membranes. Overall, the interaction between cellular
lipids and viral components is emerging as one of the possible targets for antiviral methods
against a great number of viruses.
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Among the various lipids, the highly abundant phospholipids are especially
targeted by RNA viruses (57). In general, phospholipids likely affect the replication of
most RNA viruses, which takes place within membranous structures(31). Accordingly,
lipidomics analyses of cells infected with Dengue virus and Hepatitis C virus (66, 67)
revealed enhanced virus-induced lipids biosynthesis, resulting in changes in the global
lipid profile of host cells. Phosphatidylinositol-4-phosphate (PI4P) was shown to be
enriched at sites of enterovirus replication, and RNA polymerase of Poliovirus selectively
binds to PI4P (33), suggesting that micro-environment enriched for PI4P facilitates
enterovirus replication. However, our knowledge on the roles of various phospholipids in
RNA virus replication is currently incomplete. By using tombusviruses, small model RNA
viruses of plants that can replicate in yeast surrogate host (13), a major role for
phospholipid and sterol biosynthesis has been revealed (89, 90). In this paper, development
of artificial vesicle-based replication of tomato bushy stunt virus (TBSV) identified the
essential role of phosphatidylethanolamine (PE) in RNA virus replication. It is also shown
that TBSV could recruit and enrich PE to the sites of viral replication in yeast and plant
cells. Moreover, genetic changes that increase PE levels in yeast greatly stimulated TBSV
replication, confirming the key role of PE in the formation of TBSV replicase.

4.2 Materials and Methods

Yeast Strains and expression plasmids. Parental yeast strain BY4741 (MAT a his3Δ1
leu2Δ0 met15Δ0 ura3Δ0) and single-gene deletion yeast strains (cho2∆, pex3∆) were from
Open Biosystems. E. coli protein expression plasmids for recombinant TBSV p33 and
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p92, pMAL-p33 and pMAL-p92, were previously described (102). pESC-T33/DI72 and
pYES-T92 used for yeast expression of viral components were described (9).

Preparation of CFE, membrane fraction (P40) and soluble fraction (S40). The yeast
cell-free extracts (CFE) from train BY4741 were prepared according to (49). CFE
preparations were centrifuged at 40,000 x g for 1hr to separate the membrane fraction
(P40) and the soluble fraction (S40). Collected P40 and S40 were immediately stored at 80 °C until use.

Artificial phospholipid vesicles preparation. Phospholipids were obtained from Avanti
Polar lipids, Inc. Phospholipids (269 nmol/preparation) were dissolved in chloroform and
transferred into glass vials, mixed, and subsequently dried under a small stream of nitrogen
for 1 hour under fume hood. The phospholipids were further dried in a speed-vacuum for
additional 2-3 hours to completely remove chloroform. To each glass vial, 400 µl HEPES
buffer (30 mM, pH 7.4) was added, followed by sonication in a bath sonicator (Avanti
Polar lipids, Inc.) filled with ice for 20 minutes. The mixtures became visually
homogeneous. The concentrations of the obtained phospholipid vesicle preparations were
672 µM. Phospholipids vesicles were prepared in the same day of in vitro replication
assay.

In vitro TBSV replication assay using artificial phospholipid vesicles. The procedure
for in vitro replication assay using phospholipid vesicles was adapted from the previously
published procedure using purified yeast organelles (9), except that 100,000 xg supernatant
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(S100) was replaced with S40 fraction of CFE. Briefly, 2 µl of phospholipid vesicles and 1
µl of S40 fraction were incubated at 25 °C for 1 hour in 8 µl buffer containing 30 mM
HEPES-KOH (pH7.4), 150 mM potassium acetate, 5 mM magnesium acetate, 0.6 M
sorbitol, 15 mM creatine phosphate, 1 mM ATP, CTP and GTP and 0.025 mM UTP, 0.1 µl
of [32P]UTP, 0.1 mg/ml creatine kinase, 0.1 µl of RNase inhibitor (Thermo Scientific), 10
mM dithiothreitol, 0.5 µg DI-72 RNA transcript, and 0.5 µg MBP-tagged recombinant
TBSV p33 and p92 replication proteins. Then, the reaction mix was incubated for 3 hours
in 16 µl cell-free replication buffer B (30 mM HEPES-KOH pH7.4, 150 mM potassium
acetate, 5 mM magnesium acetate) with 15 mM creatine phosphate 1 mM ATP, CTP and
GTP 0.025 mM UTP, 0.2 µl of [32P]UTP, 0.1 mg/ml creatine kinase, 0.2 µl of RNase
inhibitor, 10 mM dithiothreitol and 0.05 mg/ml actinomycin D. After reaction, total RNA
was extracted and analyzed in a denaturing gel. Determination of viral (+)RNA/(-)RNA
ratio, as well as micrococcal nuclease treatment were described previously (9).

Membrane flotation assay. [35S]methionine-labeled TBSV p33 (101) was incubated with
different phospholipid vesicles as previously described using purified yeast organelles (9).
The membrane flotation assay was performed as previous described (212) with minor
modifications. Briefly, the reaction mixture (24 µl) were mixed with 126 µl 85% sucrose
in HEPES buffer in a final concentration of 71.25%, then overlaid with 900 µl 65%
sucrose and 150 µl 10% sucrose in HEPES buffer (30 mM, pH 7.4). The gradient was
centrifuged at 134,000 x g for 16 hours at 4 °C in a swing bucket rotor (Beckman TLS-55).
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TBSV RNA recruitment assay. For the viral RNA recruitment assay, phospholipids
vesicles were mixed with MBP-tagged recombinant TBSV p33 and p92 replication
proteins (0.5µg each) as in vitro replication assay, except that UTP was omitted from the
reaction mixture, and 1 µg/µl yeast tRNA was added as non-specific competitor and 1 µl
radioactive [32P]UTP labeled DI-72 RNA transcripts were added. After incubation for 1
hour at 25 °C, the reaction mixtures were subjected to membrane flotation assay in sucrose
gradients as described above. Total RNA from the top fraction of each gradient was
extracted and analyzed in a denaturing RNA gel (5% polyacrylamide gel containing 8M
urea).

Lipid extraction and mass-spectrometry for lipidomics analysis. For yeast
phospholipid analysis, yeast carrying the TBSV expression plasmids were pre-cultured in
glucose-containing media overnight, washed and diluted to 0.3 OD600 units/ml in
galactose-containing media and cultured for approximately 24 h at 23 ºC until reaching ~2
OD600 units/ml. Yeast cells (0.4 g) were placed into a 15 ml glass tube, containing 1.2 ml
water, 2 ml chloroform, 4 ml methanol, 0.8 g glass beads, followed by mixing and
vigorous vortexing. Then, 2 ml chloroform and 2 ml water were added into the tube and
centrifuged at low speed. Then, the lower organic phase was collected. 2 ml chloroform
was mixed with the remaining inorganic phase; lower organic phase was withdraw. The
chloroform extraction step was repeated. All the organic phases from previous steps were
combined and washed with 0.5 ml 1M KCl and then with water.
To determine the phospholipids profile of TBSV-infected plants, 3 weeks old
Nicotiana benthamiana plants were inoculated with TBSV genomic RNA transcripts or
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mock-inoculated with buffer. Then, at 6 days post infection, the upper leaves showing the
characteristic TBSV symptoms were harvested. Lipid extraction was as described
previously (213). Briefly, about 0.15-0.2 grams of leaves from one plant were collected
and incubated with 3 ml isopropanol containg 0.01% butylated hydroxytoluene (BHT) at
75 °C for 15 min. Extraction of lipids with chloroform/methanol (2:1) incubated at room
temperature was performed for 1 hour, in total five times. Organic phases from each
extraction were combined and washed with 0.5 ml 1 M KCl and water, respectively.
Washed organic phase was analyzed on a triple quadrupole MS/MS equipped for
electrospray ionization (ESI). Di 10:0 PE/PC/PG (Avanti Polar Lipids, Inc) were mixed
with yeast or plant samples before extraction as spiked lipids standards for PE/PC/anionic
phospholipids during the extraction step. In addition, two internal lipid standards of each
phospholipid class were mixed with each sample before ESI-MS/MS analysis for
quantification of each lipid class (213). Data were obtained from 3 repeats.

Purifiation of biotinylated duramycin. Biotinylation of duramycin (Sigma Cat. #:
D3168), followed by purification, was performed as described for cinnamycin (214, 215).
Briefly, 500 µM duramycin in 0.1 M NaHCO3 was mixed with equal volume of 8.7 mg/ml
EZ-link NHS-LC-biotin dissolved in sterile water (Thermo Scientific, Product #: 21336)
for 4 hours at room temperature and quenched by adding one-fifth volume of 0.1 M lysine.
Biotinylated duramycin were purified by reverse-phase high-performance liquid
chromatography using Waters Nova-Pak C18 Column (Model: WAT086344). The
biotinylated duramycin was eluted with a linear gradient of 10 mM sodium acetate (pH
4.2) starting from 5% to 60% for 50 min, at a flow rate of 0.5 ml/min. Biotinylated
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duramycin was collected at 28 to 30 min after starting of elution. No peak was detected at
the “32 min” time-point, when elution of nonbiotinylated duramycin was expected,
suggesting that all duramycin molecules became biotinylated.

Imaging of PE distribution and viral protein localization in yeasts and plant
protoplasts. Yeast cultures were grown in glucose containing media overnight and
switched to galactose containing media with initial 0.3 OD600. To prepare spheroplasts,
overnight cultures were harvested and the yeast cells were fixed with 3.7% formaldehyde
for 40 min at room temperature in dark, washed twice with 0.1 M potassium phosphate
(pH 7.5), and then re-suspended in SPP (0.1 M potassium phosphate pH 7.5, 1.2 M
sorbitol) with zymolase 20T (1 mg/ml). Cells were incubated at 30 °C for 1 hour, and then
incubated with SPP with 50 mM NH4Cl for 15 min to quench free aldehyde groups.
Spheroplasts were collected after washing twice with SPP, and then applied to poly-Llysine coated slides. Slides were immersed in methanol for 6 min and acetone for 30s,
respectively, at -20 °C. Biotinylated-duramycin was added into phosphate-buffered saline
(PBS, pH 7.4) containing 0.05% Nonidet P-40 and 1% BSA (15 µg/ml), and incubated
overnight with the fixed cells at -4 °C. Slides were washed and incubated with Streptavidin
conjugated with Alexa Fluor® 405 (Life Technologies, Cat. #: S-32351) for 1 hour before
imaging.
The distribution of PE was also monitored using fatty acid-labeled NBD-PE and
NBD-PC internalization. M-C6-NBD-PE (1-myristoyl-2-(6-[(7-nitro-2-1,3-benzoxadiazol4-yl)amino]hexanoyl)-sn-glycero-3-phosphoethanolamine)

and

M-C6-NBD-PC

myristoyl-2-(6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl)-sn-glycero-3-
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(1-

phosphocholine) (Avanti Polar lipids, Inc.) were dissolved in DMSO in 8 mM
concentration (216) and stored at -20 °C. Wild type yeast transformed with pESC-mRFPT33 and pRS315-Pex13p-BFP was pre-grown in SC medium, then cultured in SC medium
containing 2% galactose with 80 µM NBD-PE or NBD-PC at 0.5 OD600, and incubated at
23 °C for 16 hours. Cells were washed with SCNaN3 medium (216) (SC medium with 2%
sorbitol and 20 mM sodium azide) and subjected to confocal laser microscope analysis.
N. benthamiana protoplasts were prepared and eletroporated with in vitro
transcribed TBSV full length genomic RNA as described previously (204). Protoplasts
were fixed with 3.7% formaldehyde in protoplast culture medium (204), applied to poly-Llysine coated slides, and processed using the above procedure for PE staining. For dual
staining of p33 and PE, anti-p33 primary antibody (a gift from Dr. Herman B. Scholthof)
was diluted (1:400) and incubated with fixed protoplasts in PBS containing 1%
BSA/0.05% Nonidet P-40 overnight. After washing three times with PBS/1% BSA/0.05%
Nonidet P-40, cells were incubated with anti-mouse secondary antibody conjugated to
Alexa Fluor® 488 (Life Technologies, Cat. #: A-11001) for 1 hour before imaging.
Confocal images were obtained with an Olympus FV1000 microscope (Olympus
America, Melvie, NY). Alexa 405, GFP/Alexa 488, and RFP were excited using 405 nm,
488 nm or 543 nm lasers, respectively. Images were obtained sequentially, and merged
using Olympus FLUOVIEW 1.5 software.

4.3 Results

Efficient replication of TBSV RNA in artificial PE vesicles. To test what type of
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phospholipids are required for tombusvirus replication, we developed an artificial
vesicle- (liposome-) based replication assay involving purified recombinant tombusvirus
p33 and p92pol replication proteins, TBSV (+) replicon (rep)RNA and cellular cytosolic
proteins present in yeast cell-free extract (CFE, Fig. 1A). Interestingly, artificial vesicles
prepared only from phosphatidylethanolamine (PE) supported TBSV repRNA
replication, reaching about half of the level that takes place in the standard CFE obtained
from wt yeast (Fig. 1A, lanes 3-4 versus 1-2). On the contrary, vesicles consisting of only
phosphatidylcholine (PC, Fig. 1A, lanes 5-6), or lysoPE showed 5% viral RNA
replication activity when compared with PE vesicles (Fig. 2A, lanes 3-4 and 13-14),
while PG, PS, PI, CA, and lysoPC vesicles did not support TBSV RNA replication (Fig.
2A). These data support a model that PE is the only phospholipid required for TBSV
replication in vitro, while the other phospholipids are not sufficient by themselves.
To examine the nature of TBSV replication in PE vesicles, we measured (-)
versus (+)-strand RNA synthesis. These experiments revealed that TBSV replication led
to the production of ~10-fold more (+)- than (-)-stranded RNAs, similar to the ratio seen
in yeast CFE preparation containing yeast membranes (Fig. 1B) (102). Thus, the in vitro
assembled TBSV replicase in PE vesicles can support a complete cycle of replication and
asymmetrical RNA synthesis, which is hallmark of (+)-strand RNA viruses. We also
tested if the PE vesicles are required for RNA synthesis by adding various concentrations
of Triton X-100, which could disrupt lipid bilayer. Viral RNA synthesis was inhibited up
to 90% in the presence of 0.01%, while it was completely blocked by the presence of 0.1
or 1.0% Triton X-100 (Fig. 1C), suggesting that the membranous environment is needed
for TBSV replication in vitro. To test if TBSV replicase could form a nuclease-resistant
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compartment, as the case in cells and in the yeast CFE (49, 102), we performed the in
vitro assays in the presence of micrococcal nuclease, which can destroy the unprotected
viral RNAs. These studies revealed that TBSV replicase formed in the presence of PE
vesicles was much less protective of the viral RNA against the nuclease than the replicase
assembled in yeast CFE (Fig. 2B). This finding suggests that not only PE, but additional
phospholipids, other types of lipids or membrane proteins in the yeast CFE also
contribute to the assembly of the authentic TBSV replicase.
To estimate optimal PE level for TBSV replication, we made artificial vesicles
containing PE and increasing amounts of a mixture of other phospholipids (PC, PI, PS,
PG, lysoPE and lysoPC, mixed as their molar ratio from TBSV infected N. benthamiana
leaves as shown in Fig. 7) (Fig. 1D). The highest level of TBSV replication was observed
with the vesicle containing 82-90% PE (Fig. 1D). On the other hand, vesicles containing
less than 70% PE did not support efficient TBSV replication in vitro. We also tested PE
and other phospholipids in pair-wise combinations. These in vitro assays revealed that the
presence of only 10% of PC or lysoPE in PE vesicles enhanced TBSV replication by
more than 50%, while these phospholipids were inhibitory when applied in higher than
20% concentrations (Fig. 3A-B). In contrast, the presence of other phospholipids (PS, PI,
CA, lysoPC) were inhibitory to TBV replication, except for 10% of PG (Fig. 3B). Thus,
various phospholipids (other than PE) have inhibitory effects on TBSV replication when
present in higher than 20% amounts. These results indicate that TBSV replication is
greatly affected by different kind of phospholipids.
To test whether phospholipids affect the membrane association of the viral
replication proteins, we performed membrane flotation experiments with artificial
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vesicles and

35

S-labeled p33 replication protein. As expected, in the absence of

membranes/vesicles, p33 stays at the bottom of the sucrose gradient (Fig. 4B), while
~30% of p33 are present in the top fraction in the presence of either PE or PC vesicles
(Fig. 7C-D). In addition, p33 can strongly associate with PG, PS and CA vesicles, while
binding to PI vesicles is poor (Fig. 4). These data suggest that, except for PI, most of
phospholipids does not inhibit p33 targeting to membrane. Similar studies with the viral
(+)repRNA, which has to be recruited to the sites of replication in the membranes by
replication proteins (3, 102, 202), revealed that the (+)repRNA bound to membrane
associated p33/p92pol replication proteins with the highest efficiency in the presence of
PE, PC and lysoPE vesicles, while PG, PS, PI, CA and lysoPC vesicles does not
stimulate (+)repRNA recruitment (Fig. 5). Therefore, we suggest that binding of
p33/p92pol replication proteins to PE, PC and lysoPE phospholipids facilitate the
recruitment of the viral (+)repRNA to replicase complexes.

PE is enriched at the sites of TBSV replication. Since TBSV requires membranes with
high PE content to assemble the functional VRCs in vitro, we wondered if PE, which is
among the most abundant phospholipids in yeast, is enriched at the sites of replication. We
used Alexa405-labeled duromycin, which specifically binds to PE (217), to monitor the
distribution of PE during TBSV replication. Interestingly, PE was highly enriched in the
subcellular locations in yeast cells containing GFP-p33 expressed alone or with p92pol
replicating the TBSV repRNA (Fig. 6A). These sites co-localized with both Pex13pmRFP/GFP peroxisomal marker and GFP/RFP-p33 (Fig. 6B), indicating that PE is
enriched at the sites of TBSV replication in the peroxisomal membrane. On the contrary,
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the peroxisomal membrane was not enriched with PE in the absence of TBSV replication
proteins and PE was dispersed in many parts of the yeast cell (Fig. 6B, -TBSV treatment).
We confirmed the above findings using fatty acid fluorescently-labeled PE (NBD-PE)
added to the culture media. Accordingly, NBD-PE was enriched in the subcellular location
also containing RFP-p33 and Pex13p-GFP (Fig. 6C). On the contrary, NBD-PE was not
enriched in the peroxisomal membranes in the absence of TBSV p33 (Fig. 6C). Unlike
NBD-PE, NBD-PC was not highly enriched at the sites of TBSV replication (Fig. 6C).
Based on these data, we propose that PE molecules are efficiently re-localized to and
enriched at the sites of viral replication in the peroxisomal membranes. To test if similar
phenomena also occur in plant cells during TBSV replication, we stained TBSV infected
plant cells (N. benthamiana protoplasts) with Alexa405-labeled duromycin and antip33/p92 antibody. Importantly, confocal imaging showed high enrichment of PE in
subcellular locations containing the p33/p92 replication proteins (Fig. 6D). The subcellular
distribution of PE was dramatically different in uninfected plant cells. Based on all these
data, the emerging picture is that PE, unlike PC, is efficiently redistributed to the
peroxisomal membranes to facilitate TBSV replication.

Increased PE level in yeast and plant cells supporting TBSV replication. To test if TBSV
replication alters phospholipid metabolism to facilitate its replication, we performed
lipidomics of yeast cells replicating TBSV repRNA or lacking all TBSV components.
These experiments revealed that the relative PE percentage within 5 major phospholipids
increased from 17.6% to 29.3% (~1.7 fold increase) in yeast replicating TBSV (Fig. 7A).
On the contrary, PC and PI levels, which are two of the most abundant phospholipids, are
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decreased by ~6% and 8.4%, respectively, when yeast supported TBSV replication (Fig.
7A). These data suggest that TBSV selectively increases PE level in yeast. The overall
phospholipid content of yeast cells after normalized by cell weight before lipid extraction
increased by 38.4% (Fig. 8A), suggesting that yeast cells are induced by TBSV to produce
new phospholipids. Considering overall phospholipids also increased in TBSV replicating
cells, the PE content of yeast cells replicating TBSV increased by ~2.3-fold. This increased
level of PE in yeast cells likely serves the virus’ need to build new membrane-bound
replicase complexes (see below). Lipidomics analysis revealed no significant changes in
the fatty acid length or saturation status of the PE in yeast replicating TBSV versus the
control yeast (Fig. 8C&D).
The PE level was also increased in TBSV-infected plant leaves from 21.2% to 28.8%
within 7 major phospholipids analyzed (Fig. 7B). In contrast to yeast, the PC level also
increased in plants, which could be the results of overall elevated phospholipid synthesis
(Fig. 8B). Nevertheless, the lipidomics data support the increased synthesis of PE in
TBSV-infected plant cells, similar to the yeast counterpart.

Increased PE level in cho2∆ yeast promotes TBSV replication. To examine if PE level
can directly affect TBSV replication in cells, we deleted CHO2, which codes for
phosphatidylethanolamine methyltransferase (PEMT), in yeast. Cho2p catalyzes the first
step in the conversion of PE to PC, and in its absence, PE level is increased and PC level is
decreased (218). We find that TBSV replication is increased by ~10-fold in cho2∆ yeast in
comparison with wt yeast (Fig. 9A, lanes 5-8 versus 1-4). In addition, the amounts of p33
and p92pol replication proteins were also increased (Fig. 9A). Lipidomics analysis of cho2∆
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yeast supporting TBSV replication showed that PE becomes the most abundant within 5
major phospholipids by reaching up to ~42% level (Fig. 9B, upper panel). And within
same amount of cell weight, PE increased ~2.5-fold comparing with wild type yeast
replicating TBSV extraction (Fig. 9B, lower panel).
We have also performed in vitro TBSV replicase assembly assay in isolated
membrane fractions from wt or cho2∆ yeasts. The viral replicase assembled with
membrane fractions from cho2∆ yeast showed ~3-fold higher activity in vitro than from wt
yeast (Fig. 9C). Since we used the same amount of the recombinant viral proteins in the
CFE preparations, the increased TBSV replicase activity from cho2∆ yeast suggests that
the high accumulation level of TBSV repRNA in cho2∆ yeast is due to enhanced replicase
activity in cho2∆ yeast (Fig. 9A). Confocal microscopy analysis of cho2∆ yeast showed
robust re-distribution of PE to the sites of TBSV replication, containing the viral
replication proteins and peroxisome membranes (Fig. 9D).
To test if the high accumulation of PE in the peroxisome membranes is critical for
TBSV replication, we deleted PEX3 peroxisome biogenesis gene in cho2∆ yeast. In the
absence of PEX3 there is no peroxisome or peroxisome membrane remnants in yeast (ref)
and TBSV switches to the ER for replication (32). ER can support as robust TBSV
replication as the peroxisomes in yeast (32, 107). We find that TBSV replication is
increased by ~13-fold in cho2∆pex3∆ yeast (Fig. 10), suggesting that TBSV can take
advantage of increased PE level in the ER membrane in the absence of peroxisomes.
To test if the pro-viral role of PE also extends to other viruses, we analyzed
replication of the closely-related cucumber necrosis tombusvirus (CNV), which also
replicates on peroxisomal membranes. Similar to TBSV, CNV replication was increased in
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cho2∆ yeast (Fig. 11A-B) and the CNV p33 protein induced the re-localization of PE in
yeast cells (Fig. 11C). To study if viruses replicating in other subcellular compartments
could take advantage of the increased PE level in cho2∆ yeast, we used Carnation Italian
ringspot virus (CIRV, a tombusvirus), which replicates in the outer mitochondrial
membranes (9, 19). CIRV accumulation is increased by ~5-fold in cho2∆ yeast (Fig.
12A). Moreover, the p36 replication protein of CIRV induced the efficient enrichment of
PE in the same subcellular locations that harbor p36 (Fig. 12B). Replication of another
mitochondrial RNA virus, the unrelated Nodamura virus (NoV) insect RNA virus, also
benefitted from the increased PE level in cho2∆ yeast (Fig. 12C). Interestingly, protein A
replication protein of NoV is also localized at highly PE-enriched subcellular locations
(Fig. 12C). Therefore, we conclude that tombusviruses and NoV could take advantage of
the increased PE level in various subcompartments in cho2∆ yeast. Similar to TBSV, the
replication proteins of these viruses can induce the efficient enrichment of PE at the sites
of virus replication, suggesting that different (+)RNA viruses build PE enriched
environment for replication.

4.4 Discussion

It is universally accepted that plant and animal RNA viruses require cellular
membranes for their propagation in infected cells (20). These viruses replicate in various
subcellular compartments that contain unique composition of lipids. However, it is
currently poorly understood how different lipids could affect the viral replication process.
By using the highly tractable tombusviruses, we show that PE plays an essential role in
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viral replication. The supporting evidence includes: (i) in vitro data with artificial vesicles
that facilitated TBSV replication only when PE was present above 70%, (ii) the relative
increase of PE in yeast and plant cells replicating tombusvirus; (iii) PE enrichment in the
replication sites of tombusviruses and Nov; and (iv) cell-based results showed increased
tombusviruses and Nov replication in cho2∆ yeast that contain high level of PE at the
expense of PC level.
Essential role of PE in TBSV VRC assembly. Based on in vitro approaches, the
major function of PE is during the assembly of the VRCs. We show that VRCs are only
functional in the presence of artificial PE vesicles, while other phospholipids are
insufficient to support efficient VRC assembly and they are inhibitory when present in
20% or more in comparison with PE level in artificial vesicles. In addition, membrane
fractions from cho2∆ yeast support enhanced TBSV replication in vitro, suggesting more
efficient VRCs assembly when PE is abundant in membranes.
Interestingly, PE does not seem to be essential at the very early steps of replication
(prior to the VRC assembly), because PE is not favored to bind to the TBSV p33
replication protein when compared to other phospholipids. Also, PC is even more efficient
than PE for facilitating the p33/p92-driven recruitment of the viral (+)repRNA in vitro.
However, efficient viral replication requires high level of PE at the replication sites. It is
likely that p33 induce PE enrichment at sites of replication after p33 associated with
subcellular membrane at the very initial step of replication. Meanwhile, binding to PE
might stabilize p33/p92, because we observed elevated levels of p33/p92 in cho2∆ yeast in
comparison with wt yeast. We have previously shown that total phospholipids are
important for p33/p92 stability in yeast (89).
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Based on TBSV replication studies with artificial vesicles, TBSV requires high
local concentration of PE at the sites of replication (above 70%, Fig. 1). However, PE is
below that level in subcellular membranes (51), such as peroxisomes(219),
mitochondria(220, 221) and ER(221). TBSV changes cell lipidome upon infection with
increased PE level, as shown by lipidomics data from yeast and plant cells. Meanwhile,
confocal microscopy images show the robust accumulation of PE at peroxisomal sites
where TBSV p33 replication protein accumulates (to form VRCs). Interestingly, PEs
(NBD-PE) provided in the yeast culture media found its way to the TBSV replication sites,
suggesting that existing PE is efficiently re-distributed to the sites of TBSV replication.
Overall, TBSV utilizes different pathways to increase the local concentrations of PE to
serve the virus’ need during VRC assembly.
The development of artificial vesicle-based TBSV replication clearly demonstrates
that TBSV requires PE for VRC assembly. TBSV replicase assembled on the PE vesicles
could support complete cycle of RNA replication, including (-)- and (+)-RNA synthesis in
an asymmetrical manner, producing ~10-times more (+)-strands than (-)-strands.
Asymmetrical replication of the RNA genome is one of the hallmarks of (+)-strand RNA
viruses (222). However, optimal TBSV replication also requires additional phospholipids,
because the highest TBSV RNA synthesis was observed with vesicles containing ~15%
additional phospholipids and ~85% PE. PE possess a conical molecular structure and
introduce negative curvature into lipid bilayer. Such negative curvature likely contribute to
membrane invagination occurs upon formation of spherule structures build by TBSV at the
sites of replication (81).
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A wide-spread role of PE in (+)RNA virus replication? Many other (+)RNA viruses also
induce membrane invagination during replication (79), including CNV (223), CIRV (114)
and NoV (224). Indeed, PE enrichment at replication sites seems to be a common feature
among these (+)RNA viruses. Using cho2Δ yeast lacking PEMT to convert PE to PC, we
demonstrate that the TBSV-related CNV (peroxisomal replication) and CIRV
(mitochondria) and the unrelated NoV (mitochondria) all supported enhanced replication
when PE is abundant in membranes. Also “forcing” TBSV to switch to ER membranes in
the absence of peroxisomes in cho2Δ yeast (due to pex3Δ background), still resulted in
efficient TBSV replication, suggesting that these (+)RNA viruses could take advantage of
abundant PE in various subcellular membranes. In summary, the emerging picture from
our work is that various (+)RNA viruses might subvert PE in order to build VRCs and
replicate efficiently in infected cells.

(Copyright © Kai Xu 2014)
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Fig. 4.1
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Fig. 4.1. In vitro reconstitution of the TBSV replicase in artificial PE vesicles.
(A) Scheme of the assay. Purified recombinant p33 and p92pol replication proteins of
TBSV in combination with the TBSV-derived (+)repRNA were added to PE or PC
vesicles or the P40 membrane-fraction of yeast CFE. The S40 fraction of CFE was also
added to each sample to provide soluble host factors required for TBSV VRC assembly.
The denaturing PAGE analysis of the 32P-labeled repRNA products obtained is shown.
The full-length repRNA is pointed at by an arrow. The CFE-based replication assay with
CFE was chosen as 100% (lanes 1-2). (B) Asymmetrical RNA synthesis by TBSV VRCs
assembled in PE vesicles. The amounts of TBSV (+) and (-)-stranded RNA products
produced by the reconstituted TBSV VRCs are measured by using the 32P-labeled
repRNA probes generated in the in vitro assays. The blot contains the same amount of
cold (+) and (-)-stranded DI-72 RNA. (C) TBSV RNA synthesis by the reconstituted
VRCs in PE vesicles requires vesicles/membranes. The PE vesicles were disturbed by
Triton-X100 treatment as shown. The denaturing PAGE analysis of the replicase products
is as shown in Panel A. (D) Increased VRC activity in PE vesicles containing a fraction
of other phospholipids. The PE vesicles contained the shown % of PE plus a mixture of
other phospholipids (the ratio was: 54.5 of PC, 6.1 of PI, 1.2 of PS, 8.3 of PG, 0.9 of
LPE, and 0.6 of LPC). The denaturing PAGE analysis of the replicase products is as
shown in Panel A.
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Fig. 4.2. In vitro reconstitution of the TBSV replicase in artificial phospholipid vesicles.
(A) Artificial vesicles were prepared from the shown phospholipids, followed by in vitro
TBSV replication assay in the presence of purified recombinant TBSV p33 and p92pol
replication proteins, TBSV repRNA in combination with the S40 fraction of yeast CFE to
provide soluble host factors required for TBSV VRC assembly. The denaturing PAGE
analysis of the 32P-labeled repRNA products obtained is shown. The full-length repRNA is
pointed at by an arrow. The PE vesicle-based replication assay was chosen as 100% (lanes
1-2). (B) High level nuclease-sensitivity of the tombusvirus replicase assembled in
artificial vesicles. Scheme of the vesicle-based TBSV replication assay shows that
micrococcal nuclease was added to the assay for 15 minutes at various time points as
shown (after which it was inactivated by EGTA). The total length of the in vitro replication
assay was 3 h. Denaturing PAGE analysis of in vitro replicase activity in comparison with
the untreated preparation (that was chosen as 100%). Note that the repRNA is protected
from micrococcal nuclease degradation by the proper formation of the membrane-bound
viral replicase complex.
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Fig. 4.3
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Fig. 4.3. Effects of various phospholipids on the TBSV replicase activity in artificial PE
vesicles.
(A) Scheme of the assay. (B) Artificial vesicles were prepared from PE only (lane 1), or
PE (always the same amount as in lane 1) + 10% (lane 2, ratio of PE versus other
phospholipid is 10:1), 20% (lane 3, 5:1 ratio), 40% (lane 4, 5:2 ratio), 60% (lane 5, 5:3
ratio) or 80% (lane 6, 5:4 ratio) of the shown phospholipids, followed by in vitro TBSV
replication assay in the presence of purified recombinant TBSV p33 and p92pol replication
proteins, TBSV repRNA in combination with the S40 fraction of yeast CFE. The
denaturing PAGE analysis of the

32

P-labeled repRNA products obtained is shown. The

full-length repRNA is pointed at by an arrow. The PE vesicle-based replication assay was
chosen as 100% (lane 1). Each experiment was done three times.
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Fig. 4.4
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Fig. 4.4. Binding of TBSV p33 to artificial vesicles containing different phospholipids.

(A) Scheme of the in vitro binding assay and membrane-flotation experiments. The 35Slabeled p33 was incubated with artificial vesicles (in the presence of the in vitro
translation system to provide soluble cellular factors, such as heat shock protein 70),
followed by centrifugation in 10-to-70% sucrose density gradient. Eight fractions of the
sucrose gradient were tested for the presence of 35S-p33. (B-J) SDS-PAGE analysis of the
presence of 35S-p33 in the eight fractions with the 1st fraction representing the bottom
fraction with the free (not membrane-bound) 35S-p33. The total amount of 35S-p33
applied to the gradient was chosen as 100%. The graph shows the amount of 35S-p33
present in the top fraction, representing the vesicle-bound 35S-p33.
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Fig. 4.5. TBSV p33/p92-mediated binding of TBSV RNA to artificial vesicles containing
different phospholipids.
(A) Scheme of the in vitro binding assay and membrane-flotation experiments. The

32

P-

labeled TBSV (+)repRNA (DI-72) was incubated with artificial vesicles in the presence of
purified recombinant TBSV p33 and p92 (in the presence of S40 fraction of yeast CFE to
provide soluble cellular factors, such as heat shock protein 70), followed by centrifugation
in 10-to-70% sucrose density gradient. The top fraction of the sucrose gradient was tested
for the presence of 32P-labeled TBSV (+)repRNA. (B) Denaturing RNA gel analysis of the
presence of

32

P-labeled TBSV (+)repRNA in the top fraction. The amount of

TBSV (+)repRNA with the PE vesicles was chosen as 100%.
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Fig. 4.6. Enrichment of PE at TBSV replication sites in yeast and plant cells.

(A) Confocal laser microscopy images show the enrichment of PE and its co-localization
with the GFP-tagged TBSV p33 expressed from GAL1 promoter in the presence of TBSV
repRNA replication (top two images) or only GFP-p33. DIC (differential interference
contrast) images are shown on the right. Localization of PE is detected by using
biotinylated duramycin peptide and streptavidin conjugated with Alexa Fluor 405. The
bottom image shows the more even distribution of PE in the absence of viral components.
(B) Peroxisomal enrichment of PE in the presence of TBSV replication proteins.
Peroxisomal membranes are visualized with the help of mRFP-tagged (top images) or
GFP-tagged (middle images) yeast Pex13 protein. The bottom image shows the lack of
PE enrichment in peroxisomes in the absence of viral components. See further details in
panel A. (C) Enrichment of exogenous PE in subcellular compartment containing the p33
replication protein. NBD-PE was added to yeast cultures (D) Enrichment of PE in N.
benthamiana protoplasts with viral proteins replicating TBSV genomic RNA. The TBSV
p33/p92 replication proteins were detected with p33/p92-specific primary antibody and
secondary antibody conjugated with Alexa Fluor488. The bottom images show the more
even distribution of PE in the absence of viral components. See further details in panel A.
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Fig. 4.7. Increased level of PE in yeast and plant cells replicating TBSV.
Relative levels of phospholipids in yeast (~24 h after induction of replication, panel A) and
plants (from systemic leaves showing symptoms, 6 days after infection, panel B)
replicating TBSV RNA or the TBSV-free control were determined using mass-spec
analysis.
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Fig. 4.8 Lipidomics analyses of phospholipids in yeast and plant cells replicating
TBSV.
(A) The amounts of phospholipids in yeast (~24 hours after induction of replication)
replicating TBSV (red columns) or TBSV-free control (blue columns) were determined
using mass-spec analysis. Each experiment was repeated three times. (B) The amounts of
phospholipids in N. benthamiana systemic leaves (6 days after infection) infected with
TBSV (red columns) or TBSV-free control (blue columns) were determined using massspec analysis. Each experiment was repeated three times. (C) Lack of changes in fattyacid composition of PE in yeast (~24 hours after induction of replication) replicating
TBSV (red columns) or TBSV-free control (blue columns) based on mass-spec analysis.
(D) Comparable analysis of fatty-acid composition of PE in N. benthamiana leaves (6
day after inoculation) replicating TBSV (red columns) or TBSV-free control (blue
columns).
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Fig. 4.9. Deletion of the CHO2 PEMT gene enhances TBSV repRNA accumulation in
yeast.
(A) Top panel: Replication of the TBSV repRNA in wt and cho2∆ yeast was measured
by Northern blotting 24 h after initiation of TBSV replication. Yeast co-expressed the
TBSV p33 and p92 replication proteins. The accumulation level of repRNA was
normalized based on the ribosomal (r)RNA. Each sample is obtained from different yeast
colonies. Middle and bottom panels: The accumulation levels of His6-p92 and His6-p33
were tested by Western blotting. Note that in the absence of Cho2p, which catalyzes the
first step in the conversion of PE to PC, the PE level is increased. Each experiment was
repeated. (B) Relative and absolute levels of phospholipids in cho2∆ versus wt yeasts
(~24 h after induction of replication) replicating TBSV RNA were determined using
mass-spec analysis. (C) Enhanced TBSV repRNA replication in CFE prepared from
cho2∆ yeast. The scheme of the CFE-based TBSV replication assay. Purified
recombinant TBSV p33 (0.5 µg) and p92pol (0.5 µg) replication proteins, DI-72
(+)repRNA (0.5 µg) in combination with the soluble fraction (S40 fraction from WT
yeast) were added to the membranous fraction (P40) of cho2∆ or wt CFEs. Denaturing
PAGE analysis of the 32P-labeled repRNA products obtained is shown. The full-length
single-stranded repRNA is pointed at by an arrow. (D) Confocal laser microscopy images
show the enrichment of PE at peroxisomal sites of TBSV p33 accumulation in cho2∆
yeast. See further details in Fig. 4.6.
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Fig. 4.10
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Fig. 4.10. Increased PE level facilitates TBSV RNA replication in the ER in
pex3∆cho2∆ yeast.
Top panel: Replication of TBSV repRNA in pex3∆cho2∆ versus pex3∆ yeast was
measured by Northern blotting 24 h after initiation of TBSV replication. Yeast coexpressed the TBSV p33 and p92 replication proteins. Middle and bottom panels: The
accumulation levels of His6-p92 and His6-p33 were tested by Western blotting. Each
experiment was repeated. Note that peroxisomal membranes are absent in pex3∆ or
pex3cho2∆ yeast, “forcing” TBSV to switch to the ER membranes for replication.
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Fig. 4.11. Increased PE level facilitates CNV RNA accumulation in cho2∆ yeast.
(A-B) Top panels: Replication of CNV in wt and cho2∆ yeast was measured by Northern
blotting 24 h after initiation of CNV replication at 23 ºC (panel A) or at 29 ºC (panel B).
Yeast co-expressed the CNV p33 and p92 replication proteins. Middle and bottom panels:
The accumulation levels of CNV His6-p92 and His6-p33 were tested by Western blotting.
Each experiment was repeated. (C) Confocal laser microscopy images show the
enrichment of PE at peroxisomal sites of CNV p33 accumulation in cho2∆ yeast. See
further details in Fig. 4.6.
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Fig. 4.12. Increased PE level facilitates CIRV and NoV RNA accumulation in cho2∆
yeast.
(A) Top panel: Replication of CIRV repRNA in wt and cho2∆ yeast was measured by
Northern blotting 24 h after initiation of CIRV replication. Yeast co-expressed the CIRV
p36 and p95 replication proteins. Middle and bottom panels: The accumulation levels of
His6-p95 and His6-p36 were tested by Western blotting. Each experiment was repeated. (B)
Confocal laser microscopy images show the enrichment of PE at mitochondrial sites of
CIRV p36 accumulation in cho2∆ yeast. See further details in Fig. 4.6. (C) Replication of
NoV RNA1 and RNA3 in wt and cho2∆ yeast was measured by Northern blotting 24 h
after initiation of NoV replication. (D) Confocal laser microscopy images show the
enrichment of PE at mitochondrial sites of NoV Flag-tagged protA replication protein
accumulation in cho2∆ yeast. See further details in Fig. 4.6.
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Chapter 5

VACUOLE TARGETING PATHWAY IS REQUIRED FOR EFFICIENT TBSV
REPLICATION AND MAYBE RELATED TO PE ENRICHMENT IN THE
PEROXISOMAL MEMBRANES

5.1 Introduction

Recent studies revealed an emerging picture on involvement of cellular early secretory
pathway in positive strand RNA viruses replication, including those viruses infecting
human (33, 225), animals (226) or plant hosts (227, 228).
Poliovirus (PV) infected cells develop special organelle-like structures specialized
for virus replication (229). This viral replication organelle is derived from rearrangement
of cellular early secretory membrane systems into clusters of vesicles, which harbor viral
replication proteins and viral RNAs (230). Formation of Poliovirus replication organelles
were identified to be associated with COPII-dependent anterograde transportation
pathway between ER and Golgi (230), as well as host factors involved in retrograde
transportation pathway (33, 231), like small RAS-family GTPase ADP-ribosylation
factor 1 (ARF1), GBF1 [a guanine nucleotide exchange factor (GEF) for ARF1] and
phosphatidylinositol 4-kinase-β (PI4KIIIβ; also known as PI4Kβ) (33). It was proposed
that initial PV replication happens in Golgi-TGN compartment. This initiated by
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interaction between PV viral protein 3A (232) and GBF1 which recruits Arf1 to the site
of replication (33). These events then bring various of effectors, including PI4Kβ, to
build ERGIC (Endoplasmic reticulum–Golgi intermediate compartment) as site for
replication (33). Recently, Dorobantu CM et al. (233) found that enterovirus recruitment
of PI4Kβ to ERGIC is independent of GBF1 and Arf1, suggesting GBF1/Arf1 may have
other roles in enterovirus replication.
Foot-and-mouth disease virus (FMDV) belongs to Aphthovirus genus,
picornaviridae, induce replication complexes on membranes that are formed from
endoplasmic reticulum (ER) exit sites (ERES) (226). RNAi mediated down-regulation of
Sar1 GTPase or over-expression of dominant negative Sar1a-GDP mutant inhibited
FMDV replication. However over-expression of dominant active Sar1a-GTP mutant or
dominant negative Arf1 mutant either have no effects or increased FMDV replication
(226). Brefeldin A (BFA), a Arf GEF inhibitor, also increased FMDV replication. These
data suggesting early secretory pathway is linked to FMDV replication.
A plant virus red clover necrotic mosaic virus (RCNMV), Dianthovirus genus,
tombusviridae, was shown to replicate on ER membranes (234). RCNMV replication
auxiliary protein p27 interacts with Arf1 directly (228). Arf1 was shown to be recruited
from Golgi apparatus to ER by p27. RNAi-mediated down-regulation of Arf1 or
expression of both dominant negative Arf1-GDP or dominant positive Arf1-GTP mutants
inhibited RCNMV replication. Expression of dominant active Sar1-GTP mutant inhibited
RCNMV replication. BFA treatment inhibited RCNMV replication and canceled ER
localization of p27 replication protein. BFA treated cell expressing ER-GFP and p27mCherry showed dispersed pattern of both proteins, however interestingly BFA did not
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change localization pattern of ER-GFP when it was expressed alone. Altogether,
disruption of anterograde or retrograde transportation pathway could inhibit RCNMV
replication, although the importance of these events for RCNMV is currently obscure.
A major question left unanswered from those studies on different (+)RNA
viruses: does early secretory pathway play a common role for (+)RNA viruses? Studies
showed different involvement of anterograde or retrograde transportation in different
(+)RNA viruses, however the actual functions of secretory pathway in (+)RNA viruses
replication remain far from understood.
In spite of variable involvement of anterograde or retrograde transportation
pathways, and different replication sites, replication proteins of many (+)RNA viruses
contain transmembrane domains (TMDs) which determine membrane association of viral
replication complexes. Properties of TMDs have emerged as major determinants of
protein fate in secretory pathways and endocytic pathways (235, 236). Bioinformatics
analyses of eukaryotic-encoded integral membrane proteins revealed that TMDs from ER
is different from post-ER organelles. TMDs of ER proteins is shorter than those in postER organelles, and do not possess the asymmetric amino acid distribution along the
membrane (236). Proteins with short TMDs are proposed to be secreted from ER to cisGolgi via COP-II-dependent secretion, and then bound by Rer1, a transmembrane protein
that cycles between the Golgi apparatus and the ER (237), at cis-Golgi (238, 239), thus
cycled back to ER via COP-I mediated retrograde transportation (235). In contrast,
proteins with long TMDs could interact with Erv14 (240) at ERES and be transported
along the secretory pathway to TGN and beyond (241).
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The physical properties of TMDs also determine localization of the given proteins
within lipid micro-domains (235). Alternatively, due to different properties, TMDs were
believed to attract and sort specific lipids around them (235, 236).
Since PE is an obligate phospholipid for TBSV replication (Chapter 4) and could
be enriched in peroxisomal membranes by TBSV p33 replication protein alone, it could
be interesting to understand which cellular pathway leads to PE enrichment at the sites of
TBSV replication.
Various cellular pathways affecting PE distribution are emerging. The source of
PE in autophagy has been extensively studied, and might shed lights on our
understanding of PE in TBSV replication. PE is a key molecule for phagophore
membrane formation in early stage of macroautophagy, where PE conjugates with Atg8p
(LC3-I) to form Atg8-PE (LC3-II), which usually used as a molecular marker of
macroautophagy occurrence. Different sub-cellular sources of PE has been proposed by
different groups, which includes ER (242), mitochondria (243) or ER-mitochondria
contact site(244). Clathrin-coated vesicles from plasma membrane also were shown to
contribute to early Atg16L1-positive autophagosome precursor formation via fusion with
VAMP7/SNARE complex (245, 246). In addition, trans-golgi network (247-251), early
endosomes (252), vesicles from early secretory pathway (253, 254) were demonstrated to
contribute to the membrane source of autophagosomes. Despite of many microscope
based experiments, an cell-free LC3 lipidation assay using fractionated sub-cellular
membranes from mouse embryonic fibroblast (255) showed that ERGIC is the only
membrane source to trigger LC3 lipidation, which requires conjugation of LC3 with PE,
suggesting ERGIC provides the initial PE source for autophagosomes formation.
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In this chapter, I used varies of approaches to identify factors affecting PE
enrichment at peroxisomal membranes by TBSV p33, and I will discuss possible subcellular route that PE was redistributed by the virus.
In yeast or plants, there are two pathways of PE synthesis, CDP-DAG pathway
and de-novo synthesis pathway (Fig. 5.1A). In CDP-DAG pathway, phosphatidylserine
(PS) decarboxylases directly convert PS into PE. In yeast there are two PS decarboxylase
genes, PSD1 (256) and PSD2 (257). Psd1 is localized in mitochondria (256, 258), while
Psd2 is localized to TGN (259, 260), endosomes(260) and vacuole membrane (259)
compartments (components of post-golgi organelles). In Arabidopsis, there are three PSD
genes, namely PSD1, PSD2 and PSD3 (261). AtPSD1 is localized in mitochondria,
AtPSD2 localized to vacuole membrane (Tonoplast), while AtPSD3 localized to ER
(261).
In de-novo synthesis pathway, ethanolamine is converted to phosphoethanolamine
by

ethanolamine

kinase

(EKI),

then

converted

to

CDP-ethanolamine

by

CTP:phosphoethanolamine cytidylyltransferase (ECT), and converted to PE by
aminoalcoholphosphotransferase (AAPT). AAPT has substrate specificity among
ethanolamine and choline. In yeast, there are two AAPTs, EPT1 and CPT1. EPT1 has
major activity using ethanolamine, while minor activity using choline. While CPT1 have
predominant substrate activity using choline for PC synthesis (262). In plants (263-266),
AAPTs were also been identified which show both ethanolamine or choline substrate
activity. TaAAPT1 and TaAAPT2 from wheat were shown to be localized to ER and
Golgi apparatus (264). A human CPT1 is localized to Golgi apparatus, while human
CEPT1 (major substrate activity to choline, minor to ethanolamine) localized to ER and
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nuclear membrane (267). However, the localization of EPT1 is not characterized yet in
yeast.
In plants, the CDP-DAG pathway is not essential since psd1/psd2/psd3 mutant
arabidopsis plants are viable and display no obvious growth or morphological defects
(261). The total phospholipid composition was unchanged, while PE level in isolated
mitochondria from mutant plant was decresed (261). In yeast, deletion of any one of the
three or two of the three PE synthesis genes, PSD1, PSD2 or EPT1, is not lethal. While
deletion of all three of them is lethal in yeast (268).

5.2 Materials and Methods

Yeast strains and expression plasmids. Yeast strains BY4741 (MAT a his3Δ1 leu2Δ0
met15Δ0 ura3Δ0) and pep4∆, tlg2∆, pep12∆, vam3∆ or vam7∆ (single-gene deletion
strain) were obtained from Open Biosystems (Huntsville, AL, USA). For TBSV
replication in yeast, pESC-T33/DI72 and pYES-T92 were described previously. Yeast
double deletion strains of tlg2∆tlg1∆ or vam3∆vam7∆ were generated from tlg2∆ or
vam7∆ using homologous recombination of a PCR fragment harboring a selection marker
hygromycin B phosphotransferase amplified fragment from Euroscarf collection plasmid
pFA6a-hphNT1(269) .
For

yeast

plasmid

pRS315-CFlag,

primer

pairs

#5100

(AGCTTGGTGGTGACTACAAGGACGACGATGACAAGGGTGGTAGATCTGGCG
TCGACTAA)/#5101
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(TCGATTAGTCGACGCCAGATCTACCACCCTTGTCATCGTCGTCCTTGTAGTCA
CCACCA) were annealed and inserted into pRS315-pTef1 (described in Chapter 3). To
generate pCUP1 driven C-terminal Flag-tagged SAR1 or ARF1, pRS315-CFlag were
digested with SacI/NotI and inserted with SacI/NotI digested PCR fragment of pCUP1
promoter

amplified

from

pEsc-His/Cup-FLAG/ssa1

with

primer

pair

#3039

(CGCGGAGCTCGACATTTGGGCGCTATACGTGCATATGT)/#5861
(GCGGCGGCCGCTACAGTTTGTTTTTCTTAATATCTATTTCGA),

resulting

plasmid pRS315-pCUP1p-CFlag. SAR1 and ARF1 mutants were generated via site
directed

mutagenesis

and

amplified

with

primer

pair

#5865

or

#3132

(CGCGGATCCATGGCTGGTTGGGATATTTTTGG)/#5866
(GCCCTGCAGAATATATTGAGATAACCATTGGAACGCCTC),
(gccggatccatgggtttgtttgcctctaagttgttc)/#5742
(GCCCTGCAGAGTTGAGTTTTTCAAACTGTTACTTAACCATTC), digested with
BamHI/PstI, and inserted into pRS315-pCUP1-CFlag.
To generate N-Terminal Flag-tagged Tlg2p, TLG2 was amplified from yeast
genome

using

primer

pair

#5717

(CGCGGATCCATGTTTAGAGATAGAACTAATTTATTTTTATCATACCGTAGG)
and #5718 (GCGCTCGAGTCAAAGTAGGTCATCCAAAGCATCATTC), digested
with BamHI/XhoI, and inserted into BamHI/SalI digested pRS315-NFlag (described in
Chapter 3), generating pRS315-NFlag-Tlg2.
To generate pTef1 promoter driven no tagged COP1 expressing vector, PCR
fragment of COP1 were amplified from yeast genome using primer pair #1858
(GGCGGGATCCATGAAGATGTTAACTAAATTTG)/
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#1859

(GGCGCTCGAGTTATACACGTATTCTTAATCCGGA), digested with BamHI/XhoI
and inserted into BamHI/SalI digested pRS315-pTef1, generating pRS315-COP1.

Confocal laser microscopy. Wild type BY4741 or sti1∆ yeast strains were transformed
with the following expression plasmids: pESC-GFP-T33/DI72, pYES-T92 (9), as well as
pRS315-Pex13-mRFP1 (described in Chapter 4). The yeast cultures were incubated in galactose
medium overnight, sampled and imaged with Olympus FV1000 confocal laser scanning
microscope (Olympus America Inc., Melville, NY). The microscope settings were the following:
excitation and emission for GFP and RFP were 488nm laser/500-530nm filter and 543nm
laser/560-660nm filter, respectively. PE staining with biotinylated duramycin and streptavidin
conjugated with Alexa-405 was described in Chapter 4.

Free GFP detection assay. pESC-GFP-T33 (described in Chapter 4) and pYES-GFP-T92
(9) together with an empty plasmid or SAR1 mutants were transformed into wild type or
mutant yeast strains. GFP-p33/p92 were induced for expression in SC media containing
2% galactose for 24 hours. Total protein was extracted and subjected to western blot
analysis using an anti-GFP antibody.

5.3 Results

TBSV replication in yeast mutants defective in PE synthesis pathways. Since PE is
essential for TBSV replication in vitro, we then ask: could any specific pathway of PE
synthesis be hijacked by TBSV to favor virus replication? Genes of PE synthesis were
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systemically deleted from wild type yeast, generating: psd1∆, psd2∆, ept1∆cpt1∆,
psd1∆ept1∆cpt1∆, psd2∆ept1∆cpt1∆ and psd1∆psd2∆. We tested TBSV replication in
yeast grown in SD media without ethanolamine (Fig. 5.1 B) or with ethanolamine (Fig.
5.1C). Since ethanolamine is the precursor of de-novo PE synthesis pathway,
psd1∆psd2∆ of which PE synthesis is inhibited will not grow without ethanolamine. In
SD media without ethanolamine, major PE synthesis come from PSD1 or PSD2 pathway.
TBSV repRNA accumulation level increased ~2 fold in those mutants, psd1∆ or
psd1∆ept1∆cpt1∆, which lacked the PSD1 mediated PE synthesis pathway. In those
mutants in which PSD2 pathway was deleted, TBSV repRNA accumulated to similar
level as wild type (Fig. 5.1B, upper panel). While viral protein accumulated to a similar
level among all the mutant strains (Fig. 5.1B lower level).
In a growth condition where ethanolamine was provided (Fig. 5.1C), all three PE
synthesis pathways could contribute to the overall PE pool in the cell. In such condition,
TBSV repRNA accumulation also increased by ~80% in psd1∆ept1∆cpt1∆ yeast, in
which PSD2 mediated PE synthesis pathway is the only PE source. While when PSD2
and de-novo PE synthesis pathways were deleted in psd2∆ept1∆cpt1∆ yeast, TBSV
repRNA accumulation decreased to ~60% (Fig. 5.1C upper panel). p33 replication
protein accumulation in psd2∆ept1∆cpt1∆ yeast also decreased comparing to wild type
(Fig. 5.1C lower panel). In other mutant yeasts, TBSV replication and viral protein level
are comparable to those in wild type yeast (Fig. 5.1C).

TBSV p33 replication protein is partially localized within TGN. In addition to the
characteristic punctuate structures, we also observed diffused pattern of GFP-p33 in
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yeast, which did not co-localize with peroxisome marker protein (Fig. 5.2A). In Fig.
5.2A, GFP-p33 was co-expressed with p92 and DI72 repRNA, as well as Pex13p-mRFP
as a peroxisome marker for 10 hours after induction of protein expression. We observed
some GFP- p33, which did not overlap with the peroxisome marker Pex13p-mRFP. Since
we know that peroxisome in yeast under microscope is visible as round punctuate
structure, those diffused pattern with GFP-p33 suggested that TBSV p33 might be
localized to other membrane structures during infection besides peroxisome. In chapter 4,
we also observed that PE was also co-localized to these diffused structure with p33. It
was interesting to identify which cellular compartment the diffused structures belong to.
The answer may help us to understand PE enrichment at the site of TBSV replication.
Confocal microscopy was used to identify the localization of the diffused
structure with many cellular marker proteins. Among those, TGN tSNARE protein Tlg2p
(270) was identified to co-localize with the diffused structure of TBSV p33 (Fig. 5.2B).

PE is enriched at both peroxisome and TGN locations in the presence of p33. To
demonstrate that PE enriched at peroxisome and TGN locations of p33, we transformed
yeast with plasmids expressing GFP-p33 together with peroxisome marker Pex13pmRFP (Fig. 5.3 A) or TGN marker mRFP-Tlg2p (Fig. 5.3 B). Viral proteins and repRNA
were induced in galactose containing media for 10 hours, then the yeast cells were fixed
and subsequently incubated with biotinylated duramycin, streptavidin-conjugated with
Alexa Fluor 405 dye. Cells were observed under confocal microscope. In Fig. 5.3A,
obvious punctuate structure was highlighted in all channels detecting PE, GFP-p33 and
peroxisomes. However, PE and GFP-p33 were also co-localized and observed as diffused
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pattern. To demonstrate that this diffused pattern indeed represented TGN, mRFP-Tlg2p
were used to label TGN in addition to GFP-p33 and PE (Fig. 5.3B). In Fig. 5.3B, indeed,
PE and GFP-p33 were co-localized and showed a diffused area outside the punctuate
structure. This diffused area was labeled with TGN marker protein mRFP-Tlg2p.

Deletion of TLG2 interfered with the enrichment of PE at site of TBSV replication.
Since both the genetic study of PE synthesis pathway and confocal microscope study of
PE localization site suggested the relevance of Trans-Golgi network in PE enrichment to
TBSV site of replication. As well as in previously yeast single gene deletion library
screen (12), deletion of TLG2 was shown to affect tombusvirus replication. We focused
on the role of Trans-Golgi network in TBSV replication.
First, we confirmed that deletion of TLG2 could reduce TBSV replication to
about 16% , by comparing repRNA accumulation with that of wild type yeast (Fig. 5.4A).
Meanwhile, overexpression of a N-terminus Flag-tagged Tlg2 could compliment TBSV
replication caused by the deletion of TLG2 in the mutant strain.
Secondly, in tlg2∆ yeast, plasmids expressing GFP-p33, p92, repRNA and
pex13p-mRFP were co-transformed. Cells were induced for viral protein expression and
labeled with biotinylated duramycin to detect PE localization. Importantly, in tlg2∆ yeast,
PE was not co-localized with GFP-p33 (Fig. 5.4B).

Deletion of genes coding for SNARE proteins in post-Golgi organelles reduces TBSV
replication. Since genetic analysis showed that in mutant strains, in which only PSD2
mediated PE synthesis, TBSV repRNA accumulation was ~2x fold more than wild type,
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it suggested that PSD2 pathway might be the easiest for TBSV to hijack. PSD2 were
shown to be localized at TGN or compartments of endocytic pathway in yeast or in plant
(259-261). Furthermore, deletion of TLG2 in yeast also lead to dramatically decreased
TBSV replication possibly due to lack of PE enrichment at TBSV replication sites. Tlg2p
is a tSNARE on TGN (270). It would be interesting to see if gene deletion of other
tSNAREs in endocytic pathway where Psd2p is localized could affect TBSV replication.
We tested deletion strains of TGN tSNAREs: tlg2∆ or tlg2∆tlg1∆, late endosome
tSNARE: pep12∆ and vacuole tSNAREs: vam3∆, vam7∆ or vam3∆vam7∆. Surprisingly,
all the SNARE protein deletions decreased TBSV repRNA accumulation to about 10%
comparing to the wild type (Fig. 5.5A upper panel). Also p33 accumulation was
decreased in all the mutant strain (Fig. 5.5A lower panel).
To test if p33 was targeted to the endocytic pathway, we utilized the vacuolar
protease resistant feature of GFP when present as a fusion protein. TBSV p33 or p92 was
tagged with GFP at the N-terminus (Fig. 5.5B). Free GFP detected by GFP-antibody
would suggest presence of GFP-p33 or GFP-p92 in vacuole. We first checked GFPp33/p92 degradation pattern in wild type yeast, by western blot using anti-GFP antibody
(Fig. 5.5C). In wild type yeast expressing GFP-p33/p92, anti-GFP antibody detected free
GFP with size about 30kDa (Fig. 5.5C middle and right panel). While in wild type yeast
expressing His-GFP, a expected ~33kDa band was detected (Fig. 5.5C left panel).
In addition, wild type yeast and SNARE gene mutants described above as well as
a yeast strain with single gene deletion of PEP4, which aborts protein degradation in
vacuole (271), were transformed with plasmids containing GFP-p33/p92 and induced for
gene expression for 24 hours in 23°C. Total protein were analyzed by western blot using
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anti-GFP antibody (Fig. 5.5D). In every strain, GFP-p33 and GFP-p92 were detected,
however free GFP were only detected in wild type, tlg2∆, vam3∆, vam7∆ or
vam3∆vam7∆, but not in pep4∆, tlg2∆tlg1∆ or pep12∆ (Fig. 5.5D upper panel and middle
panel). Presence of free GFP in wild type strain and missing of free GFP in pep4∆ strain
suggested a vacuole targeting of GFP-p33. And disruption of vesicle transport pathway
by deletion of certain SNARE genes abolished the targeting of GFP-p33 to vacuole.

Over-expression of SAR1 dominant mutant blocks vacuole targeting of p33 and
reduces TBSV replication. Most of membrane proteins secreted to endocytic pathway
through Golgi are dependent upon anterograde transportation pathway (235, 238). SAR1
encode a GTPase which regulate anterograde transportation COP-II vesicle coat assembly
and disassembly (272). Expression of GTP locked mutant SAR1-H77L could block cargo
transportation to golgi (273, 274). Thus we tested its effects on p33 vacuole targeting as
well as TBSV replication.
A C-terminal Flag-tagged SAR1-H77L was induced under controllable CUP1
promoter at the same time point as the GFP-tagged viral proteins. After 24 hours protein
expression, total proteins from different treatments were subjected to western blot
analysis using anti-GFP antibody (Fig. 5.6A). As previously shown (Fig. 5.5 C &D), free
GFP were detected in wild type yeast but not in pep4∆ strain (Fig. 5.6A). In wild type
yeast co-expressing wild type SAR1 gene, free GFP was also detected in a similar
amount as in wild type yeast. However in yeast co-expressing a SAR1 dominant mutant
SAR1-H77L, free GFP was present in reduced amount in comparison with wild type
yeast (Fig. 5.6A).
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To test effect of SAR1-H77L on TBSV replication, vectors expressing wild type
SAR1 or SAR1-H77L, or an empty vector were transformed into yeasts together with
TBSV p33, p92 and repRNA expressing plasmids. Viral components were induced
together with SAR1 mutant for 24 hours. Total RNA and proteins were extracted from
different treatments for RNA and protein blot analysis (Fig. 5.6B). Over-expression of
wild type SAR1 did not affect TBSV repRNA accumulation, while over-expression of
SAR1-H77L reduced TBSV repRNA accumulation to ~23%.

Expression of ARF1 dominant-active mutant ARF1-Q71L, but not dominant-negative
mutant ARF1-T31N, blocks TBSV replication. Since p33 is partially localized to TGN,
and disruption of TLG2, tSNARE of TGN, aborted PE enrichment on peroxisome and
reduced TBSV replication (Fig. 5.4), retrograde transportation from TGN could be a
potential pathway that TBSV might hijack, and thus benefit to PE enrichment on
peroxisome. To test this hypothesis, we utilized dominant mutants of ARF1, dominantnegative mutant ARF1-T31N (275), or dominant-active mutant ARF1-Q71L (275, 276).
Dominant negative mutant ARF1-T31N blocks the formation of COP-I vesicle, thus
blocks COP-I-dependent retrograde transport. Dominant-active ARF1-Q71L stimulates
formation of COP-I vesicles coats but blocks coatomer disassembly, thus also blocks
retrograde transportation.
Empty vector, or vectors expressing controllable CUP1 promoter driven ARF1,
ARF1-T31N and ARF1-Q71L ORFs were co-transformed with plasmids expressing
TBSV viral proteins and repRNA. TBSV replication was induced in galactose containing
media supplemented with copper to induce ARF1 and mutants expression. After 24 hours
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induction of replicaiton, total RNA or proteins were extracted from samples and analyzed
using RNA blot or western blot (Fig. 5.7A). RepRNA accumulation from samples overexpressing ARF1 or ARF1-T31N did not show significant difference comparing to yeast
samples transformed with an empty vector. While over-expression of dominant active
ARF1-Q71L reduced replication to ~34%. Viral protein accumulation in ARF1-Q71L
(lower panels in Fig. 5.7A) did not show significant difference comparing to those
expressing an empty vector, ARF1 or ARF1-T31N.

Alpha subunit of COP-I vesicle coatomer, Cop1p, inhibits TBSV replication. ARF1Q71L encodes a GTP locked form of ARF1, which stimulates the assembly of COP-I
vesicle coatomer. To test if formation of COP-I vesicle benefits or inhibits TBSV
replication in yeast, we tested TBSV replication while alpha subunit of COP-I vesicle
was down-regulated. In yeast, COP1 encodes alpha subunit of COP-I vesicle coatomer
and is essential to yeast growth (277). Replacing the COP1 promoter on the genome with
a tetracycline (tet)-regulatable promoter would allow control of the expression of COP1
and study its function (278, 279).
We first obtained yeast strain of Tet-COP1 from Tet-promoters Hughes
Collection (yTHC) (278). When 10 μg/ml doxycycline was added to media, Tet-COP1
yeast growth was inhibited, suggesting genomic expression of COP1 was shut down.
However expression of COP1 driven by a constitutive promoter from plasmid pRS315COP1 could rescue the inhibitory effect, thus allowed Tet-COP1 growth in doxycycline
containing media (Fig. 5.7B).
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Vectors expressing TBSV replication proteins and repRNA were transformed to
Tet-COP1 strain with or without pRS315-COP1. Yeasts were cultured to induce TBSV
replication with or without doxycycline. In the growth media with doxycycline where
COP1 expression was inhibited, TBSV repRNA accumulation increased ~3 fold,
comparing to that in yeast without doxycycline treatment. However, over-expression of
COP1 under a constitutive promoter from plasmid inhibited TBSV repRNA accumulation
to ~30% in the growth condition either with or without doxycycline, suggesting that
COP1 or formation of COP-I complex inhibited TBSV replication.

5.4 Discussion

Can PE synthesis pathway be co-opted by TBSV? In chapter 4, TBSV p33 was
demonstrated to induce PE accumulation in peroxisomal membranes, the site of TBSV
replication. To better understand the virus-driven lipid sorting process, we tested yeast
mutants with deletion of genes involved in PE synthesis pathways for TBSV replication.
From previous studies (268, 280, 281) we know that PE is essential for yeast growth,
three PE synthesis pathways could not be deleted in the same yeast, but single or double
deletion of the three pathways are possible. This suggests that PE from any of the three
pathways could be transported to other cellular components where PE is needed.
However, this endogenous PE transportation process has not yet revealed, except that a
study using purified yeast post-Golgi vesicles in an cell-free environment showed that
yeast post-golgi secretory vesicles contains ~80% of PE in the cytosolic leaflet, and P4
ATPases Drs2p and Dnf3p are required to maintain the assymetry (282).
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We tested TBSV replication in yeast strains with single or double deletions of PE
synthesis pathways genes (Fig. 5.1), and found none of these deletions caused TBSV
replication to drop more than 50% comparing to that in the wild type yeast.
However, we noticed that in the presence of ethanolamine, in the yeast mutant
psd2∆ept1∆cpt1∆ where the only PE source come from the PSD1 pathway, TBSV
repRNA accumulation reduced to ~60% (Fig. 5.1C). These data suggesting that deletion
of PE source from PSD2 and EPT1 would affect TBSV replication, although not totally
required. Meanwhile, in yeast strain psd1∆ept1∆cpt1∆, TBSV repRNA accumulation
increased to 180%, suggesting that in this yeast strain PE could be more accessible for
TBSV. PSD2 pathway is the only PE source in psd1∆ept1∆cpt1∆, and thus TBSV may
utilize PE from PSD2 pathway more easily.
We also tested growth condition without ethanolamine. In this growth condition,
PSD1 or PSD2 pathway contribute to the major cellular PE sources, while double
deletion mutant psd1∆ psd2∆ could not grow due to lack of ethanolamine which is PE
precursor. TBSV repRNA accumulation increased to ~2-2.5 fold in the yeast strain psd1∆
or psd1∆ept1∆cpt1∆, comparing to that of the wild type. In these strains, PSD2 pathway
is the dominant/only PE synthesis pathway. PSD2 localized at TGN (259, 260),
endosomes(260) and vacuole membrane (259). This finding is in line with the hypothesis
that PE from post-Golgi compartments could be accessed by TBSV easier than from
other pathways.

TGN tSNARE Tlg2 co-localizes with TBSV p33 and affects PE redistribution to
peroxisome as well as TBSV replication. In addition to peroxisome localization of p33,
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we also observe diffused pattern of GFP-p33 outside the peroxisome marker Pex13pmRFP (Fig. 5.2A), especially when cells were harvested at 10-12 hours after the
induction of viral protein expression in yeast. A TGN tSNARE Tlg2p was shown to
localize with the diffused GFP-p33 (Fig. 5.2B). This finding added new level of subcellular dynamics of TBSV infection. Indeed in a study performed by another research
group, similar pattern of TBSV p33 distribution outside of peroxisome was also detected
in plant cells after 24 hours of plasmids bombardment (18). The observed reticular
distribution of p33 was claimed to be peroxisomal-ER (pER) based on its co-localization
with Chloramphenicol acetyltransferase tagged to 36 C-terminal residues of Peroxisomal
ascorbate peroxidase (CAT-APX), which was believed to be sorted to peroxisome
through a sub-domain of ER (pER). But they also found that the reticular p33 pattern did
not co-localiz either with concanavalin A-stained ER or immunostained ER endogenous
protein calreticulin (18). However, whether p33 interferes with the targeting of CATAPX to peroxisome remains unknown. In other words, CAT-APX localization may
changed during p33 expression, thus its co-localization with reticular p33 pattern may not
suggest their presence in a sub-domain of ER.
We later demonstrated that PE was not only enriched in peroxisomal membranes
by p33, but also enriched at TGN (Fig. 5.3B). Based on this finding, we hypothesize that
enrichment of PE driven by p33 may be connected to cellular functions of TGN. Indeed,
when TLG2 was deleted, PE did not co-localized with p33 (Fig. 5.4B). Although p33
localization to the peroxisome was not affected. Since tSNARE is essential for TGN's
function, this finding supported previous hypothesis that cellular function of TGN is
required for PE enrichment with p33.
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Disruption of vesicle transport in endocytic pathway inhibited replication. We
previously hypothesis PSD2 pathway of PE synthesis was more accessible for TBSV p33
to hijack, and we also showed that cellular function of TGN is important for viral
hijacking of PE. Psd2 localized with TGN (259, 260), endosome (260) and Vacuolar
membrane(259), and tSNARE proteins from these sub-cellular compartments also
important for TBSV replication similar to that of tlg2∆. It might be that disruption of
vesicle transport in endocytic pathway would interfere transportation of PE from PSD2
source. It is also surprising to see minor amount of GFP-p33 is targeted to vacuole,
whether p33 is directly involved in PE re-distribution to peroxisomal membranes remains
to be tested.

Arf1 regulated retrograde transportation is not needed for, but could interfere with,
TBSV replication. One question may raise due to complicated locations and functions of
TBSV p33: how does the presence of p33 in endocytic pathway benefit assembly of
TBSV replication complexes?
One possibility maybe that p33 was retro-transported from TGN to ER or
peroxisome and PE was hijacked from the carrying vesicle. Although previous evidences
suggested that asymmetrical distribution of PE on one side of membrane bilayers only
happened on post golgi organelles and ER possess a symmetrical lipid distribution across
the bilayer (282), we still tested the hypothesis.
By over-expression a dominant negative mutant of ARF1, ARF1-T31N, which
inhibit COP-I dependent coatomer assembly, we showed that COP-I dependent
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retrograde transportation is not required for TBSV replication. However over-expression
of ARF1-Q71L, which stimulate COP-I coatomer assembly but not disassembly,
inhibited TBSV replication to ~34%. The difference of these to mutants was probably
due to stimulation of assembly of COP-I vesicles by ARF1-Q71L also led a consumption
of phospholipids, including PE, from TGN, thus interfere with PE recruitment by TBSV.

Summary: In this chapter, efforts were made for finding the PE source for TBSV
replication. However, deletion of single or double PE synthesis genes did not lead to
significantly reduced TBSV replication in yeast. However, PSD2 mediated PE synthesis
pathway was favored among three PE synthesis pathways by TBSV.
TBSV p33 was demonstrated to localize to both TGN and peroxisome. PE was
also enriched at both TGN and peroxisome together with p33. Moreover, a TGN
tSNARE Tlg2p was shown to have major function in TBSV replication, possibly due to
its ability to regulate PE enrichment in replication complexes.
By using GFP tagged TBSV replication proteins, a vacuole targeting pathway of
p33 and p92 was identified. This p33/p92 targeting requires vesicle transportation
pathway on the TGN and endocytic compartments. And disruption of vesicle transport in
the endocytic pathway also have negative effect on TBSV replication.
This p33/p92 secretion was shown to be dependent on COP-II mediated
anterograde transportation from ER to Golgi, and was essential for TBSV replication in
yeast. However, a COP-I dependent retrograde transportation seems not to contribute to
TBSV replication, but interfere with replication.
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Overall, we found evidences that p33 secretion from ER to vacuole through COPII dependent early secretory pathway contributed to TBSV replication. An TGN tSNARE
Tlg2p was also shown to regulate PE enrichment at TBSV site of replication.

(Copyright © Kai Xu 2014)
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A. PE synthesis pathways in yeast
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Fig. 5.1 Reduced TBSV replication in PE synthesis pathways deletion yeast strains.
(A) Schematic of three PE synthesis pathways in yeast. (B) Replication of TBSV in yeast
deletion strains grown in media without ethanolamine. Upper Panel: Northern blot of
repRNA and 18S ribosomal RNA. Lower Panel: Western blot of total proteins extracted
from different strains tested. TBSV p33 and p92 were tagged with HIS6 tag on their Nterminals and detected with an anti-HIS antibody. Total proteins were stained with
Ponceau S on PVDF membrane after transfer. (C) Replication of TBSV in yeast in
deletion strains grown in media with ethanolamine. Note that psd1∆psd2∆ strain was able
to grow under this condition. See further details described in panel B. Each experiment
was repeated.
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DIC

Fig. 5.2 p33 co-localization to peroxisomes and TGN.
(A) GFP-tagged p33 localized in peroxisomal membrane. Wild type yeast was
transformed with vectors expressing GFP-tagged p33, p92 and DI-72, as well as pex13pmRFP. Viral components were induced in yeast grown in SC media containing 2%
galactose for 10 hours. Cells were collected and subjected to confocal laser microscopy
analysis. Results showed partial co-localization of TBSV GFP-p33 with peroxisomal
marker Pex13p-mRFP. DIC (differential interference contrast) images are shown on the
right. (B) Confocal laser microscopy images showed that TBSV GFP-p33 also partially
co-localized with TGN marker Tlg2p-mRFP.
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Fig. 5.3 PE is enriched in both peroxisome and TGN where TBSV GFP-p33 is
localized.
(A) Confocal laser microscope image showed that PE was enriched at sites of GFP-p33
accumulation and partially co-localized with peroxisomal marker Pex13p-mRFP as
punctuate structures. PE was visualized using biotinylated duramycin and streptavidin
conjugated with Alexa-405. (B) TGN localization of GFP-p33 where PE was also
enriched showed diffused pattern, which is visually distinguishable from peroxisomal
punctuate structures.
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A TBSV replication in tlg2Δ yeast
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Fig. 5.4 TGN tSNARE Tlg2 is required for efficient TBSV replication in yeast,
affecting PE enrichment to sites of replication.
(A) Deletion of TLG2 dramatically reduced TBSV replication, and expression of a Nterminal Flag-tagged Tlg2 from a vector complemented the effect caused by deletion of
TLG2 from genome. Upper panel: Northern blot repRNA and ribosomal 18S RNA.
Lower panel: Western blot detecting viral proteins as well as Flag-Tlg2p by anti-HIS
antibody or anti-FLAG antibody. Total protein was detected with Ponceau S on PVDF
membrane after transfer. Experiments were repeated. (B) Confocal microscope images
showed that unlike in wt yeast PE was not enriched at sites of replication in tlg2∆ yeast.
See further description of yeast growth condition in Fig. 5.2, PE detection method in Fig.
5.3.
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Fig. 5.5 Targeting of TBSV p33/p92 to vacuole through vesicle transport pathway.
(A) Deletion of tSNARE genes of TGN or endocytic pathway dramatically reduced
TBSV replication. (B) Cartoon representation of partial proteolysis of GFP tagged viral
proteins in vacuole. (C) Free GFP was detected in wild type yeast expressing GFP tagged
p33/p92 using anti-GFP antibody. Arrows on the left showed sizes of protein markers.
Arrows on the right showed expected bands of Free GFP or GFP tagged viral proteins.
Right panel is a digitally over-exposed (ex.) copy of His-GFP-p33/p92 sample. (D) Free
GFP was not detected in pep4∆, tlg2tlg1∆ or pep12∆ yeast strains expressing GFP-tagged
p33/p92. Upper panel: protein blot of total protein from different yeast strains expressing
GFP-tagged p33/p92 using anti-GFP antibody. Middle panel: Small portion of digitally
over-exposed image of boxed area from upper panel, showing the free GFP bands.
Noting that Free GFP was not detected in pep4∆, tlg2tlg1∆ or pep12∆ yeast strains.
Lower panel: coomassie blue staining of total protein loaded.
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B SAR1 dominant mutant inhibits TBSV replication
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Fig. 5.6 SAR1 dominant mutant SAR1-H77L inhibits vacuole targeting of GFPp33/p92 as well as TBSV replication.
(A) SAR1-H77L inhibited GFP-p33/p92 targeting to vacuole, based on less amount of
free GFP detected. See further details on Fig.5.5C and D. (B) Reduced TBSV replication
in SAR1-H77L-Flag expressing yeast. Upper panel shows repRNA accumulation reduced
upon expression of Sar1(H77L)-Flag. Lower panel shows protein expression level of
TBSV p33, p92 and Sar1 or Sar1(H77L). Total protein was stained by ponceau S.
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Fig. 5.7 COP-I dependent retrograde transport from TGN to ER is not required for
TBSV replication in yeast.
(A) ARF1 dominant active mutant ARF1-Q71L inhibit TBSV replication, but not
dominant negative mutant ARF1-T31N. See further detail about RNA and protein blot
from Fig. 5.6B. (B) Doxycycline inhibited a yeast strain whose COP1 was under a
tetracycline (tet)-regulatable promoter, while plasmid (pRS315-COP1) expression of
COP1 rescued yeast growth caused by doxycycline. (C) Over-expression of COP1 from
pRS315-COP1 inhibited TBSV replication, while down-regulation of COP1 from
genome under tetracycline (tet)-regulatable promoter by adding doxycycline into growth
media stimulated TBSV repRNA accumulation to ~3 fold comparing to that of without
adding doxycycline.
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Chapter 6

CLASS III PHOSPHOINOSITIDE 3-KINASE VPS34 IS A KEY HOST FACTOR
IN TOMBUSVIRUS REPLICATION

6.1 Introduction
During the past decades, PI3K or its product Phosphatidylinositol 3-phosphate
(PI3P) emerged as an important host factor regulating diseases caused by various of
pathogens (284), including influenza viruses (285), hepatitis C virus (286), human
pathogenic bacteria(287, 288), plasmodium (284) and pathogenic fungi (284, 289).
Phosphatidylinositide 3-kinases (PI3Ks) are a group of proteins defined by their
enzymatic activity to phosphorylate the 3 position hydroxyl group of the inositol ring of
phosphatidylinositol (PtdIns), or 4 , 5 position phosphorylated PtdIns . There are three
classes of PI3Ks based on their substrate specificity in vitro and protein size (290, 291).
Class I PI3Ks, usually ~110 kDa in size, could phosphorylate Phosphatidylinositol (PI),
Phosphatidylinositol 4-phosphate (PI4P) or Phosphatidylinositol (4,5)-bisphosphate
(PI(4,5)P2), but with substrate preference toward PI(4,5)P2. Class II PI3Ks , about ~170
kDa, prefer PI over PI4P over PI(4,5)P2 for substrate (290, 291).
Although two classes of PI3Ks play important role in human and animal cells,
they are not found in yeast and in plants (292, 293). Class III PI3Ks, or Vps34 (Vacuole
protein sorting 34), is the only class of PI3Ks present in yeast and plants. It has substrate
activity solely toward PI. VPS34's function was firstly known in regulating vacuole
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protein sorting, as indicated by its name. Deletion of VPS34 from plants, at least in
Arabidopsis thaliana, is lethal for plant development and growth (293). However deletion
of VPS34 in yeast is viable for yeast growth .
Besides genetic approaches, chemical inhibitors were developed to inhibit the
activity of the lipid kinase domain of PI3Ks. There are many PI3Ks inhibitors been
developed and used in PI3K functional studies. These inhibitors showed varied inhibitory
sensitivity towards different forms/classes of PI3Ks. For example, the famous PI3K
inhibitor Wortamanin have significantly less half maximal inhibitory concentration (IC50)
value with mammalian hVps34 than with yeast Vps34p (294). Specificity of different
PI3K inhibitors restricted the study of different PI3Ks functions. However this issue is
minor in yeast and plant in which Vps34p is the only PI3K.
Vps34p is involved in many cellular protein and membrane trafficking processes,
including vacuole protein targeting, macroautophagy, endocytosis, Gpa1p signaling, et al
(292). Different Vps34p complexes are responsible for different functions (292). There
are two major distinct Vps34p complexes in yeast proposed by Kihara, A. et al. (295),
both contain Vps34p, Vps15p and Vps30p. Complex I contains one additional protein
Atg14, and is required for autophagy (296). Complex II contains protein Vps38p,
regulating vacuole sorting of the lysosomal hydrolase CPY (carboxypeptidase Y).
Complex I is localized to vacuolar membrane and perivacuolar pre-autophagosomal
structure (PAS), while complex II is localized to TGN, late endosome and vacuolar
membrane (295-298).
However, deletion of VPS30 does not affect vacuole targeting and processing of
newly synthesized protease A or protease B (292, 295). In additon, GTP-binding alpha
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subunit of the heterotrimeric G protein (Gpa1p) forms complex with Vps34p and Vps15p
and controls pheromone signalling (299). Thus, based on these information, Jonathan M.
Backer proposed two additional Vps34p complexes in yeast (292) (Fig. 6.3A).
Single-copy AtVPS34 is the only PI3K in Arabidopsis thaliana. Although
heterozygous T-DNA insertion mutant of AtVPS34 exist, homozygous vps34 mutation is
not viable, since VPS34 is essential for plant growth, including pollen development
(293). Blocking of the PI3P in plant cells by over-expression of a PI3P specific binding
domain from human early endosome antigen 1 inhibited targeting of vacuolar protein
sporamin (300). Treatment of tobacco cells with PI3K inhibitor Wortmannin also
inhibited the vacuole targeting of COOH-terminal propeptide (CTPP) of the barley lectin
precursor, but not the sporamin precursor (301). Plant Vps34 as well as Vps30, Atg3,
Atg7 were shown to restrict spreading of hypersensitive reaction (HR) of tobacco mosaic
virus (TMV) infected cells to adjacent cells in leaves (302).
In this Chapter, we show evidence supporting a novel and essential function of
VPS34 for positive RNA virus replication in yeast and in plant. We will also discuss the
molecular and cellular mechanism of VPS34 in TBSV replication.

6.2 Materials and Methods

Yeast strains and expression plasmids. Yeast strains BY4741 (MAT a his3Δ1 leu2Δ0
met15Δ0 ura3Δ0) and vps34∆, vps30∆, vps38∆ or atg14∆ (single-gene deletion strain)
were obtained from Open Biosystems (Huntsville, AL, USA).
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For yeast plasmid expressing Vps34p, VPS34 gene fragment was amplified from yeast
genomic

DNA

using

primer

pair

#5014

(GGAAGATCTAAAATGTCACTGAACAACATAACATTCTGTG)/

#5015

(GCCCTGCAGGGTCCGCCAGTATTGTGCC), digested with BglII/PstI and inserted into
BamHI/PstI digested pRS315-CFlag (Chapter 5), generating pRS315-Vps34-CFlag. PCR
fragment

of

mRFP1

or

rsGFP

using

primer

pair

(CGGAGATCTATGGCCTCCTCCGAGGAC)/

#2691
#2631

(GGACTCGAGTTAGGCGCCGGTGGAGTGG)

or

#4568

(GGCAGATCTGGTAAAGGAGAAGAACTTTTCACT)/

#3721

(GCCGAGATCTCGGATAACAATTTCACACAG) were digested with BglII/XhoI and
inserted into BglII/SalI digested pRS315-Vps34-mRFP1, or pRS315-Vps34-GFP.

PI3K inhibitor AS604850. AS604850 was obtained from Selleck Chemicals, dissolved in
DMSO in concentration of 5mM.

Split-Ubiquitin based Y2H assay. For pray constructs pPR3N-Vps34 or pPR3C-Vps34,
VPS34 was amplified from genomic DNA using primer pair #5104/#5105, digested with
BglII, and inserted into BamHI/SmaI digested pPR-N-RE or pPR-C-RE (99). Bait
construct pGAD-BT3-N-His33 or pGAD-BT3-N-His92 (110) together with pray
construct were co-transformed into yeast NMY51 [MATahis3∆ 200 trp1-901 leu2-3, 112
ade2

LYS2::(lexAop)4-HIS3

ura3::(lexAop)8-lacZ

ade2::(lexAop)8-ADE2

GAL4] (Dualsystems), and plated onto Trp−/Leu− synthetic minimal medium plates.
Transformed colonies were picked, re-suspended in water, diluted 4 times with 10 fold
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dilution each time, and spotted onto TLHA− (Trp−/Le u−/His−/Ade−) plates to test bait
and pray interaction.

6.3 Results

VPS34 deletion affects PE enrichment in peroxisomal membrane and dramatically
reduces TBSV replication in yeast. To test the role of VPS34 in TBSV replication, we
utilized vps34∆ deletion yeast strain. Plasmids (9) (pESC-T33/DI72, pYES-T92)
expressing viral replication components together with empty vector or pRS315-VPS34CFlag were transformed into wild type or vps34∆ deletion yeast strain. Cells were grown
in SC media containing 2% galactose to induce TBSV replication, and harvested at 1 day
post induction. Total RNA and protein were extracted and subjected for RNA and protein
blot analysis. In vps34∆ strain, we observed a reduction by 90% of repRNA accumulation
compared to that from wild type. However, a plasmid expressing Vps34p-Flag
complemented TBSV replication caused by deletion of VPS34. Viral protein p33 and p92
accumulation was reduced comparing to that in wild type yeast, while p92 also showed
less accumulation level.
This reduction of p33/p92 protein level was also observed in TBSV replicating
cells where TLG2 or other tSNAREs in endocytic pathways were deleted (In Chapter 5).
Since TLG2 deletion could affect virus driven enrichment of PE in peroxisomal
membrane during TBSV replication, we also tested the PE localization in vps34∆ strain
(Fig. 6.1B). Surprisingly, PE was not enriched at the site of replication, however TBSV
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p33/p92 still localized to peroxisome, as shown by co-localization of peroxisome marker
Pex13p-GFP and mRFP-p33/p92.

PI3K inhibitor AS604850 inhibits (+)RNA virus replication in yeast and in plant.
AS604850 is a specific PI3K inhibitor, with higher specificity toward Class I PI3K
isoform γ (PI3Kγ /p110γ) comparing to isoform α/β (303, 304). We tested its effect on
TBSV replication in yeast and in plants (Fig. 6.2A/B).
At the concentration of 4µM, AS604850 inhibited TBSV replication in yeast as
the repRNA accumulation was reduced to ~13% comparing to that in wild type. Similarly
to deletion of VPS34, we observed an reduction in p33 accumulation level (Fig. 6.2A,
lower panel). In Nicotiana benthamiana protoplast transfected with TBSV full length
genomic RNA, 0.5 µM AS604850 inhibited TBSV genomic replication by 80%
comparing to that of adding the solvent only. At concentration of 2.5 or 5 µM, TBSV
replication is close to detection limit (Fig. 6.2B).
CIRV replication proteins or CNV replication proteins could also replicate DI-72
repRNA in yeast mitochondria outer (9) or peroxisome membranes (10), respectively.
Different concentrations of AS604850 were also added to growth media of yeast
transformed with pESC-C36/DI72 and pYES-C95, or pESC-HisCNVp33-DI72 and
pYES-CNVp92 (9). Interestingly, 4µM AS604850 could also effectively inhibit repRNA
replication by CIRV or CNV replication proteins (Fig. 6.2C upper & middle panels).
AS604850 was also used to test its effect on Nodamura virus (NoV), a unrelated
positive strand RNA virus replication using the mitochondrial outer membrane (109, 224,
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305). At concentration of 4µM, AS604850 inhibited Nov replication, similar to the
results obtained with TBSV, CIRV and CNV.

Deletion of genes encoding components of different Vps34p complexes reveals a role
for vacuole targeting complexes in viral replication. We have tested single gene
encoding deletions encoding protein components of different Vps34p complexes (Fig.
6.3A) for their effects on supporting tombusvirus replication.
Deletion of VPS15 dramatically reduced repRNA accumulation in yeast cells
expressing TBSV p33, p92 and DI72 to ~5% of wild type yeast strain. While VPS30 and
VPS38 deletion also reduced repRNA accumulation to ~48% and ~27% respectively.
However, deletion of ATG14, which is responsible for autophagy or pheromone
signaling did not affect TBSV replication (Fig. 6.3B Upper panel). TBSV p33
accumulation in vps15∆ and vps38∆ reduced significantly, similar to that in vps34∆ strain
(Fig. 6.3B lower panel).
RepRNA DI-72 replication by CNV replication proteins was also tested (Fig.
6.4C). In VPS15 deletion strain, repRNA was reduced to ~42%, however replication was
not significantly affected in vps30∆, atg14∆ or vps38∆

strains. The above results

suggested involvement of different Vps34p complexes controlling vacuole protein
targeting are involved in TBSV or CNV replication in yeast.

Vps34p is co-localized with TBSV p33 in yeast. To observe the localization of Vps34p
during TBSV replication, we utilized a plasmid-borne C-terminal mRFP1 tagged Vps34p
and GFP-tagged p33. Plasmids pESC-GFP-T33/DI72, pYES-T92 (9) and pRS315-
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Vps34-mRFP1 were transformed into vps34∆ yeast strain. Yeast cells were induced to
support repRNA replication in growth media containing 2% galactose for 4, 6 or 24 hours
and subjected to confocal microscope analysis (Fig. 6.4A). We observed Vps34p-mRFP1
showed punctuate structures in yeast, and some of Vps34p-mRFP1 containing punctuates
co-localized with GFP-p33 after 4, 6 or 24 hours induction of viral replication. These colocalized Vps34p-p33 structures may represent Vps34p complexes responsible for TBSV
replication (Fig. 6.3).
Pex13p tagged with mRFP on its C-terminal end was also used to test Vps34p
localization during TBSV repRNA replication in yeast. Plasmids pESC-T33/DI72,
pYES-T92, pRS315-pex13-mRFP and pRS314-Vps34-GFP were transformed to diploid
Sc1 yeast strain. RepRNA replication was induced in growth media containing 2%
galactose for 24hours. Yeast cells were collected and subjected to confocal laser
microscope analysis. Vps34p-GFP forms many punctuate structures similar to

the

observation using Vps34p-mRFP1, and some of the Vps34p-GFP punctuate structures
were co-localized with peroxisome marker Pex13p-mRFP (Fig. 6.4B). Thus these
observations supported that some of the Vps34p localized to peroxisome in TBSV
replicating yeast.

Vps34p does not interact with tombusvirus replication proteins in Split- Ubiquitin
based yeast two hybrid assay. To test if Vps34p interacts with TBSV replication proteins,
we utilized a split-ubiquitin based yeast two hybrid assay, designed for testing the
interaction of a pray protein with a membrane bait protein (110).
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Vps34p was tagged with N-terminal half of ubiquitin (NubG) on its N-terminal or
C-terminal and expressed from a plasmid which was co-transformed into yeast strain
NMY51 (110) together with a plasmid expressing C-terminal Cub (C-terminal half of
ubiquitin)-tagged CNV p33 or p92. Transformed yeast cells were spotted on Trp-/Leu/His-/Ade- (TLHA-) or Trp-/Leu- (TL-) media with 10X dilution sequentially for 5 times
(Fig. 6.5 A&B right panels). Growing of the yeast cells from TLHA- media suggested
interaction between bait and prey proteins. A known interacting protein Ssa1p (101) was
used as positive control, while an empty plasmid was used as negative control.
Yeasts transformed with plasmids containing Cub-tagged p33 or p92 with NubG
tagged Ssa1p grown in TLHA- media suggested an interaction between viral proteins and
Ssa1p. However, yeast co-expressing N or C terminal NubG tagged Vps34p and viral
proteins did not show growth, suggesting lack of interaction between viral proteins and
Vps34p.

TBSV replication does not induce pexophagy. Pexophagy is selective macro-autophagy
for peroxisome, which is controlled by VPS34 (306). The pexophagy event is usually
monitored by vacuolar degradation of peroxisome matrix protein Pot1p (306), or
visualization of vacuolar localization of peroxisomal matrix targeted BFP-SKL (307), or
free GFP caused by vacuolar degradation GFP-tagged peroxisome membrane proteins,
including Pex11p-GFP(283).
Since minor amount of free GFP was detected from yeast cells expressing GFPp33/p92 (Chapter 5, Fig. 5.5C&D) , it could be possible that pexophagy was also
involved besides previously identified COP-II dependent secretion and endocytic
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pathway that transfers p33 from ER to TGN/endosome/vacuole (Chapter 5, Fig. 5.5 &
5.6). To test if pexophagy contributes to TBSV replication, we utilized GFP-tagged
p33/p92 expressed in wild type or vps34∆ deletion yeast strain. GFP-p33/p92
accumulation was dramatically reduced in vps34∆ yeast strain (Fig. 6.6A), in which
pexophagy did not occur due to deletion of VPS34. The reduced GFP-p33/p92
accumulation level in pexophagy-free vps34∆ yeast strain was contrary to the vacuolar
degradation of pexophagic cargo proteins, suggesting pexophagy is not involved in
targeting GPF-p33/p92 to vacuole.
To test if TBSV viral protein expression induces pexophagic degradation of
peroxisomal matrix protein Pot1p/Fox3p, we detected Pot1p protein level by protein blot
using anti-Pot1p antibody (kindly provided by Daniel J. Klionsky from University of
Michigan) between samples with or without TBSV replication, in wild type or vps34∆
deletion strain (Fig. 6.6B). We found that Pot1p level was not significantly different
between different samples described above.

Total protein, mitochondria membrane

protein Porin, ER membrane protein Sec61p and cytosolic protein PGK were used as
control to show equal loading between samples. Thus, our data suggest that TBSV
replication in yeast does not induce pexophagy, and the role of Vps34p function in TBSV
replication is not related to pexophagy-like event. This finding supported the previous
finding that ATG14 deletion did not affect TBSV replication in yeast (Fig. 6.3).

6.4 Discussion

190

VPS34 is involved in RNA viruses replication. Based on genetic study on model host
yeast for TBSV replication, as well as utilizing a PI3K inhibitor AS604850 in yeast and
plant cells, we identified VPS34/PI3K as a host factor important for TBSV replication
(Fig. 6.1A, 6.2A&B). In plant protoplast cells transfected with TBSV full genomic RNA,
TBSV replication was almost eliminated by adding 5 µM AS604850 into the incubation
media (Fig. 6.2B). In yeast, either deletion of VPS34 or 4 µM AS604850 could reduce
repRNA accumulation to ~11%. Interestingly, the accumulation of plasmid driven viral
protein was also reduced dramatically. Such reduced level of repRNA as well as lower
viral protein accumulation as also observed when tSNAREs from endocytic pathway or
TGN were deleted. It could be interesting if PE distribution was affected during TBSV
replication, since deletion of TGN tSNARE TLG2 abolished PE enrichment in
peroxisome at the presence of TBSV replication. Interestingly, PE also did not
accumulate in peroxisome in vps34∆ when mRFP tagged p33/p92 were expressed (Fig.
6.1B).
PI3K inhibitor AS604850 was also tested for its effect on DI-72 replication using
CIRV or CNV replication proteins in yeast, and Nodamura virus genomic RNA1
replication in yeast. Results showed that at concentration of 4 µM, it inhibited viral
replication in all these three cases (Fig. 6.2C). It is notable that PE was also enriched at
site of CIRV, CNV or Nov replication (Chapter 4).

Identifying a vacuolar protein targeting function of VPS34 in TBSV replication. As
TBSV driven PE enrichment in peroxisome was affected in tlg2∆ or vps34∆ deletion
strains, we wonder if these two gene have common functions? Vps34p in yeast is known

191

to function in distinct complexes (Fig. 6.3A), containing additional proteins including
Vps15p, Vps30p, Vps38p or Atg14p (292, 295). We used single gene deletion yeast
strains of vps15∆, vps30∆, vps38∆ or atg14∆ to dissect different functions of VPS34 in
tombusvirus replication. Deletion of VPS15 reduced TBSV repRNA and proteins
accumulation to similar level comparing to VPS34 deletion, while deletion of VPS30 or
VPS38 also reduced TBSV replication (Fig. 6.3B). In case where DI-72 was replicated by
CNV p33 and p92 (Fig. 6.3C), repRNA accumulation was only reduced in VPS15
deletion strain, and did not change in VPS30, VPS38 or ATG14 deletions.
Based on Jonathan M. BACKER's model of four Vps34p complexes (292), I
demonstrated that vacuole protein targeting function of VPS34 seems to be involved in
TBSV replication. This results agreed with the finding that PE was not enriched in
peroxisome in yeast deletion strain of TGN tSNARE TLG2, which is involved in
vesicle/protein transportation.

Vps34p localized at site of TBSV replication, but does not interact with p33/p92. In
vps34∆ yeast expressing Vps34p-mRFP1, GFP-p33/p92, of which fluorescence under
confocal laser microscope, co-localized with some of the punctuate-like structures of
Vps34p-mRFP1, suggesting a direct involvement of Vps34p in TBSV replication. This
result was confirmed by co-localization of Vps34p-GFP and a peroxisome marker
Pex13p-mRFP in a diploid yeast cell when TBSV replication (Fig. 6.4).
We asked if Vps34p directly interacts with TBSV replication proteins. In a split
ubiquitin based yeast membrane protein two hybrid system, Vps34p does not show
interaction with p33 or p92 (Fig. 6.5). However other components of the Vps34p
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complexes were not tested for their interaction with TBSV p33/p92 yet. Besides direct
interaction, an existing function of Vps34p on peroxisome may be co-opted by TBSV to
aid its replication.

Pexophagy pathway is not co-opted for TBSV replication. A known function of VPS34
in peroxisome regulation involves pexophagy during nutrition stressed environment
(306). We tested degradation pattern of TBSV viral proteins GFP-p33/p92 and
peroxisomal matrix protein Pot1p accumulation in wild type as well as pexophagy-free
vps34∆ yeast strains (306). Pot1p level was similar in samples with or without TBSV in
both WT and vps34∆ yeast strains, suggesting TBSV replication does not induce
detectable pexophagy. GFP-p33/p92 accumulation reduced, not increased, in pexophagy
free yeast strain suggesting that pexophagy does not play a role in stability of TBSV
protein. Pexophagy is a selective macro-autophagy event, which is controlled by VPS15,
VPS30 and ATG14, but not VPS38 (306). Absence of involvement of pexophagy in
TBSV replication agreed with previously identified non-autophagy function of VPS34
(Fig. 6.3).

Summary: In this chapter, we show evidence that VPS34 is involved in TBSV replication
in yeast and in plant, and possibly in CIRV, CNV and NoV replication in yeast. I
identified a role in the vacuole protein targeting of Vps34 in TBSV replication. Colocalization of Vps34p and TBSV p33/p92 suggests involvement of cellular functions of
Vps34p in peroxisome that might be co-opted for TBSV replication. However this
cellular function is not pexophagy, instead a non-autophagic function, possibly
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vesicle/protein transport function of Vps34p, is involved in TBSV replication.
Importantly I discovered that VPS34's function correlates to PE enrichment in
peroxisome during TBSV replication.
(Copyright © Kai Xu 2014)
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A TBSV replication in vps34∆ yeast strain

WT

vector

vps34∆

Vps34p-Flag
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repRNA
rRNA
100±17.7

85±8.2
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B PE localization in wild type andvps34∆ yeast strain during replication

PE
(Duramycin)

mRFP-p33+
Pex13p-GFP mRFP-p92+DI72

WT

vps34∆

Fig. 6.1
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Fig. 6.1 VPS34 is required for efficient TBSV replication in yeast and is involved in PE
enrichment at the site of replication.
(A) TBSV replication in WT or vps34∆ strain was induced by expression of TBSV His6p33 and His6-p92 under the galactose-inducible GAL1 promoter and DI-72 (+)repRNA
from the galactose-inducible GAL10 promoter at 23°C for 24 hours. Northern blot
analysis of DI-72 accumulation or 18S rRNA accumulation was shown in upper panels.
DI-72 accumulation data was normalized based on 18S rRNA. Each experiment was
repeated three times. Lower panels: Western blot of TBSV p33, p92 or Flag-tagged
Vps34p was performed using anti-HIS or anti-Flag antibodies. Total protein was shown
as loading control. (B) Confocal microscope images showed that PE was not enriched at
sites of replication in vps34∆ yeast. See further description of yeast growth condition in
Fig. 5.2, PE detection method in Fig. 5.3.
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A VPS34/PI3K inhibitor (AS604850) in yeast inhibit TBSV replication
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B VPS34/PI3K inhibitor (AS604850) in plant protoplasts inhibit TBSV full genome replication
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Fig. 6.2 PI3K inhibitor AS604850 inhibits positive strand RNA viruses replication.
(A) AS604850 inhibited TBSV repliation in yeast at different concentrations. Notably at
4µM, AS604850 inhibited TBSV repRNA accumulation to ~13% comparing to that of
adding solvent DMSO alone. See further detail of RNA and protein blot in Fig. 6.1A (B)
Genome replication of TBSV in plant protoplasts was inhibited by AS604850, as shown
by RNA blot analysis of genomic TBSV RNA as well two sub-genomic RNA generated
during TBSV genomic RNA replication (Upper panel). Lower panel: ribosomal RNA
stained by ethidium bromide was shown as a loading control.
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A. Vps34p complexs in yeast (adapted from Biochem. J. (2008) 410, 1–17)
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B TBSV DI-72 replication in yeast lacking components of the Vps34 complexs
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C CNV-driven DI-72 replication in yeast lacking components of the Vps34 complexs
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92.8±11.1

%repRNA

Fig. 6.3 Dissecting the function of different Vps34p complexes in tombusvirus
replication.
(A) A cartoon illustration of Vps34p complexes as proposed by Jonathan M. Backer
(292).(B) TBSV repRNA replication in wild type, vps15∆, vps30∆, atg14∆ or vps38∆.
Upper panel: RNA blot of repRNA accumulation and 18S rRNA accumulation. Lower
panel: Protein analysis of TBSV p33, p92 See further detail about growth condition and
RNA or protein blot on Fig. 6.1A. (C) DI-72 replication by CNV His6-p33 and His6-p92
driven under the galactose-inducible GAL1 promoter.
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A Vps34p-mRFP co-localizes with TBSV replicase complex
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B Vps34p-mRFP localizes to peroxisome during TBSV replication
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Fig. 6.4 Confocal laser microscope analysis of Vps34p localization during TBSV
replication in yeast.
(A): Vps34p-mRFP is localized to site of TBSV replication visualized by GFP-tagged
p33 expression in vps34∆ yeast strain. (B) Vps34p-GFP is localized to peroxisome during
TBSV replication in yeast.
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Fig. 6.5 Split-ubiquitin based Y2H assay to test viral protein interaction with Vps34p.
(A) Bait protein TBSV p33 was used to test the interaction with Vps34p tagged with Nterminal half of ubiquitin (NubG) on its N-terminal or C-terminal. (B) Bait protein TBSV
p92 was used to test the interaction with Vps34p.
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Fig. 6.6 GFP-p33/p92 and a peroxisomal matrix protein Pot1p were analyzed for
accumulation during TBSV repRNA replication in wild type and vps34∆ yeast strains.
(A) Western blot analysis of GFP-p33/p92 of yeast cells with or without induction
repRNA replication Both anti-HIS and anti-GFP antibody were used. Note that: free GFP
was detected when using anti-GFP antibody in wild type yeast with repRNA replication.
(B) Western blot analysis of Pot1p, mitochondria porin, ER membrane protein Sec61p
and cytosolic protein PGK of samples prepared as in Fig. 6.6A. No significant change of
Pot1p accumulation was observed in wild type cells with viral protein expression.
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Chapter 7

CONCLUSION AND PERSPECTIVE

7.1 Conclusion

(+)RNA virus replication can take place on alternative organellar membranes. In
Chapter 2, we demonstrated that in a cell-free environment, peroxisome/ER-based
tombusvirus TBSV could utilize mitochondrial membrane to assemble replicase
complexes, supporting asymmetric replication of (+)repRNA. While mitochondria-based
CIRV could use ER membrane for assembly of replicase complexes only inefficiently.
The ability of using ER or mitochondria membranes depended on the p33/p36 region of
TBSV/CIRV replicase protein. Despite the C-terminal RdRp region coming from TBSV
p92 or CIRV p95, p33 prefers ER and p36 prefers mitochondria to assemble the replicase
complexes. The difference might come from co-evolution of TBSV or CIRV with
different cellular membrane environments, however, it was surprising that TBSV or
CIRV have the potential to explore alternative sub-cellular membranes for viral
replication. Thus these viruses are more flexible in exploiting various membranes as
previously anticipated.
Cymbidium ringspot virus (CymRSV) is a tombusvirus closely related with
TBSV, replicating on peroxisome membrane. Previous study using chimeric viruses
made between CymRSV and CIRV also suggested swapping a small N-terminal region of
CIRV p36/p95 with CymRSV p33/p92 could led to a recombinant CymRSV (majority of
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genome from CymRSV which replicates on peroxisomal membrane ) to replicate on
mitochondrial outer membrane (114). While replacing the N-terminal region of CIRV
p36/p95 with CymRSV p33/p92 could make a recombinant CIRV replicating on
peroxisome (114). Although this study suggested that recombination event could change
the sub-cellular replication site, it was still not answered if a non-modified tombusvirus
could explore an alternative sub-cellular membrane for replication. Later studies on the
N-terminal region of CymRSV (8) or CIRV (19) replication proteins proposed that this
region contains perixosome or mitochondria targeting sequences as well as two transmembrane domains.
Similar study of changing sub-cellular replication site by modifying replicase
protein was shown with an animal virus, Flock house virus (FHV). By replacing
mitochondria targeting domain in FHV RdRp Protein A with three different types of ER
targeting sequences, the replication of FHV was re-targeted from mitochondrial outer
membrane to ER membrane (308). Surprisingly the replication of FHV increased when
FHV was replicating on ER membrane.
Are the sites of replication of (+)RNA viruses simply decided by the organelle
targeting sequence in their replication proteins? Or are other motifs in (+)RNA virus
replication proteins also important for choosing the replication sites? In my studies in
Chapter 2, when TBSV or CIRV replicase proteins were simply mixed with purified
organellar membranes without a cellular targeting event, the wild type viral replicase
proteins could utilize different organelles for viral replication, suggesting that the native
replicase proteins have the ability of using an alternative membrane. However, their
preference in using the native organellar membranes also suggested that non-organelle
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targeting motifs of the replicase proteins could be co-evolved within the native membrane
environment and contribute to selectivity of (+)RNA virus replication sites. It is also
possible that viruses use the alternative membranes when the original membranes are
becoming saturated with viral proteins during late infection.
Studies of TBSV or CymRSV also showed that genetic modification of a host cell
could also lead to change in viral replication site. Pex3p is a peroxisomal membrane
protein which controls peroxisome biogenesis (309). Deletion of PEX3 abolishes
peroxisome biogenesis and relocates replication site of TBSV or CymRSV from
peroxisome to ER (15, 32) in yeast model host. Recent study also showed that in the
absence

of

an

important

lipid

biogenesis

gene,

PAH1

(phosphatidic

acid

phosphohydrolase), TBSV replication switched from peroxisome to ER (310).
These studies discussed above including my study in chapter 2 suggest an
emerging picture that (+)RNA viruses have the ability of using alternative replication
sites in host cell (Summarized in Fig. 7.1). Such event could be observed in cell-free
environment (9), viral protein recombination/modification (114, 308) or genetically
altered host cell (15, 32, 310).

TPR domain containing protein Sti1p inhibits CIRV replication. Previous work showed
that some members of TPR-containing protein family act as cell-intrinsic negative
regulators of tombusviruses replication (109, 150). Study on Sti1p which inhibited CIRV,
not TBSV, replication provided a more detailed picture on how these TRP-containing
proteins, often Heat shock protein 70 co-chaperones, affect tombusviruses replication.
Specificity of Sti1p's inhibition of CIRV replication could provide more information on
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CIRV replication protein targeting and replicase assembly process on mitochondria outer
membrane, and emphasize importance of further analysis of more proteins from this
TPR-containing proteins family.

PE is required for TBSV replication. Utilizing a novel artificial vesicle-based cell-free
replication system, different phospholipids showed different effects in three steps of
TBSV replication: 1) viral replication protein association with membranes, 2) viral RNA
recruitment by viral replication proteins to membranes, 3) asymmetric viral RNA
replication. PE was the only phospholipid capable of supporting all three processes.
These findings suggested that sub-cellular membrane is not simply a bilayer platform that
functions as a scaffold, different head groups of different lipids may directly interact with
viral replication proteins to stimulate their RdRp activity, or may introduce membrane
curvature (For example, negative membrane curvature introduced by PE) which is
favored for viral RdRp activity.

Finding pathway for PE re-localization to the site of viral replication. Building up of
PE enriched micro-environment by TBSV replication protein p33 was a surprising
finding, suggesting that heavy modification of phospholipid transportation could be
achieved by a single viral protein expression in a host cell. Finding the exact pathway of
p33 induced PE enrichment to peroxisome could pioneeringly contribute to
understanding of the cell biology of virus infected cell.
To hijack an PE synthesis pathway to build up PE enriched micro-environment,
could require recruitment of PE synthesis enzyme/s to peroxisome, and also need PS or
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CDP-ethanolamine, the precursors of PE synthesis in two different pathways, to be
funneling to peroxisome. By deleting different PE synthesis genes, we concluded that no
single PE synthesis pathway directly contribute to the virus-driven PE enrichment in
peroxisomes. I have demonstrated that vesicle transport pathway is involved in PE
enrichment in peroxisome driven by TBSV p33.
I provide multiple evidence supporting that TBSV p33/p92 are indeed targeted to
post-Golgi compartment. Inhibition of p33/p92 secretion from ER to golgi inhibited
TBSV replication suggesting post-Golgi p33 is essential for efficient viral replication.
TGN localization of p33 as well as abolishment of PE enrichment in tlg2∆ yeast strain
suggested that post-golgi p33 may directly induce PE enrichment in peroxisome through
vesicle transport pathway.

7.2 Perspective

PE source for TBSV replication. PE is an important lipid for autophagy pathway.
Lipidation of LC3 (Atg8p) requires covalently linking its molecule with PE, and serves as
marker for autophagy event (247, 298). However membrane source of preautophagosomal structure (PAS) was extensively studied and still remains unclear (244,
246, 247, 249, 251). By studying the role of VPS34 and associated components in TBSV
replication, we learned that autophagy is unlikely required for TBSV replication.
By utilizing yeast genetics as well as cell biology tools, we were able to narrow
down certain pathway/s affecting PE enrichment in peroxisome. Current results
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suggested vesicle transport pathway is involved in PE enrichment. Next question is
WHY?
Aminophospholipid flippase could be involved in PE enrichment at peroxisome.
Aminophospholipid flippases belong to P4 subfamily of P-type ATPases, which
introduce phospholipid asymmetry on different sides of membrane bilayer (282). There
are five P4 ATPase in yeast with overlapping functions, namely Drs2p, Dnf1p, Dnf2p,
Dnf3p, and Neo1p (282). Dnf1p and Dnf2p are localized primarily at plasma membrane
(311), Drs2p and Dnf3p are mostly localized at TGN (312), while Neo1p is mainly
localized at endosomes (313). Nele Alder-Baerens and co-workers showed that
phospholipid asymmetry exists on post-Golgi vesicles, including up to 80% of PE on the
cytosolic leaflet of the total post-Golgi vesicles, while deletion of Drs2p and Dnf3p could
abolish most of the PE asymmetry (282).
PE is the pro-fusion kind of phospholipid, which facilitates vesicle fusion into
membrane bilayer (57, 314, 315). It could be that by hijacking post-Golgi vesicles
generated from TGN or endosomes with enriched PE at cytosolic leaflets, TBSV might
build up PE enriched micro-environment on peroxisomal membranes. This hypothesis
fits to the current results that vesicle transport rather single PE synthesis pathway is
required for PE enrichment in peroxisome. However since the asymmetric distribution
could not change the overall PE content on post-golgi vesicles, this hypothesis could not
directly explain why PE is enriched in peroxisome as observed under the confocal laser
microscope, unless other cellular host factors also contribute to this hypothetic pathway.
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Role of Vps34p during TBSV replication. Vps34p forms complexes with Vps15p,
Vps30p and Vps38p at late golgi, late endosome and vacuole to regulate vesicle transport
(295, 297, 298). A major organizer of endosomal and vaclular membrane/protein sorting
is phosphoinositide phosphatidylinositol-3-phosphate (PI3P), a product of Vps34p,
serving as a molecular signal (316). PI3P is predominantly localized at late endosome or
in multivesicle bodies (MVB), and recruits many effectors containing PI3P binding
domains, such as PX (Phox homology) and FYVE (Fab1, YOTB, Vac1, EEA1) domains
(317). These effectors facilitates various membrane rearrangement events as the
retromer-coated tubules budding (SNX1,2,6,27), the fusion of endosomes (EEA1) and the
ESCRT-dependent intraluminal sorting of ubiquitinated cargos in multivesicular
endosomes (Hrs) (316).
The accumulation of Vps34p at peroxisome was especially interesting, since one
role of Vps34p on peroxisome is to induce pexophagy. However no macro-autophagy
events was induced upon TBSV replication (Fig. 6.6). If PI3P on peroxisome membrane
does not facilitate autophagy, it might instead recruits those effectors which have PI3P
binding modules and introduce various endosome/ multivesicle bodies (MVB) -like
events. One of the ESCRT-I component Vps23p was recruited to peroxisome upon TBSV
replication (81). ESCRT factors, including Vps23p, Vps24p, Snf7p and Vps4p have been
shown to help TBSV assemble replication complexes by introducing membrane
invagination (81). CIRV could also recruit Vps23p to mitochondria upon infection (318).
Very interestingly, these invaginated peroxisomes or mitochondria upon tombusvirus
infections possessed MVB-like morphology, and were once called MVB by scientists
(114). Vps23p has been shown to bind to p33 or p36, however the binding sites between
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Vps23p and these viral replication proteins were quite different (81, 86, 318). N-terminal
ubiquitin E2 domain of Vps23p was shown to bind to p33 depending on ubiquitination of
two lysine sites N-terminals of p33 and a "late domain" between two trans-membrane
domains (86). However, Vps23p C-terminal steadiness box domain showed ability to
bind to N-terminal 16 amino-acid long sequence in CIRV p36 (318). Lack of conserving
binding domain of vps23p to two related tombusviruses replication proteins may
suggested a possibility that this binding maybe a result rather than a cause of vps23p
recruitment.
ESCRT-I components are involved in ubiquitin-dependent sorting of proteins into
the endosome/MVB (319), and Vps34p/PI3P controls ESCRT-I dependent intraluminal
sorting into MVB (316). It is possible that Vps34p/PI3P controls the ESCRT-I
recruitment to viral replication sites.
Since CIRV replication on mitochondria also led to PE enrichment (Chapter 4)
and required Vps34p (Fig. 6.2), it is possible that PI3P serves as molecular signal on
peroxisome or mitochondria to recruit ESCRT factors and other effectors which leads to
PE enrichment and membrane invagination. It is quite interesting that PE possesses a
physical property which favors negative curvature during formation of virus-induced
spherules in peroxisomes or mitochondria, suggesting that membrane invagination
introduced by ESCRT might be accompanied with PE enrichment.
PE was also shown to be enriched at site of Nodamura virus (NoV) replication
(Chapter 4). At early stage of NoV infected muscle cells of suckling mouse, membrane
invagination on mitochondria outer membrane (or vesiculation of mitochondria outter
membrane) was observed (224), suggesting PE might play a common role for membrane
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invagination. Interestingly, PI3P inhibitor also inhibited NoV replication (Fig. 6.2C),
suggesting function of Vps34p during NoV replication could also be similar to its
function in TBSV or CIRV replication.
In summary, we found that p33 was transported to TGN through COP-II
dependent vesicle transport from ER, and peroxisome possibly via pex19p mediated
proxisomal protein targeting (107). We hypothesize that TGN localized p33 as well as
peroxisome localized Vps34p may induce vesicle transport from TGN and endocytic
pathway to peroxisome, lead to a MVB-like peroxisome in TBSV replicating cells as well
as PE enrichment in peroxisome ( Summarized in Fig. 7.2).

Role of secretory pathway. Current studies (235, 236) on trans-membrane protein sorting
through early secretory and endocytic pathways shed a light on our understanding of
(+)RNA virus RdRp function. Most of the (+)RNA virus RdRp or their auxiliary proteins
are membrane associated, and their function depends on their sub-cellular association
with membrane (20).
Membrane proteins accounts for 20-30% of the total protein products produced
from eukaryotic genome (320). Their sorting were believed to be contributed by motifs
residing on cytosolic part of the protein (321), however trans-membrane domain of these
proteins also received attentions for their functions in determining protein localization
and transport (235, 236). TMDs were shown to function in ER retention, golgi or plasma
membrane localization and sorting through endocytic pathways [reviewed in (235)]. The
sorting function of TMDs together with cytosolic organellar targeting signals on viral
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replication proteins could explain various sub-cellular locations of (+)RNA viruses
replication sites.
Current progress showed that early secretory pathways are involved in (+)RNA
virus replication (33, 72, 226-228, 232, 322). Despite that other viral factors may join and
modify ER membranes as well as early secretory pathway, TMDs within viral replication
proteins could be a driving force of (+)RNA viruses to find the replication site on cellular
membranes during evolution.
(Copyright © Kai Xu 2014)
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Fig. 7.1 Alternative replication sites found for different (+)RNA viruses.
Solid lines show original replication sites for TBSV, CymRSV, CIRV and FHV. Dotted
lines show alternative replication sites of these (+)RNA viruses in different experimental
systems.
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Fig. 7.2 Working Model for sub-cellular transport of TBSV replicase proteins.
Portion of TBSV p33 and p92 molecules translated on ER or in cytoplasm are transported
directly to peroxisome, while part of p33/p92 are transported to TGN and beyond through
COP-II dependent early secretory pathway. Dotted lines suggest a proposed role played
by p33, in which p33 induces vesicle transportation from TGN or early endosome (EE) to
peroxisome, and thus produce MVB-like structures as well as PE enriched microenvironment. See text for further detail and possible role of Vps34p in this model.
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